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CHAPTER 1 
General IntroducƟ on
8  |  Chapter 1
Tuberculosis (TB) is an infecƟ ous disease caused by the bacterium Mycobacterium tuberculosis. 
The most frequent clinical manifestaƟ on of the disease is pulmonary TB, but it can aī ect any part 
of the body (extra-pulmonary TB), including the skin, lymph nodes, spine, joints, genitourinary 
tract, nervous system, and gastrointesƟ nal tract.[1]
 TB is an old disease. It existed in ancient Egypt; historical records show that pathological signs 
of TB were present in a mummy daƟ ng back to 2400 BC.[2] An eī ecƟ ve treatment for TB only 
became available in the 1940s, when the fi rst anƟ -TB drug streptomycin was discovered.[3]
 The use of anƟ -TB drugs, together with improved socio-economic condiƟ ons and systemaƟ c 
control of TB in many Western countries, led to a fi rm belief in the 1980s that TB had been 
conquered and that priority status was no longer jusƟ fi ed for the disease.[4,5] However, 
the emerging HIV epidemic in Africa in the laƩ er half of the 1980s caused a second wave TB 
epidemic that increased at an alarming speed due to TB-HIV co-infecƟ on. MulƟ -drug resistant 
TB (MDR-TB) concurrently emerged in several countries due to poorly organized TB services.[3] 
As a result, the World Health OrganizaƟ on (WHO) declared TB a global emergency in 1993,[6,7] 
which boosted internaƟ onal eī orts to curb the TB epidemic. WHO and the InternaƟ onal Union 
against Tuberculosis and Lung Diseases (IUATLD) introduced the direct observed treatment short 
course therapy (DOTS) strategy.[8] The Stop TB Partnership was established in 2000 as a global 
movement to accelerate social and poliƟ cal acƟ on aimed at stopping TB.[9] ReducƟ on of the TB 
burden has also been part of the Millennium Development Goals (MDGs) that aim to halt and 
reverse the incidence of TB by 2015. A substanƟ al amount of internaƟ onal funding has been 
secured and channeled through the Global Fund iniƟ aƟ ve since 2002. However, despite all of 
these eī orts, TB remains a major global health threat and a leading cause of death from curable 
infecƟ ous disease worldwide, especially in Africa and Asia.[9] As the country with the fi Ō h highest 
TB burden, Indonesia had an esƟ mated 430,000 new cases in 2009, with an esƟ mated mortality 
of 62,000.[10] TB was the second leading cause of death in Indonesia in 2009.[11]
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1.1 | TB EPIDEMIOLOGY
M. tuberculosis was fi rst described as the causaƟ ve agent of TB by Robert Koch in 1882. It is a 
bacillus with an acid/alcohol fast staining property and a unique cell wall structure that provides 
a lipid barrier responsible for the bacteria’s virulence, growth rate, development of resistance to 
anƟ bioƟ cs, and host defense mechanisms. The bacilli have a slow growing rate, are capable of 
intracellular mulƟ plicaƟ on, and are resistant to harsh physio-chemical environments, in which 
they can remain dormant as a latent infecƟ on.[12]
 A person with pulmonary TB can transmit TB bacilli through small airborne droplets, called 
droplet nuclei, when the person sneezes, coughs, sings, or talks. The infecƟ ous droplet nuclei 
can remain airborne for hours aŌ er expectoraƟ on.[13] AŌ er being inhaled by a non-infected 
person, the infecƟ ous droplets have to overcome the physical defense of the respiratory tract. 
When the bacilli pass this defense system and reach the alveoli in the lungs, they are taken up 
by macrophages, iniƟ aƟ ng a chain reacƟ on of cell-mediated immune response.[8,12] In a person 
with a good immune response, the bacilli can be contained in necroƟ c lesions, which undergo 
fi brosis and calcifi caƟ on, resulƟ ng in latent infecƟ on.[12] In a less immune competent person, 
the infecƟ on can progress to acƟ ve TB, in which a lung cavity is formed, breaking into the bronchi 
as the necrosis reacƟ on expands. When this reacƟ on occurs, the host becomes an infecƟ ous 
individual with smear-posiƟ ve sputum upon microscopic examinaƟ on. Approximately 50-80% of 
all smear-posiƟ ve TB paƟ ents will die in the absence of treatment.[14]
 An esƟ mated 5-10% of infected persons develop acƟ ve TB during their lifeƟ me.[12] The risk 
of acƟ ve TB increases to 15% annually among TB-infected HIV-posiƟ ve paƟ ents in the absence of 
anƟ -retroviral treatment.[15] The risk also increases under condiƟ ons that compromise the host 
immune system, e.g., malnutriƟ on, extensive corƟ costeroid therapy, diabetes mellitus, or cancer 
chemotherapy.[8] The risk of extra-pulmonary TB is approximately 20% in immune-competent 
individuals, but the risk is higher among HIV-posiƟ ve TB paƟ ents.[8,9] The more common forms 
of extra-pulmonary TB include pleural eī usion, lymphadenopathy, pericardiƟ s, and involvement 
of the spine, bones and joints, central nervous system (meningiƟ s or cerebral tuberculoma), or 
gastrointesƟ nal system.[8] Another fatal form of extra-pulmonary TB is disseminated or miliary 
TB. The bacilli spread throughout the body via the blood, leading to mulƟ -organ involvement.[12] 
The clinical manifestaƟ on of pulmonary involvement is a miliary, rather than infi ltrate, paƩ ern. 
Mortality is high despite chemotherapy and may be related to delays in diagnosis and underlying 
medical condiƟ ons.[8]
 In countries in which the TB transmission rate is high or stable for many years, the incident 
cases are highest among young adults due to recent infecƟ on or re-infecƟ on. As the rate of 
transmission falls, new TB cases shiŌ  to older age groups and are mostly due to re-acƟ vaƟ on of 
a latent infecƟ on.[16] TB occurs more frequently among males in many countries, possibly due 
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to the fact that females have less access to health faciliƟ es, but it may also refl ect the underlying 
epidemiological diī erences between males and females with regard to infecƟ on exposure and 
suscepƟ bility to disease.[17]
 The WHO esƟ mates that one-third of the world populaƟ on has been infected with M. 
tuberculosis. Globally, 14 million TB cases were reported in 2009, approximately 9.4 million of 
which were new TB cases. Among HIV-negaƟ ve individuals, 1.3 million deaths were caused by 
TB.[10] More TB cases exist today than at any other Ɵ me in history,[5] and the absolute number 
of cases conƟ nues to increase slightly from year to year. Most cases occur in Asia and Africa 
(55% and 30%, respecƟ vely). Approximately 50% of the new cases were in the fi ve highest 
burden countries: India, China, Nigeria, South Africa, and Indonesia.[10] The case detecƟ on rate 
(CDR), defi ned as all cases detected out of the esƟ mated incident cases, was 63% in 2009 and is 
equivalent to 5.8 million noƟ fi ed TB cases.[10]
 In 2009, an esƟ mated 12% (1.1 million) of TB paƟ ents globally were co-infected with HIV. 
Countries in sub-Saharan Africa have the highest co-infecƟ on rate at approximately 37% of TB 
cases. Approximately 80% of TB-HIV co-infecƟ ons were in the African region. The number of TB 
deaths among new TB paƟ ents with an HIV-posiƟ ve status was esƟ mated to be 0.4 million in 
2009.[10]
 The number of MDR-TB, which is defi ned as TB cases with resistance to two anƟ -TB drugs 
(isoniazid and rifampicin),[18,19] was esƟ mated at 440,000 cases in 2008. Currently, 27 countries 
(including 15 countries in Eastern Europe) are considered as having a high MDR-TB burden.[10] 
The more advanced form of anƟ -TB drug resistance is referred to as extensive drug-resistant 
TB (XDR-TB), defi ned as resistance to isoniazid, rifampicin, and fl uoroquinolone, a second line 
injectable anƟ -TB drug. This condiƟ on is virtually untreatable with currently available anƟ -
TB drugs. A study in South Africa found that 70% of XDR cases die within 30 days of sputum 
collecƟ on for culture examinaƟ on, and the death rate increases to 98% in 7 months.[20] By July 
2010, 58 countries and territories had reported at least one case of XDR-TB.[10] The true scale of 
the MDR/XDR TB problem, however, remains uncertain. A lack of laboratory capacity to idenƟ fy 
drug-resistant TB hinders many countries from reporƟ ng such cases.[10]
1.2 | TB CONTROL
The framework for TB control is based on the epidemiological model of the natural history of 
the disease (Figure 1.1).[22] Case management has always been the focus of TB control because 
it reduces the risk of death, restores health, and prevents further transmission.[21,22] Most 
intervenƟ on technologies used in TB control today are based on technologies used in the 19th 
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and 20th centuries, such as sputum smear microscopy examinaƟ on, the tuberculin skin test (TST), 
BCG vaccine, and most TB drugs. 
TB diagnosƟ cs
In many high burden countries, microscopic examinaƟ on of sputum, a technique that was used 
by Robert Koch when he discovered M. tuberculosis, is the only available TB diagnosƟ c test. The 
method is cheap, fast, and highly specifi c, but sensiƟ vity is low, especially among HIV-posiƟ ve 
individuals.[23,24] Culture of TB bacilli in Löwenstein-Jensen (LJ) media is currently the gold 
standard for TB diagnosis, but it takes 6-8 weeks, which limits the usefulness of culture as a 
fi rst line diagnosƟ c test.[21] To diagnose TB infecƟ on, Koch introduced a technique to inoculate 
anƟ gens produced from killed tubercle bacilli, called the tuberculin skin test (TST).[13] The 
test is performed by intradermally injecƟ ng purifi ed protein derivaƟ ve (PPD) containing fi ve 
tuberculin units; a posiƟ ve result is demonstrated by induraƟ on at the site of injecƟ on aŌ er 48 
to 72 hours.[12] The test is essenƟ al for understanding the dynamics of tuberculosis epidemics 
in the community, but the sensiƟ vity and specifi city are infl uenced by cross-reacƟ on with 
environmental mycobacteria and previous BCG vaccinaƟ on.[12,13]
Figure 1.1 | The framework of TB control based on the epidemiological model of the natural history of 
TB.[22] 
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Through the FoundaƟ on for InnovaƟ ve New DiagnosƟ cs (FIND), the WHO supports the 
development of new TB diagnosƟ c tests using modern technologies. Sputum processing, 
fl uorescence microscopy, and a light emiƫ  ng diode (LED) lighƟ ng source are improvements 
to exisƟ ng microscopic examinaƟ on.[23,25,26] A liquid culture system that detects the CO2 
producƟ on or O2 consumpƟ on of the bacilli has been developed to reduce the Ɵ me needed 
in convenƟ onal culture methods.[23,27] A new nucleic acid amplifi caƟ on test (NAAT) based TB 
diagnosƟ c termed MTB/RIF was recently endorsed by the WHO.[28] The NAAT test provides 
sensiƟ vity comparable to culture but leads to results in less than 2 hours. The test can also be 
used to detect mulƟ -drug resistance.[29] Furthermore, the test performs beƩ er than other 
convenƟ onal tests in terms of safety, contaminaƟ on, and ease of use.[28] Interferon gamma 
release assays (IGRAs) are an aƩ racƟ ve alternaƟ ve to TST as a diagnosƟ c test for latent infecƟ on; 
it has higher specifi city than TST and is not aī ected by BCG vaccinaƟ on.[30] Despite the progress 
in diagnosƟ c technology, researchers are sƟ ll challenged to explore specifi c biomarkers to develop 
a simple, inexpensive point of care test for TB.[31] A point of care test, which is defi ned as a 
simple and rapid test that can be applied easily in a primary health care seƫ  ng without extensive 
technical support, would markedly reduce diagnosƟ c delay and improve disease outcomes.
TB drugs
The WHO currently endorses a 6 to 8-month short course regimen with a fi xed dose combinaƟ on 
(FDC). Treatment is divided into two phases: an iniƟ al phase for 2 months followed by a 
conƟ nuaƟ on phase of 4 months. Only a limited number of anƟ -TB drugs are available today. 
WHO lists fi ve essenƟ al drugs as fi rst line anƟ -TB drugs against M. tuberculosis: isoniazid (H), 
rifampicin (R), pyrazinamide (Z), ethambutol (E), and streptomycin (S)). The preferred regimen 
is isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE) three Ɵ mes a week during the 
iniƟ al phase, followed by isoniazid and rifampicin (HR) daily or three Ɵ mes a week during the 
conƟ nuaƟ on phase.[32,33] The alternaƟ ve regimen is isoniazid, rifampicin, pyrazinamide, and 
ethambutol (HRZE) daily during the iniƟ al phase, followed by isoniazid and ethambutol (HE) daily 
for 6 months. The current WHO policy is to phase out this alternaƟ ve regimen due to a lack 
of evidence regarding a diī erence in the failure or relapse rate between daily and three Ɵ mes 
weekly regimens.[32,33] Isoniazid is the drug of choice for prophylacƟ c or prevenƟ ve therapy. 
Evidence suggests that isoniazid prevenƟ ve therapy (IPT) combined with highly acƟ ve anƟ -
retroviral (HAART) treatment provides a 76% to 89% reducƟ on in TB risk among HIV-infected 
individuals in countries with a high TB burden.[34,35] The eī ect of isoniazid as a prophylacƟ c or 
prevenƟ ve therapy on tuberculosis incidence may be due to the treatment of early, subclinical M. 
tuberculosis infecƟ on. Isoniazid has been reported to improve the host immune response, which 
may provide long-term protecƟ on.[36]
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TB vaccines
No eī ecƟ ve vaccine yet exists to prevent adult pulmonary TB. Bacille CalmeƩ e-Guerin (BCG) 
vaccine, which was introduced in 1921, is the only available TB vaccine. The vaccine provides 
good protecƟ on against miliary and meningeal TB early in life, but it does not oī er protecƟ on 
against adult pulmonary TB. New TB vaccines are on the horizon, with approximately 10 vaccine 
candidates currently in the clinical trial stage. These vaccine candidates aim at replacing BCG or 
enhancing BCG-induced immunity.[37]
TB global strategy
The MDGs for TB control are to halt and begin to reverse the incidence of TB by 2015.[38] The 
Stop TB Partnership has set two addiƟ onal targets: to halve TB prevalence and death rates by 
2015 compared to the levels in 1990, and eliminaƟ on of TB by 2050.[9,38] To achieve these 
goals, the WHO has endorsed the DOTS strategy, which was launched in 1994 following the 
announcement of TB as a global emergency. DOTS has also become a brand name for a policy 
package with fi ve pillars[3,38]:
1. PoliƟ cal commitment,
2. Quality-assured sputum microscopy,
3. Uninterrupted supply of anƟ -TB drugs,
4. Standardized short-course chemotherapy for all TB cases under directly observed treatment 
(DOT),
5. Recording and reporƟ ng system.
The DOTS strategy was well accepted internaƟ onally. The World Bank considered this strategy 
the most cost-eī ecƟ ve intervenƟ on in health. As a result, internaƟ onal organizaƟ ons, countries, 
and donors support this strategy. The TB control program has gained global momentum, and 
119 countries had adopted the DOTS strategy in their naƟ onal TB control programs by 1998. To 
achieve the MDG target in 2015, the WHO, in the Global Plan to Stop TB 2001-2005, called for 
program expansion to meet the immediate target of 70% CDR among the esƟ mated infecƟ ous 
cases, and successfully treat 85% of the detected cases. The CDR increased markedly from 35% 
in 1995 to 57% in 2005. The rate stabilized at around 60% in 2008, but sƟ ll has not met the target 
of 70% CDR.[10,39] With the increase in TB-HIV co-infecƟ on and MDR-TB, and to accelerate the 
case detecƟ on rate, the Global Plan to Stop TB 2006-2015 addresses the challenge of TB-HIV 
co-infecƟ on and MDR-TB acƟ viƟ es. Case detecƟ on was also intensifi ed through the involvement 
of all health care providers using a public-private mix approach, and by integraƟ ng TB case 
detecƟ on into a broader respiratory case management strategy, the ‘PracƟ cal Approach to Lung 
Health’ (PAL) approach (WHO 2006). The Global Plan also addressed the need for strengthening 
the health system. Evidence indicates that a strong health system is a prerequisite for reaching 
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the MDGs [40-42], and there is a growing consensus that the health system in many developing 
countries is too fragile and fragmented to deliver the volume and quality of services needed.[41]
1 .3 | CAREͳSEEKING BEHAVIOR
The care-seeking behavior of paƟ ents with disease is crucial for many control programs. The fact 
that people do not engage in an expected health behavior has been discussed and documented 
frequently.[43] Several concepts and theories exist about such behavior in psychology (e.g., 
theory of planned behavior, reasoned acƟ on, and health belief model),[43,44,45] sociology (sick 
role and illness behavior), and anthropology (temporal model of stages in medical care).[46] One 
thing is certain, care-seeking behavior involves complex inter-relaƟ ng factors, which diī er from 
one context to another.
 Care-seeking behavior also plays a criƟ cal role in TB control program and is considered one 
priority area in the operaƟ onal research of TB programs,[47] parƟ cularly because TB control 
program use passive case detecƟ on. Styblo, who developed the foundaƟ on for the DOTS 
strategy, argued that a paƟ ent with TB symptoms is usually ill enough to seek treatment.[48] 
Furthermore, acƟ ve case detecƟ on is not considered cost eī ecƟ ve.[49] However, various studies 
have shown that a high proporƟ on of TB paƟ ents go to private health providers.[50-52] Private 
health providers correlate with several unsuccessful consultaƟ ons involving several providers, 
increasing the risk of longer diagnosƟ c delay.[52-57] A longer diagnosƟ c delay is associated with 
increased disease severity, increased risk of further transmission, and poor prognosis of disease 
outcome.[58-60]
 DiagnosƟ c delay is defi ned as the duraƟ on between the reported onset of TB symptoms and 
the Ɵ me of TB diagnosis. It consists of two components: paƟ ent delay and health system delay. 
PaƟ ent delay is usually defi ned as the duraƟ on between the reported onset of TB symptoms 
and fi rst contact with health care providers, parƟ cularly medical health providers. Health system 
delay is usually defi ned as the delay from the fi rst contact with medical health providers to 
diagnosis or iniƟ aƟ on of anƟ -TB treatment. Some consider health system delay as provider or 
doctor delay or health services delay and use the terms interchangeably.[3,61]
1.4 | TB CONTROL IN INDONESIA
Historically, TB control in Indonesia can be traced back to the pre-independence era, before 
1945. The fi rst naƟ onal TB control program was iniƟ ated in 1969.[62] From 1972 to 1995 the 
TB control program was implemented at the primary health care level on an ambulatory basis. 
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AŌ er a successful implementaƟ on of the pilot DOTS strategy in three provinces, the Indonesia 
Ministry of Health adopted and started to scale up the DOTS strategy naƟ onally in 1995. From 
1995 to 2000, naƟ onal guidelines for TB control applying the DOTS strategy were implemented in 
health centers. StarƟ ng in 2000, the TB program in Indonesia accelerated DOTS implementaƟ on 
naƟ onwide and started to involve public and private hospitals as a part of a public-private mix 
(PPM) policy. Since 2003, the PPM strategy was scaled up naƟ onwide. During seven years of 
implementaƟ on, 563 of 1478 hospitals were involved in the TB control program, with an average 
of 80 hospitals per year.[63]
 As a result of this systemaƟ c eī ort, TB prevalence reduced three-fold over a period of 25 
years (from 317/100,000 to 104/100,000 in 2004).[64] The 70% CDR target was met naƟ onally 
in 2006. Treatment successes above 85% were maintained from 2000 onwards.[65] However, 
much eī ort is sƟ ll needed. Indonesia has diī erent epidemiological seƫ  ngs and health system 
performance varies across the country. In 2004, a naƟ onal TB prevalence survey showed marked 
geographical diī erences in prevalence between Java/Bali and the eastern part of Indonesia 
(59/100,000 versus 189/100,000, respecƟ vely).[64] Clustered TB cases, which may indicate 
barriers to health care access, were also found in eastern Indonesia. 
 Though Indonesia was iniƟ ally considered as a country with a low prevalence of HIV with a 
concentrated epidemic, the prevalence of HIV has increased at an alarming speed over the past 
few years. The esƟ mated HIV prevalence was 0.1% in 2001 and doubled to 0.2% in 2007.[66] 
The esƟ mated number of people living with HIV increased dramaƟ cally from 93,000 in 2001 to 
270,000 in 2007.[66] The prevalence among risk groups is highest among injecƟ ng drug users 
(IDUs), prisoners, transvesƟ tes, partners of IDUs, and sex workers, with a prevalence of 26.8%, 
12.0%, 11.8%, 8.9%, and 3.6%, respecƟ vely.[67] The number of AIDS cases has increased 15-Ɵ mes 
in 10 years.[68] TB was reported as the leading opportunisƟ c infecƟ on among hospitalized AIDS 
paƟ ents.[69] Thus, there is growing concern for the threat of a dual epidemic in Indonesia.
 NaƟ onally, the TB control program is managed by the Directorate General (DG) of Disease 
Control and Environmental Health. However, the program also involves the DG of Medical Care, 
which is responsible for medical services in hospitals and clinics, and the DG of Community 
Health, which is responsible for services in primary health centers. OperaƟ onally, TB services are 
managed at the district level. Each district health oĸ  ce appoints a district TB manager, who is 
responsible for the treatment register, regular reports, coordinaƟ on between various faciliƟ es, 
and TB drug supply. TB services are mainly provided in primary health centers. In districts that 
have implemented PPM, some hospitals and/or private pracƟ Ɵ oners provide DOTS services. At 
the provincial level, DOTS teams have been established that provides technical support to district 
TB control programs in addiƟ on to monitoring.
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1.5 | INDONESIA’S HEALTH SYSTEM MODEL
A health system is defi ned as all organizaƟ ons, people, and acƟ ons whose primary intent is to 
promote, restore, or maintain health. This includes eī orts to infl uence determinants of health as 
well as more direct health improving acƟ viƟ es. Thus, a health system is more than the pyramid 
of publicly owned faciliƟ es that deliver personal health services.[70]
 In Indonesia, the public health system is organized as a Ɵ ered system. Referral hospitals are 
available at district, provincial, and central levels. Primary medical services and many public 
health intervenƟ ons (including TB control) are provided through community/primary health 
centers. At least one health center is located in every subdistrict, with two to three sub health 
centers depending on the size of the coverage area and/or populaƟ on. At the village level there 
are village midwife clinics and integrated health posts.[71]
 Parallel with the public health system is the rapidly growing, but not systemaƟ cally regulated, 
group of private health providers. The private providers consist of private pracƟ Ɵ oners (e.g., 
physicians, midwives, nurses), private clinics, and private hospitals. Approximately 75% of public 
health workers are also part-Ɵ me private pracƟ Ɵ oners, and 51% of hospitals in Indonesia are 
private hospitals.[72] Roughly 60% of the populaƟ on seeks medical care in the private sector.
[73] Furthermore, alternaƟ ve health providers are available, such as providers of tradiƟ onal 
and alternaƟ ve medicine, which are predominantly not registered at the health oĸ  ces and, 
therefore, unregulated.
 To idenƟ fy determinants of the performance of the TB control program, we uƟ lized a 
health system model developed by Erasmus MC and the WHO as a theoreƟ cal framework for 
our studies. The model is a compartmental model that describes pulmonary TB paƟ ents’ care-
seeking behavior and the steps in the health system unƟ l detecƟ on and treatment (Figure 1.2). 
The model starts with all symptomaƟ c TB cases in the populaƟ on (i.e. all smear-posiƟ ve paƟ ents), 
and a subpopulaƟ on of smear-negaƟ ve paƟ ents with symptoms serious enough to potenƟ ally 
prompt them to seek health care. Some of the paƟ ents will never seek care, but most of them 
will seek care and eventually be diagnosed either in DOTS or (private) non-DOTS services. The 
model was adjusted to the Indonesian context and is presented in detail in Chapter 2 of this 
thesis.
1.6 | O BJECTIVES AND RESEARCH QUESTIONS
The overall objecƟ ve of this thesis is to idenƟ fy ways to improve TB case detecƟ on in Indonesia, 
focusing on two major issues in the TB control program: 1) the interacƟ on of TB paƟ ents or 
individuals suspected to have TB with the health system providing TB services, and 2) new 
challenges in the Indonesia TB control program, parƟ cularly the emerging HIV epidemic.
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The specifi c research quesƟ ons of the thesis are as follows:
1. What are the paƩ erns of care-seeking behavior among TB suspects in Indonesia?
2. How eī ecƟ ve is the performance of the health system providing DOTS services?
3. Which improvement would benefi t the performance of TB program the most?
4. How will the HIV epidemic impact the TB program in Indonesia?
Figure 1.2 | Health system model for TB control in Indonesia and the associated research quesƟ ons in 
the thesis.
1.7 | STUDY SETTING: JOGJAKARTA PROVINCE
Jogjakarta province is located in the central part of Java Island, Indonesia. Indonesia is the largest 
archipelago in the world. The country has a total populaƟ on of 237 million and is the fourth 
most populous country in the world. Over half of the total populaƟ on lives on Java Island, with a 
populaƟ on density of more than 1,300 per km2 in some areas.
 Jogjakarta province consists of one urban, one suburban, and three rural districts, has 3.5 
million inhabitants, and covers an area of 3,185 km2. The average populaƟ on density is 1,099 per 
km2. The province has a relaƟ vely well-funcƟ oning health system, with primary care consisƟ ng of 
approximately 2000 private pracƟ Ɵ oners and 117 public community health centers staī ed with 
doctors, midwives, and nurses. This fi rst-level network is backed up by nine public and 24 private 
hospitals.
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The province has a relaƟ vely well-established TB control program with the lowest esƟ mated 
incidence rate of smear-posiƟ ve TB in Indonesia, at 63/100,000 populaƟ on in 2004. The 117 public 
health centers are the backbone of the naƟ onal tuberculosis control program’s DOTS services in 
Jogjakarta. Since 2000, hospitals have been involved in the TB program as part of the PPM policy 
in Indonesia through the Hospital DOTS Linkage (HDL) project iniƟ aƟ ve.[74] The iniƟ aƟ ve was a 
pilot project to develop a model for hospital involvement in the TB program in Indonesia. Five 
lung clinics and 24 hospitals were involved and connected to the exisƟ ng health centers network 
to improve TB case management. As a result, the number of noƟ fi ed new TB cases in the TB 
program increased three-fold from 22/100,000 in 2000 to 70/100,000 in 2004.[74] Following the 
successful implementaƟ on of the pilot project, the PPM project management was subsequently 
integrated into the provincial health oĸ  ce’s TB control program in 2006. The involvement of 
small-scale private providers was also piloted in 2004 by engaging private pracƟ Ɵ oners to refer 
individuals suspected to have TB to DOTS faciliƟ es for a diagnosƟ c work-up.[75]
 Our studies were conducted from 2006 to 2010. The studies in Chapters 2, 7, and 8 were 
conducted from 2006 to 2007. Studies in Chapters 3 and 5 were conducted from 2007 to 2008. 
The study in Chapter 4 was conducted in 2009, and the study in Chapter 6 was conducted from 
2009 to 2010.
1.8 | THESIS STRUCTURE
This thesis consists of seven scienƟ fi c papers. The fi rst paper (Chapter 2) provides the theoreƟ cal 
framework of the thesis. The framework is based on a mathemaƟ cal model of TB and the health 
system developed at the Department of Public Health of Erasmus MC in collaboraƟ on with the 
WHO. Chapters 3 and 4 answer the fi rst research quesƟ on; Chapter 3 explores the determinants 
of paƟ ent delay in health faciliƟ es using the theory of planned behavior (TPB), whereas Chapter 
4 describes the paƩ ern of care-seeking behavior among TB suspects in the community. Chapters 
5 and 6 answer the second research quesƟ on; Chapter 5 describes the interacƟ on between 
TB paƟ ents and the health system during their care-seeking process prior to TB diagnosis, and 
Chapter 6 describes TB diagnosƟ c performance at DOTS faciliƟ es. Chapters 3-6 also answer the 
third research quesƟ on. In parƟ cular, Chapters 7 and 8 discuss the impact of the HIV epidemic 
on the TB control program in Indonesia. Chapter 7 describes the burden of HIV-posiƟ ve cases 
among TB paƟ ents and the use of voluntary HIV counseling and tesƟ ng (VCT) among TB paƟ ents. 
Chapter 8 discusses the acceptance and barriers of introducing HIV tesƟ ng in the TB control 
program. Table 1.1 provides a summary of the methodology used in each chapter.
 This thesis concludes with a general discussion of the fi ndings in Chapter 9, their policy 
implicaƟ ons, and recommendaƟ ons for improving TB case detecƟ on in Indonesia.
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CHAPTER 2
How to opƟ mize tuberculosis case fi nding: 
exploraƟ ons for Indonesia with a health system model
Ahmad RA, Mahendradhata Y, Cunningham J, Utarini A, de Vlas SJ. 
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SUMMARY
Background: A mathemaƟ cal model was designed to explore the impact of three strategies for 
beƩ er tuberculosis case fi nding. Strategies included: (1) reducing the number of tuberculosis 
paƟ ents who do not seek care; (2) reducing paƟ ent delay; and (3) engaging non-DOTS providers 
in the referral of tuberculosis suspects to DOTS services in the Indonesian health system context. 
The impact of these strategies on tuberculosis mortality and treatment outcome was esƟ mated 
using a mathemaƟ cal model of the Indonesian health system.
Methods: The model consists of mulƟ ple compartments represenƟ ng logical movement of a 
respiratory symptomaƟ c (tuberculosis suspect) through the health system, including paƟ ent and 
health system delays. Main outputs of the model are tuberculosis death rate and treatment 
outcome (i.e. full or parƟ al cure). We quanƟ fi ed the model parameters using a two round Delphi 
survey with fi ve Indonesian tuberculosis experts. 
Results: The model validaƟ on shows that four criƟ cal model outputs (average duraƟ on of 
symptom onset to treatment, detecƟ on rate, cure rate, and death rate) were reasonably close 
to exisƟ ng available data, erring towards more opƟ misƟ c outcomes than are actually reported. 
The model predicted that an intervenƟ on to reduce the proporƟ on of tuberculosis paƟ ents 
who never seek care would have the biggest impact on tuberculosis death prevenƟ on, while an 
intervenƟ on resulƟ ng in more referrals of tuberculosis suspects to DOTS faciliƟ es would yield 
higher cure rates. This fi nding is similar for situaƟ ons where the alternaƟ ve sector is a more 
important health resource, such as in most other parts of Indonesia.
Conclusion: We used mathemaƟ cal modeling to explore the impact of Indonesian health system 
intervenƟ ons on tuberculosis treatment outcome and deaths. Because detailed data were not 
available regarding the current Indonesian populaƟ on, we relied on expert opinion to quanƟ fy 
the parameters. The fact that the model output showed similar results to epidemiological data 
suggests that the experts had an accurate understanding of this subject, thereby reassuring the 
quality of our predicƟ ons. The model highlighted the potenƟ al eī ecƟ veness of acƟ ve case fi nding 
of tuberculosis paƟ ents with limited access to DOTS faciliƟ es in the developing country seƫ  ng. 
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2.1 | BACKGROUND
Tuberculosis (TB) is one of the world’s leading causes of death and disease. Despite the 
development and availability of eī ecƟ ve treatment for several decades, TB sƟ ll results in 
1.6 million deaths per year.[1] Reducing the burden of global TB disease is a part of broader 
developmental frameworks such as the Millennium Development Goals (MDG). The MDG 
clearly state that prevalence and mortality rate of TB should be addressed with a goal towards 
increase in case detecƟ on rate (CDR) and treatment success rate within DOTS (Direct Observed 
Treatment, Short course) strategy. The importance of intensifi ed case fi nding was acknowledged 
by the Second Ad Hoc CommiƩ ee on the Tuberculosis Epidemic, who recognized that DOTS alone 
was incapable of reducing morbidity and mortality in TB paƟ ents.[2]
 Indonesia is ranked third in the world for tuberculosis burden [1]. Following the naƟ on-wide 
introducƟ on of DOTS in 1995, the country’s NaƟ onal TB Control Program (NTP) has successfully 
reached the internaƟ onal targets for case detecƟ on (>70%) and treatment success (>85%).[1] 
However, much work remains to be done to ensure these achievements contribute to the TB-
related MDG of cuƫ  ng the prevalence and death rate in half by 2015. The Stop TB Partnership 
has recommended a six-point strategy to reach these goals. The strategy components are: (1) 
quality DOTS expansion and enhancement; (2) addressing TB/HIV, mulƟ -drug resistant TB (MDR-
TB), and other challenges; (3) health system strengthening; (4) broader engagement of all care 
providers; (5) empowering communiƟ es; and (6) promoƟ ng research.[3] This recommendaƟ on 
addresses the importance of intensifi ed eī orts towards case fi nding. The Indonesian NTP has 
accordingly adopted this strategy into its 2006-2010 strategic framework.[4] Thus the current 
challenge for the NTP is determining how to best allocate limited resources across the six-point 
strategy. Clearly, with limited resources, there is a need to raƟ onally set prioriƟ es. 
 In an eī ort to determine the most eĸ  cacious method of case fi nding, we developed a 
mathemaƟ cal model of the health system through which TB paƟ ents seek care. We explored 
the potenƟ al use of this model to opƟ mize TB case fi nding in the Indonesian health system 
context, by comparing three possible case fi nding intervenƟ on strategies: (1) reducing the 
number of TB paƟ ents who do not seek care; (2) reducing paƟ ents’ delay in seeking treatment; 
and (3) engaging non-DOTS providers in the referral of TB suspects to DOTS services. Applying an 
innovaƟ ve method, the parameters in the model are quanƟ fi ed by an adjusted Delphi approach 
using expert knowledge.
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2.2 | METHODS
Model structure
We developed a compartmental model that describes a TB paƟ ents’ care seeking behavior and 
the health system performance of both DOTS and non-DOTS services (e.g. private physicians, 
nurses, and midwives) in Indonesia. The model was developed with ModelMakerTM version 
3.0.3. The model mimics the journey of pulmonary TB paƟ ents beginning with the onset of 
symptoms and follows their care seeking behavior through the health system (Figure 2.1). Our 
model populaƟ on is applicable to all symptomaƟ c TB cases; all smear posiƟ ve paƟ ents, and a 
subpopulaƟ on of smear negaƟ ve paƟ ents with symptoms serious enough to potenƟ ally prompt 
them to seek health care.
 There are 11 compartments within the model. Each compartment represents a situaƟ on 
that TB paƟ ents encounter during care seeking aŌ er the onset of TB clinical symptoms. The 
model begins with symptomaƟ c TB paƟ ents in the populaƟ on not yet seeking health care (Not 
seeking care). A proporƟ on of TB paƟ ents will never be idenƟ fi ed because they never seek help 
(Never seeking), or prematurely drop out of the health care system before being idenƟ fi ed as a 
TB case. However, the majority of paƟ ents will eventually be diagnosed and cured aŌ er proper 
chemotherapy. 
 TB paƟ ents may choose three diī erent types of health care providers: AlternaƟ ve, Non-
DOTS, and DOTS services; however, adequate (not necessarily standardized) infrastructure for TB 
diagnosis and treatment can only be accessed through DOTS and Non-DOTS service providers. The 
AlternaƟ ve services concern all health providers that do not pracƟ ce modern western medicine, 
such as tradiƟ onal healers and spiritualist. AlternaƟ ve services also include self-medicaƟ on, both 
using tradiƟ onal or modern (over the counter) medicine. We assume that paƟ ents can move 
directly from the AlternaƟ ve services to either DOTS or Non-DOTS services, while paƟ ents in 
DOTS or Non-DOTS services need to move back to Not seeking care before possibly moving to 
another sector. If paƟ ents do not drop out, they will eventually be idenƟ fi ed as TB suspects and 
referred for diagnosƟ c tesƟ ng (DOTS lab1 or Non-DOTS lab1). 
 Several potenƟ al outcomes may result from the diagnosƟ c process. Following diagnosƟ c 
tesƟ ng, paƟ ents may be (i) idenƟ fi ed as TB posiƟ ve (i.e. true posiƟ ve diagnosis) and referred for 
treatment (DOTS treatment and Non-DOTS treatment), (ii) idenƟ fi ed as TB negaƟ ve (i.e. false 
negaƟ ve diagnosis) but require addiƟ onal tesƟ ng, or (iii) idenƟ fi ed as TB negaƟ ve with a move 
back to the Not seeking care compartment, i.e. drop-out. TB paƟ ents who are referred for a 
second diagnosƟ c test (DOTS lab2 and Non-DOTS lab2) may follow one of the following courses: 
(i) diagnosed as TB posiƟ ve and recommended for treatment, (ii) diagnosed as TB negaƟ ve and 
exit the health system, or (iii) fail to complete tesƟ ng and drop out of the system.
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Figure 2.1 | Basic structure of the health system compartmental model, and corresponding parameters 
as quanƟ fi ed through expert consultaƟ on. Boxes represent compartments, i.e. stages of the care seeking 
process. Arrows represent the fl ow (transiƟ on) of individuals between compartments. These individuals 
are TB suspects/respiratory symptomaƟ cs, who are defi ned as paƟ ents with pulmonary TB symptoms 
serious enough to trigger them to seek health care. TB diagnosis and treatment is not available in 
the alternaƟ ve health sector. In DOTS services, the fi rst laboratory examinaƟ on (DOTS lab1) is smear 
microscopy and the second examinaƟ on (DOTS lab2) is chest X ray, while in Non-DOTS services the 
situaƟ on is vice versa. Parameters are duraƟ ons and proporƟ ons. DuraƟ ons are defi ned as the average 
full duraƟ on of being in a certain compartment, thus not including dropout. ProporƟ ons concern fracƟ ons 
of TB paƟ ents moving into the next compartments. Main outcomes of the model are TB death, cure, and 
spontaneous recovery. A; B; C are the intervenƟ on strategies simulated in this model (see text and Table 
3). * NegaƟ ve test result; ** drop out during diagnosƟ c process. The doƩ ed arrow represents a direct 
fl ow from AlternaƟ ve to DOTS services.
The two fi nal compartments, DOTS treatment and Non-DOTS treatment are stages where TB 
paƟ ents receive treatment. Some of the referred paƟ ents will not receive treatment and drop 
out of the system. However most paƟ ents will be cured or parƟ ally cured. ParƟ ally cured means 
TB paƟ ents have received treatment for some period of Ɵ me, but have failed to complete the full 
course of therapy; thus they are at risk of relapse. 
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DuraƟ ons and proporƟ ons are parameters of the model that may vary based on strategic 
intervenƟ on or changes in paƟ ent behavior. DuraƟ ons are defi ned as the average full duraƟ on 
of being in certain compartment; these values do not include the duraƟ on of paƟ ents who drop 
out from the compartment. ProporƟ ons concern the fracƟ ons of TB paƟ ents moving into the 
next compartments. All duraƟ ons are reported in weeks. The duraƟ on and proporƟ ons per 
compartment were translated into transiƟ on rates (i.e. number/week) of TB paƟ ents moving to 
adjacent compartments. 
 Other parameters included in the model are TB death rate and spontaneous recovery rate 
for TB paƟ ents not receiving treatment. Using the Berg study data from the pre-treatment 
era,[5] we esƟ mated that the TB death and recovery rate are approximately 0.3 and 0.2 per year, 
respecƟ vely. These rates correspond to a cumulaƟ ve TB death and recovery of 40% and 29% aŌ er 
two years, or 73% and 26% aŌ er 10 years, respecƟ vely, in the absence of eī ecƟ ve treatment. 
 The main outcomes of the model are death, spontaneous cure, and parƟ al or full cure aŌ er 
treatment. AddiƟ onal outcomes are the average duraƟ on of the care seeking process i.e. duraƟ on 
before treatment, the case detecƟ on and cure rate, and TB death rate. 
Parameter quanƟ fi caƟ on process
Parameter quanƟ fi caƟ on was conducted through a two round modifi ed Delphi survey. Due to the 
poor response rate when using quesƟ onnaires, as suggested in the standard Delphi guideline, we 
instead conducted direct interviews with all parƟ cipants. Ten experts were idenƟ fi ed, and fi ve of 
these agreed to parƟ cipate. The experts were selected based on their experience related to the 
Indonesian TB control program and/or paƟ ents care seeking behavior. We made appointments to 
meet the experts individually for each round. During each individual encounter we posed several 
quesƟ ons displayed as a Word fi le on a laptop computer. Responses were entered directly into 
the fi le. We reviewed the answers with the expert before we saved the fi le as their fi nal response 
for that round.
 During the iniƟ al round, parƟ cipants were fi rst asked to give their view on the basic 
assumpƟ ons of the model structure, in parƟ cular the assumpƟ ons that some of the paƟ ents 
never seek care, that drop-outs move back to the Not seeking care compartment, and the 
specifi c diagnosƟ c process sequence. ThereaŌ er they were asked to provide iniƟ al esƟ mates for 
all duraƟ ons and proporƟ ons in the model. In the second round, the mean, median, and extreme 
responses were presented and parƟ cipants were invited to revise their esƟ mates given the iniƟ al 
round results. For our analysis we used the reported median of proporƟ ons and duraƟ ons from 
the second round. 
 The experts were asked to consider the context of Jogjakarta province, which is located in the 
central part of Java Island. The province consists of a mix of urban, semi urban, and rural districts. 
It has a relaƟ vely well-established TB control program according to Indonesian standards. It has 
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a TB incidence of 63/100,000, which is the lowest incidence rate in Indonesia.[6] Furthermore, 
several new TB control intervenƟ ons, such as public-private hospital involvement, have been 
piloted in this province with posiƟ ve outcomes.[7] 
 DOTS services in Indonesia are mainly based in public health centers. However, current NTP 
policy is to involve hospitals (both public and private) as part of the “engaging all care providers” 
strategy. In Jogjakarta province, the hospital DOTS linkage had been implemented for fi ve years 
and reached its maturity prior to conducƟ on of this study. Thus, we can safely assume that the 
diagnosis procedures and treatment in DOTS hospitals are to a large extent idenƟ cal to the health 
centers.
Model exploraƟ ons and data validaƟ on
IniƟ ally, we ran the model to validate the quanƟ fi caƟ ons derived from the experts and verify that 
they resulted in meaningful predicƟ ons. To this end, we used the model to simulate a cohort of 
symptomaƟ c TB paƟ ents and predict in which compartments they would ulƟ mately be located. 
The following four typical TB program indicators were compared with actual data: duraƟ on 
before treatment, case detecƟ on rate, cure rate, and TB death rate. DuraƟ on before treatment 
is the average duraƟ on of Ɵ me from iniƟ al locaƟ on within the Not seeking care compartment 
to the point before entering the DOTS treatment compartment for all symptomaƟ c TB cases 
ulƟ mately ending in the DOTS treatment compartment. Case detecƟ on is the proporƟ on of a 
full cohort of symptomaƟ c TB cases starƟ ng in Not or Never seeking care that eventually move 
to DOTS treatment via DOTS lab1. Cure rate is the proporƟ on of all symptomaƟ c TB cases in the 
DOTS treatment compartment that are ulƟ mately cured. TB death rate is the proporƟ on of a full 
cohort of symptomaƟ c TB cases starƟ ng in Not or Never seeking care that die over Ɵ me due to 
TB. 
 For model validaƟ on, we compared these four typical TB program indicators with actual data 
from the naƟ onal or provincial TB program. 
 – The duraƟ on before treatment was derived from the latest Indonesian TB prevalence survey 
in 2004.[6] 
 – In the model, case detecƟ on rate was defi ned as all TB paƟ ents (smear posiƟ ve and smear 
negaƟ ve) detected in both DOTS and Non-DOTS services. However, since the exisƟ ng 
informaƟ on available from the Indonesian TB program only includes smear posiƟ ve TB cases 
detected in DOTS services, we compared the smear posiƟ ves detected in DOTS lab1 in our 
model output with the proporƟ on of smear posiƟ ve detected within the WHO esƟ mated 
number of total TB cases and the proporƟ on of smear posiƟ ve detected within the WHO 
esƟ mated number of smear posiƟ ve cases. If we assume that symptomaƟ c cases consist 
of all smear posiƟ ve cases and between 10%-40% of smear negaƟ ve TB cases, using the 
WHO esƟ mated incidence rate of all cases (239/100,000) and the esƟ mated smear posiƟ ve 
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incidence (108/100,000) for Indonesia,[8] the esƟ mated incidence for all symptomaƟ c 
cases is between 121 and 160 per 100,000 populaƟ on. Using the esƟ mated smear posiƟ ve 
incidence for Jogjakarta province (63/100,000),[6] this translates to an esƟ mated incidence 
of all symptomaƟ c cases in this province of 71-94/100,000 populaƟ on. Given the populaƟ on 
size of Jogjakarta of 3.44 million in 2005,[9] this leads to 2,400-3,200 symptomaƟ c cases in 
Jogjakarta. Using the noƟ fi ed number of 1,240 smear posiƟ ve TB cases reported in Jogjakarta 
province in 2005,[9] this leads to 39% to 52% of all symptomaƟ c TB cases detected in the 
DOTS services in Jogjakarta.
 – The cure rate is the proporƟ on of new smear posiƟ ve TB paƟ ents cured aŌ er treatment 
received within DOTS services. The reported number of paƟ ents cured in the Jogjakarta 
province TB program surveillance system was 1053 of a total of 1300 TB paƟ ents treated in 
DOTS faciliƟ es in Jogjakarta province in 2005.[9] This represents a cure rate of 81%.
 – TB observed death rate is esƟ mated from the 2005 WHO-reported TB mortality rate of 
Indonesia, 41/100,000.[8] We adjusted this value to exclude extra-pulmonary TB cases by 
assuming that the pulmonary TB death rate is 80% of the WHO fi gure. Furthermore, we 
assume that the Jogjakarta fi gure is 60% of the naƟ onal pulmonary TB death. This lower 
death rate is based on the general health indicators of Jogjakarta province, which are beƩ er 
than those of Indonesia as a whole. Although the crude mortality rate is slightly higher (7.8 
compared to 6.6/100,000), the life expectancy at birth and maternal mortality rate are 
considerably beƩ er in Jogjakarta. Moreover, the health system performance in Jogjakarta is 
far beƩ er than in Indonesia in general; TB is one of the top ten causes of death naƟ onally, 
while this was not the case in Jogjakarta province. Based on these calculaƟ ons, the pulmonary 
TB death rate in Jogjakarta province should be 20/100,000. Given the populaƟ on size of 3.44 
million, we arrive at approximately 700 pulmonary TB deaths in Jogjakarta per year. This 
means that the ‘observed’ TB death is between 22%-29% in 2005.
These model outcomes were used as the baseline situaƟ on to be compared with three strategies 
to improve TB case fi nding. The strategies are as follows: strategy (A) is to reduce the proporƟ on 
of TB paƟ ents who never seek care (Never seeking care compartment) by 50%; the second 
strategy (B) is to reduce paƟ ents’ delay (reduce duraƟ on in Not seeking care compartment by 
50%); the third strategy (C) is to refer all TB suspect paƟ ents from non-DOTS services to DOTS 
services (i.e. from Non-DOTS services to DOTS lab1 compartment). 
 We also considered a diī erent scenario in which a greater proporƟ on of TB paƟ ents remain 
in the AlternaƟ ve services sector. In this model, we assumed that 20% of the TB paƟ ents that 
would have gone to the DOTS and Non-DOTS compartment now move to the AlternaƟ ve services 
compartment. Also in this model, paƟ ents cannot move directly from the AlternaƟ ve sector 
to other sectors, but fi rst need to return to the Not seeking care compartment. This scenario 
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refl ects the health system situaƟ on of Indonesian seƫ  ngs outside Java-Bali, where the number 
of health care faciliƟ es (both public and private) is less, and TB paƟ ents face greater geographical 
challenges.
SensiƟ vity analysis
A univariate sensiƟ vity analysis was performed to assess how the main results (proporƟ ons 
death and parƟ ally cured) change with diī erent model assumpƟ ons. To this end we mulƟ plied 
the baseline values of the transiƟ on rates of paƟ ents going out of each compartment by 2/3 and 
3/2, one rate at a Ɵ me, and ran the model again. The change in outcomes gives an indicaƟ on of 
the sensiƟ vity of the model to the assumed parameter values. By varying transiƟ on rates, rather 
than the expert-derived proporƟ ons, all proporƟ ons moving out of parƟ cular compartments sƟ ll 
add up to 100%.
2.3 | RESULTS
Parameter quanƟ fi caƟ on
All experts (Table 2.1) agreed that the model structure and diagnosƟ c process sequence provided 
an adequate representaƟ on of reality for TB paƟ ents and the TB control program in Indonesia. 
The medians of the expert derived average duraƟ ons and proporƟ ons are reported in Figure 2.1. 
In general, the experts suggested that most of the TB paƟ ents (90%) seek treatment, with an 
average duraƟ on of 2.5 weeks aŌ er their fi rst symptoms before entering the healthcare system. 
FiŌ y percent of those seeking treatment go to DOTS services and 20% to AlternaƟ ve services as 
their fi rst health service preference. The experts also acknowledged that DOTS services have a 
beƩ er capacity to diagnose and treat TB paƟ ents, with a lower drop out rate during treatment 
and a higher cure rate, compared to non-DOTS services. The experts reported a slightly longer 
duraƟ on unƟ l treatment for the Non-DOTS sector compared to the DOTS sector. In parƟ cular, 
the assumed duraƟ on prior to TB suspicion was 1.5 weeks longer, whereas this was only partly 
counterbalanced by a 0.5-week shorter duraƟ on unƟ l diagnosis by the fi rst lab. Furthermore, 
there were no considerable diī erences in the experts’ esƟ mated parameter values (i.e. duraƟ ons 
and proporƟ ons) between the fi rst and second Delphi round (data not shown).
Model simulaƟ on
Figure 2.2 shows a baseline cohort of TB paƟ ents during their care seeking process. Most of the 
paƟ ents are cured aŌ er treatment. Only a small fracƟ on of TB paƟ ents, mainly those who never 
seek treatment, remain as a source of infecƟ on aŌ er 100 weeks (approximately 2 years). The 
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model also demonstrates that only a negligible proporƟ on of TB paƟ ents stay in the AlternaƟ ve 
services sector, compared to the DOTS or Non-DOTS services. 
Table 2.1 | CharacterisƟ cs of the expert panel
Expert 1: TB project manager with a vast experience in developing public-private mix among hospitals (TB 
Hospital DOTS Linkage/HDL) in Jogjakarta province since 2000-2005. 
Expert 2: Microbiologist who works at the university and as laboratory technical consultant for the TB 
control program. The expert is also involved in the laboratory capacity strengthening, as a part 
of the TB Hospital DOTS Linkage project in Jogjakarta. Member of naƟ onal TB laboratory working 
group, has recent experience with the study of TB paƟ ents’ care seeking behavior in this province.
Expert 3: Urban district TB control program manager with recent experience of conducƟ ng a TB paƟ ents 
care seeking behavior study in Jogjakarta province.
Expert 4: Former rural district TB-control program manager who has health promoƟ on experƟ se and vast 
experience in health seeking behavior intervenƟ ons. 
Expert 5: Medical doctor who was head of a public health center in Jogjakarta during the dayƟ me and a 
private pracƟ Ɵ oner in the evening. As the head of the health center the expert has experience in 
involving private pracƟ Ɵ oners in the health center catchment area.
Figure 2.2 | CumulaƟ ve outcome of the care seeking process of TB paƟ ents’ cohort, starƟ ng in Not 
seeking care (90%) and Never seeking care (10%) compartments. 
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It is reassuring that the Delphi survey quanƟ fi caƟ ons correspond with an average total duraƟ on 
before treatment of 9.3 weeks. This is in agreement with fi ndings from a recent Indonesia 
naƟ onal TB prevalence survey, which reported a mean of 10.3 weeks (Table 2.2). Other criƟ cal 
model outputs are also similar to the exisƟ ng data. The model predicƟ on for the proporƟ on of 
smear posiƟ ve TB paƟ ents through DOTS services is within the range of the exisƟ ng TB case 
fi nding data, and the predicted cure rate is slightly less than that found in the data. However, the 
predicted mortality rate in the model is lower than the esƟ mated range of TB death in Jogjakarta 
province. As a whole, all model predicƟ ons are reasonably close to the reported data, but to 
some degree overly opƟ misƟ c.
Table 2.2 | Comparison of model output with available data
ExisƟ ng data Model output
Mean duraƟ on from the fi rst TB symptoms to treatment (weeks) 10.3 a  9.3
ProporƟ on (%) of all TB-cases detected as smear posiƟ ve through 
DOTS services 39 - 52
 b 48.0
ProporƟ on (%) of TB paƟ ents in the DOTS services eventually cured 81.0 c 72.3
ProporƟ on (%) of all TB cases that eventually die 22 - 29 d 16.6
Model output and data concern symptomaƟ c pulmonary TB cases; both smear posiƟ ve and part of smear negaƟ ves, 
with symptoms serious enough to potenƟ ally prompt them to seek health care.
a based on an Indonesian TB prevalence survey in 2004 [7].
b based on smear posiƟ ve cases detected in Jogjakarta province TB program, assuming that all smear posiƟ ve and 
between 10%-40% smear negaƟ ve TB cases are symptomaƟ c.
c the reported cure rate from Jogjakarta provincial TB program in 2005 [9].
d based on the WHO esƟ mated death rate for Indonesia as a whole, aŌ er correcƟ on for 20% extra-pulmonary TB 
and a 40% lower death rate in Jogjakarta Province [1].
If we consider an alternaƟ ve situaƟ on in which 20% of paƟ ents move to the alternaƟ ve sector, 
instead of to the DOTS and Non-DOTS services, the average total duraƟ on before treatment would 
be 12 weeks (not shown). Also for this scenario, most of the TB paƟ ents are cured; however a 
larger proporƟ on of TB cases would die and the cure rate would be lower than in the previous 
situaƟ on (Table 2.3). 
 Table 2.3 illustrates the outcomes of diī erent possible case fi nding strategies simulated in 
the model. Strategy A, which is to reduce the number of TB paƟ ents who never seek care, is 
more eī ecƟ ve in prevenƟ ng deaths than strategy B and C. However, strategy C, involving private 
providers in the referral of TB paƟ ents to DOTS facility, leads to a substanƟ ally higher proporƟ on 
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of fully cured paƟ ents among those receiving treatment. These fi ndings are similar for the 
scenario with a higher rate of paƟ ents iniƟ ally entering the alternaƟ ve health sector.
Table 2.3 | Predicted eī ect of three intervenƟ ons (A, B, C) on a cohort of TB paƟ ents (%)
Scenario Model outcome No intervenƟ on With intervenƟ on
A B C
Baseline a Death 16.6 14.2 15.5 16.5
ParƟ ally cured 19.6 20.7 20.1 11.5
Cured 52.8 55.7 54.1 61.0
Spontaneous recovery 11.1 മ9.5 10.3 11.0
More important alternaƟ ve 
health sector b
Death 18.1 15.8 16.6 18.0
ParƟ ally cured 18.5 19.6 19.2 11.1
Cured 51.2 54.1 53.1 58.9
Spontaneous recovery  12.1 10.5 11.1 12.0
A: strategy to reduce the proporƟ on of TB paƟ ents who never seek care (Never seeking compartment) by 50%; 
B: strategy to reduce paƟ ents’ delay (i.e. reduce duraƟ on in Not seeking care compartment) by 50%; 
C: strategy to refer all TB suspect paƟ ents from non-DOTS services to DOTS services (from Non-DOTS services to 
DOTS lab1 compartment).
a: SimulaƟ on using experts esƟ mated parameters
b: SimulaƟ on using adjusted parameters in the alternaƟ ve health sector, i.e. if 20% of the fl ow of TB paƟ ents to 
the DOTS and Non-DOTS services compartments now move to the AlternaƟ ve services compartment (i.e. the 
proporƟ on of TB paƟ ents move from Not seeking care compartment to AlternaƟ ve, Non-DOTS, and DOTS services 
compartments are 36%, 24%, and 40% respecƟ vely), and paƟ ents cannot go directly to the DOTS and Non-DOTS 
services.
Figure 2.3 shows the results of sensiƟ vity analysis. It is clear that changing the model parameters 
has only a limited impact on outcomes. TB death varied maximally from 15.9 to 17.2 (baseline 
value of 16.6), while the proporƟ on parƟ ally cured varied from 17.9 to 21.7 (baseline value of 
19.6). The transiƟ on rate from Not seeking care to Non-DOTS services has the strongest infl uence 
on the proporƟ on parƟ ally cured. A higher fl ow to Non-DOTS services leads to more paƟ ents 
parƟ ally cured, and the proporƟ on TB death slightly decreases as well. The fl ow from Not seeking 
care to DOTS services has by far the biggest infl uence on TB death, and illustrates that assuming a 
higher rate of paƟ ents going to the DOTS services corresponds with a decreased death rate. The 
proporƟ on parƟ ally cured decreases to a comparable degree. Dropout rates (i.e. moving back to 
Not seeking care) show a modest but consistent paƩ ern: a higher rate of dropping out from the 
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non-DOTS compartments of the model always leads to more TB death and less parƟ ally cured, 
whereas dropping out from the DOTS compartments always leads to both more TB death and 
more parƟ ally cured. 
Figure 2.3 | SensiƟ vity analysis: impact of changes of the transiƟ on rates between the diī erent model 
compartments on the predicted percentage of parƟ ally cured and TB-related death. Grey dots represent 
the results using a transiƟ on rate of 2/3 Ɵ mes the baseline value, and black dots represent the results 
using a transiƟ on rate of 3/2 Ɵ mes the baseline value. The two verƟ cal black lines represent the respecƟ ve 
baseline outcomes.
2.4 | DISCUSSION
This mathemaƟ cal model guided by parameter values based on expert opinion is a novel approach 
to study the role of health systems in TB control. Findings from the model simulaƟ on suggest that 
some criƟ cal outputs of the model are reasonably close to the exisƟ ng data, although they tended 
to be somewhat opƟ misƟ c. Model exploraƟ ons show that increasing care-seeking behavior may 
36  |  Chapter 2
have a considerable impact on prevenƟ ng TB death. AddiƟ onally, referral of suspected TB cases 
to DOTS faciliƟ es will increase treatment success and prevent parƟ al cure. This fi nding is similar 
to a situaƟ on with more paƟ ents iniƟ ally entering the alternaƟ ve health sector. Furthermore, 
sensiƟ vity analysis revealed that the model predicƟ ons are not very sensiƟ ve to the assumed 
parameter values, with the health care seeking rates having the biggest impact.
 As the TB control program relies on passive case fi nding, success is determined by paƟ ents’ 
care seeking behavior and health system performance. Previous studies examining TB case 
fi nding mainly focus on either the care-seeking behavior of TB paƟ ents,[10-14] or the health 
system determinants.[7,15-17] In the 1970s, Piot developed a model of the TB treatment-seeking 
process, which included both paƟ ent and health system determinants.[18] Two recent studies 
have addressed the interacƟ on between TB paƟ ents and health system through modeling; 
however these studies focused more on the diagnosƟ c process rather than case fi nding strategies.
[19,20] Our study contributes to the body of knowledge by combining all factors related to 
TB control into one coherent framework using mathemaƟ cal modeling. This model takes into 
account the various types of exisƟ ng health services, the duraƟ on and paƩ ern of care seeking 
behavior, and TB paƟ ent outcome (i.e. death, parƟ al/full cure, and spontaneous recovery).
 Our model does not account for the complexiƟ es present in the natural history of TB infecƟ on, 
but considers a simple constant risk of death or spontaneous recovery while being in the health 
system. Including progression and regression of the disease through diī erent stages of severity 
would allow predicƟ on of the impact of early case detecƟ on. Relapse aŌ er treatment failure or 
incomplete cure, MDR-TB, and HIV co-infecƟ on will have a diī erent impact on the progression 
and risk of death in individual TB cases. A more complex model has been designed that considers 
these factors.[21] Our model also does not include TB transmission. In reality, earlier and beƩ er 
treatment of TB paƟ ents will to some extent lower the transmission rate and thereby result in 
fewer secondary cases in the populaƟ on. Our predicƟ ons on prevented TB deaths are therefore 
underesƟ maƟ ons. 
 It is diĸ  cult to esƟ mate the number of TB paƟ ents exisƟ ng outside government run health 
services in Indonesia and other developing countries. Consensus methods, such as Delphi, are 
likely the only means to obtain quanƟ taƟ ve informaƟ on.[22,23] Despite the fact that most of the 
Delphi studies are not designed to be staƟ sƟ cally signifi cant and the ideal panel size has not been 
idenƟ fi ed,[22] most studies involve large numbers of parƟ cipants.[22-26] Therefore, our expert 
esƟ mated parameters should be interpreted with cauƟ on. SƟ ll, our results show that the criƟ cal 
outcomes of our model are reasonably close to the exisƟ ng data, which supports the validity of 
the parameters (Table 2.2). It is notable that outcomes of our model are consistently ശ but to 
diī erent degrees ശ more opƟ misƟ c than epidemiological data. We realize that we could not do a 
formal staƟ sƟ cal validaƟ on of the model, since the ‘observed’ data themselves are partly based 
on model predicƟ ons (by WHO) and addiƟ onal assumpƟ ons.
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Because health system characterisƟ cs and TB paƟ ents’ care seeking behavior diī ers in diī erent 
regions, our study results may not be directly generalizable to other seƫ  ngs. However, the model 
can be adapted to others seƫ  ngs provided parameter values are regionally specifi c.
 At present, there is a recognized global urgency to improve TB case detecƟ on.[27] The Second 
Ad Hoc CommiƩ ee on the Tuberculosis Epidemic also acknowledged that a high DOTS treatment 
rate alone was incapable of reducing morbidity and mortality, without addiƟ onal intensifi ed 
case fi nding.[2] Heller et al. used modeling simulaƟ on and suggested a similar result.[28] There 
are several diī erent strategies for increasing case fi nding, such as acƟ ve case fi nding (ACF), 
enhanced case fi nding (ECF),[29] and expanded passive case fi nding via increased interacƟ on 
with private sectors.[30] The diī erence between ACF and ECF is the level of direct interacƟ on 
with the target populaƟ on. ACF is oŌ en more labor intensive, involving face-to-face contact and 
immediate onsite evaluaƟ on. ECF educates the populaƟ on about the symptoms of TB through 
publicity and educaƟ on, and encourages self-presentaƟ on to medical services.[29] Studies 
also show that implementaƟ on strategies of ACF (radiography screening or symptom based 
screening,[31] tuberculin screening,[32] and contact tracing [33-35]), ECF (health educaƟ on, 
community involvement,[29] or outreach program [36]), and case fi nding in the public and 
private sector outside of DOTS program (via involvement of private pracƟ Ɵ oners in suspected 
TB case referral,[37] diagnosis and treatment [30,38]) can be feasible and eī ecƟ vely improve TB 
case fi nding. 
 Three strategies are hypothesized to potenƟ ally improve TB detecƟ on and cure rates. Strategy 
A can be implemented through symptom-based household contact screening as conducted in 
Northern Lima, Peru.[35] An example of intervenƟ on to achieve strategy B is the community 
outreach program in rural Southern Ethiopia,[36] where a TB campaign was conducted prior to 
a monthly outreach visit to communiƟ es. Strategy C is exemplifi ed by the involvement of private 
providers, such as informal village doctors in Bangladesh, to refer TB suspects to DOTS faciliƟ es.
[37] All these intervenƟ ons lead to substanƟ al improvement in TB case fi nding. However, the 
feasibility of actually adopƟ ng the suggested intervenƟ on strategies in Jogjakarta province 
remains to be seen. For example, to refer all TB suspect paƟ ents to DOTS faciliƟ es (strategy C) 
requires involvement of all private providers. In reality, this may be impracƟ cal and diĸ  cult to 
achieve. The feasibility and acceptability of an intervenƟ on is to a large extent seƫ  ng-specifi c. Any 
intervenƟ on program should be assessed aŌ er consultaƟ on with local experts. SƟ ll, exploraƟ ons 
with the model can at least demonstrate the most promising control opƟ ons with regard to their 
expected eī ecƟ veness.
 Eī ecƟ veness of a disease intervenƟ on is commonly measured by averted disease burden 
in terms of disability adjusted life years (DALY). In TB, 86% of healthy life lost can be aƩ ributed 
to premature death, while only 14% is due to illness.[30] The model shows that reducing the 
number of never seeking care TB paƟ ents will have the greatest impact on mortality, and will 
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thus result in the greatest improvement in DALY. Further, Borgdorī  et al. suggested that ACF 
would only have limited impact on mortality if the intervenƟ on detects paƟ ents who would 
otherwise have been detected through self-reporƟ ng.[39] Thus challenges remain in targeƟ ng 
specifi c high-risk TB sub-groups, e.g. prison inmates, HIV paƟ ents, and urban slums dwellers, 
who have limited access to health services and are less likely to seek care on their own.
 The potenƟ al eī ecƟ veness of implementaƟ on strategies should also be judged against the 
potenƟ al costs for implemenƟ ng such strategies. This is a parƟ cularly important consideraƟ on 
in resource-constrained seƫ  ngs such as Indonesia. In these seƫ  ngs, cheaper, albeit less 
eī ecƟ ve, intervenƟ ons may be a more pragmaƟ c opƟ on. Several economic evaluaƟ on studies 
have assessed the cost eī ecƟ veness of diī erent TB control strategies, mainly related to DOTS. 
However, only a limited number of economic evaluaƟ ons on case fi nding strategies are available, 
mainly in the seƫ  ng of developed countries.[30,32,40,41] Further, no economic evaluaƟ on has 
been published on community based case fi nding or intervenƟ ons to refer TB suspects from 
private providers to DOTS faciliƟ es. A study in Dar es Salaam suggests that an acƟ ve case fi nding 
strategy may cost less than $276 US per case treated (1996 exchange rate), in a situaƟ on where 
household cost is the main component of cost for tuberculosis management.[42] The Indonesia 
NTP’s marginal costs of a case successfully treated for 2004-2005 is approximately US $450.[1,43] 
This suggests that the ACF strategy in high-risk populaƟ ons with limited access to DOTS faciliƟ es 
could potenƟ ally be considered cost-eī ecƟ ve in the Indonesian context. Notwithstanding, formal 
cost eī ecƟ veness analysis comparing ACF, community based case fi nding, and intervenƟ on to 
refer TB suspects from private providers to DOTS faciliƟ es (which is beyond the scope of this 
study) clearly needs to be carried out before ACF can be advocated as a priority policy opƟ on. 
Results of an economic study of an intervenƟ on to refer TB suspects from private providers 
to DOTS faciliƟ es in Jogjakarta province is undergoing evaluaƟ on at the Ɵ me of wriƟ ng and is 
expected to shed more light on this issue.
 Our model development process has demonstrated signifi cant gaps in knowledge. In general 
there is liƩ le data about the TB diagnosis and treatment process and the outcome in non-DOTS 
services. Also, liƩ le is known about TB paƟ ents who never seek care and TB paƟ ents who enter 
the alternaƟ ve services sector. Another knowledge gap exists regarding the sensiƟ vity of health 
services in idenƟ fying TB suspects. Further, there are limited evidences of cost eī ecƟ veness of 
TB case fi nding implementaƟ on strategies. Thus, further studies are needed to provide such 
evidence.
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2.5 | CONCLUSION
We used mathemaƟ cal modeling to explore the impact of Indonesian health system intervenƟ ons 
on tuberculosis treatment outcome and deaths. We relied on expert opinion to quanƟ fy the 
parameters. The fact that the model output showed similar results to epidemiological data 
suggests that the experts had an accurate understanding of this subject, thereby reassuring the 
quality of our predicƟ ons. The model highlighted the potenƟ al eī ecƟ veness of acƟ ve case fi nding 
of tuberculosis paƟ ents with limited access to DOTS faciliƟ es in the developing country seƫ  ng. 
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ABSTRACT
ObjecƟ ves: Indonesia has a high incidence of tuberculosis (TB), despite the successful 
introducƟ on of the Directly Observed Treatment Short course strategy (DOTS-strategy). DOTS 
depends on passive case fi nding. It is therefore important to idenƟ fy determinants of paƟ ent 
delay and reasons for visiƟ ng a DOTS healthcare provider when seeking care. The aim of this 
study was to assess these determinants in TB suspects (coughing for at least two weeks). 
Methods: Cross-secƟ onal data were gathered with a structured quesƟ onnaire in which 
psychosocial determinants were based on an extended version of the Theory of Planned Behavior 
(TPB). The study was conducted in fi ve governmental lung clinics of Jogjakarta province. In total 
194 TB suspects that registered at the lung clinics were interviewed. 
Results: The median paƟ ent delay was 14 days (range 0-145). Ordinal regression analyses 
showed that visiƟ ng a private healthcare provider when fi rst seeking healthcare, reporƟ ng travel 
distance/travel Ɵ me as reason for choosing a certain healthcare provider when fi rst seeking 
healthcare, discussing the symptoms with family, a reported short travel Ɵ me, but no factors of 
TPB, were signifi cantly associated with a shorter paƟ ent delay. An important factor negaƟ vely 
associated with visiƟ ng a DOTS clinic was the reported travel Ɵ me. 
Conclusion: Accessibility of the healthcare provider was the main determinant of paƟ ent delay, 
but the role of psychosocial factors cannot be fully excluded. Urban and suburban areas have 
relaƟ vely good access to (private) healthcare, hence the short delay. Thus, future studies should 
be focused on extending the DOTS strategy to the private sector.
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3.1 | INTRODUCTION
Indonesia has a high incidence of tuberculosis (TB); it ranks the fi Ō h highest among all countries 
in terms of the prevalence of TB .[1] To control the TB epidemic, the World Health OrganizaƟ on 
(WHO) has recommended the Directly Observed Treatment Short course strategy (DOTS-
strategy). The implementaƟ on of this strategy started in 1995 and in 2007 there was a populaƟ on 
coverage of 100% in Indonesia with a case detecƟ on rate of 51% of all new TB cases.[2] The 
main clinical elements of the DOTS strategy are free diagnosis, free treatment, and supervised 
treatment.[3] The global targets set by the WHO for 2015 are to have halted and begin to reverse 
the incidence of TB by 2015 and to halve TB prevalence and mortality rates compared with a 
baseline of 1990. In Indonesia the mortality rate has, as of 2006, decreased by 50% compared 
to 1990; however, the prevalence rate was decreased by 32% in 2009 and the incidence rate is 
basically constant since 1990.[1]
 The DOTS strategy depends on passive case fi nding; thus, an important factor in the successful 
diagnosis and treatment of TB is the healthcare seeking behavior of individuals suspected of 
having TB. According to the TB/HIV clinical manual, a TB suspect is defi ned as someone with 
a cough that has lasted for at least two weeks.[4] A long delay in diagnosis is associated with 
increased transmission of TB.[5] To improve the control of TB, it is very important to understand 
the determinants of paƟ ent delay ശ defi ned as the Ɵ me between onset of symptoms and the fi rst 
visit to a healthcare provider ശ and the reasons for fi rst visiƟ ng a DOTS healthcare provider. 
 A limited number of studies has reported on healthcare seeking behavior in the Indonesian 
context. A qualitaƟ ve study performed in Jogjakarta province suggested that income and the 
advice of household members had the strongest infl uence on seeking healthcare.[6] Another 
qualitaƟ ve study by Watkins and Plant idenƟ fi ed addiƟ onal determinants of seeking healthcare, 
including knowledge and awareness of TB, availability of the healthcare provider, cost, and 
sƟ gmaƟ saƟ on.[7] Other studies have shown that age, gender, educaƟ on, and place of residence 
were determinants of seeking healthcare in paƟ ents with TB.[8-10] However, to date, all studies 
on determinants of paƟ ent delay of paƟ ents suspected of TB in the Indonesian populaƟ on were 
qualitaƟ ve; no quanƟ taƟ ve studies have assessed the relaƟ ve importance of various factors, 
including social cogniƟ ve factors, in determining healthcare seeking and paƟ ent delay. 
 Insight in psychosocial determinants of paƟ ent delay and visiƟ ng a DOTS clinic is important as 
these determinants can be used as change targets in health promoƟ on programs. We deployed 
an extended version of the Theory of Planned Behavior (TPB) as a theoreƟ cal framework for 
assessing the psychosocial determinants of paƟ ent delay.[11] The Theory of Planned Behavior 
(TPB) is a social cogniƟ ve model that proposes that the intenƟ on to perform a certain behavior 
is a direct proxy of acƟ on and that this intenƟ on is determined by: (1) the aƫ  tude toward the 
behavior, (2) the subjecƟ ve norm, or the perceived social pressure associated with performing 
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the behavior, and (3) the perceived behavioral control, or the extent to which the paƟ ent thinks 
he/she is capable of performing the behavior.[11] To enhance the predicƟ on of human behavior 
we extended the model wit the following factors; perceived vulnerability for TB, the perceived 
severity of TB, knowledge of TB, perceived severity of symptoms and perceived sƟ gmaƟ saƟ on of 
TB. A detailed descripƟ on of the extended version of the TPB is given in Appendix 2.
 The aim of our study was to assess the (psychosocial) determinants of paƟ ent delay for 
paƟ ents that presented at one of the fi ve governmental lung clinics (with a cough that had 
lasted more than two weeks) in Jogjakarta province, Central Java – with a focus on psychosocial 
determinants. Moreover, we assessed which of these determinants was associated with visiƟ ng 
a DOTS healthcare provider when fi rst seeking healthcare. 
3.2 | MATERIALS AND METHODS 
Design and study populaƟ on
A cross-secƟ onal study was conducted by interviewing TB suspects with a structured 
quesƟ onnaire. The study was conducted in all fi ve lung clinics (all governmental) in Jogjakarta 
province during the second quarter of 2008. The DOTS strategy has been implemented in these 
fi ve lung clinics, and in all healthcare centers (117 in total) and 18 public and private hospitals. 
Details about the study seƫ  ng can be found in Appendix 1. PaƟ ents were eligible for inclusion 
when coughing lasted for at least two weeks. PaƟ ents were excluded from the study when they 
reported coughing for more than 6 months (i.e., to reduce recall bias), when it was not possible to 
interview the paƟ ent (i.e., due to not being able to speak the Indonesian language, severe illness, 
unconsciousness, severe psychiatric disease, severe intellectual impairment, and hearing loss), 
or when the paƟ ent was under 15 years old. The targeted sample size was 200 paƟ ents, based on 
the rule of thumb of a minimum of 15 paƟ ents per predictor with an esƟ mated model consisƟ ng 
of 10 predictors. The number of paƟ ents included in each lung clinic was weighted based on the 
number of paƟ ents diagnosed with TB in each clinic in the second quarter of 2007. ConsecuƟ ve 
sampling was used to include the paƟ ents in the study upon registraƟ on at the lung clinic. All 
paƟ ents provided informed and signed consent to parƟ cipate in the study. Due to cultural norms 
ശ as it is inappropriate to ask further quesƟ ons aŌ er the paƟ ent refused to parƟ cipate – no basic 
socio-demographic data and reasons for refusal could be collected on paƟ ents who refused to 
parƟ cipate. Approximately 15% of the paƟ ents refused to parƟ cipate in the study.
 The study was approved by the Ethical CommiƩ ee of Research in Medical Health of the 
Faculty of Medicine of Gadjah Mada University, Indonesia. 
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QuesƟ onnaire 
The quesƟ onnaire was developed in English, translated into the Indonesian language, and then 
translated back into English to check the translaƟ on. It included socio-demographic data, quesƟ ons 
to asses paƟ ent delay – measured in days from onset of coughing unƟ l fi rst visit to a healthcare 
provider – and healthcare seeking behavior and the items of the extended version of the TPB. 
The socio-economic status was mainly based on property (see Appendix 3 for more detail). Based 
on the cumulaƟ ve score (range 0-46), we classifi ed the paƟ ents as either lower (score <18) or 
upper class (score >18) using a median split as this gave the best correlaƟ on with paƟ ent delay. 
The items of the extended version of the TPB were mainly derived from a study by Watkins and 
Plant conducted on Bali.[7] The TPB items were assessed with quesƟ ons based on a 5-point scale. 
The quesƟ ons were posed to the paƟ ents by asking them to consider what they would do if they 
started coughing again. Thus, paƟ ents were asked about their current consideraƟ ons; they were 
not asked to recall the consideraƟ ons made when they fi rst visited a healthcare provider during 
the current episode of coughing. A detailed outline of the quesƟ onnaire is shown in Appendix 3. 
 To assess the internal consistency of the direct measures of the extended version of the TPB, 
Cronbach’s alpha was calculated (Table 3.1).[12] 
Data collecƟ on
Four trained interviewers performed the interviews in the Indonesian language. AŌ er obtaining 
informed consent, the paƟ ent was interviewed in a quiet room where confi denƟ ality could 
be guaranteed. For paƟ ents 15-18 years old, parental consent was also obtained. To assess 
quesƟ ons related to an event in the past (e.g., the beginning of the cough), the paƟ ent was 
shown a calendar that indicated important holidays and events of the year. PaƟ ents received a 
small non-fi nancial incenƟ ve for parƟ cipaƟ ng in the study. 
Data analyses
The data were double entered in Epi Info soŌ ware, version 3.4.3 (CDC, hƩ p://www.cdc.gov/
epiinfo/). Analyses were performed with SPSS (version 16.0 for MicrosoŌ  Windows).
 PaƟ ent delay was not normally distributed, the Shapiro-Wilk test showed a p-value <.0001; 
therefore, paƟ ent delay was categorised into fi ve categories with approximately equal numbers 
of paƟ ents per category. The determinants of paƟ ent delay were analysed with ordinal 
regression, which takes into account the order of the categories of the dependent variable. 
Ordinal regression assumes that the eī ect of the independent variables is the same across the 
diī erent categories of the dependent variable. The test of parallel lines showed a p-value >.05, 
refl ecƟ ng that use of ordinal regression was jusƟ fi ed.[13] LogisƟ c regression was used to idenƟ fy 
factors that determined the choice of visiƟ ng a DOTS clinic when fi rst seeking healthcare. For 
both outcome measures (paƟ ent delay and fi rst visit being a DOTS clinic), univariate analysis was 
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conducted to esƟ mate the crude eī ects of the factors. Unless otherwise indicated, factors of the 
extended version of the TPB were analysed conƟ nuously. Variables with a p-value <.20 were then 
selected for the mulƟ variate analyses. A likelihood raƟ o backward selecƟ on procedure was used 
to select the variables for the model; variables with a p-value < .10 were maintained. Based on 
the mulƟ variate analyses, adjusted odds raƟ o’s were presented for the variables maintained in 
the model.
3.3 | RESULTS 
PaƟ ent characterisƟ cs 
From the end of April to the end of June 2008, 194 paƟ ents who had been coughing for over 
two weeks were interviewed. The interviews lasted on average 45 minutes to an hour. For fi Ō y-
six paƟ ents (29%), this interview represented their fi rst Ɵ me seeking healthcare. PaƟ ents had 
sought healthcare a median of two Ɵ mes and a maximum of nine Ɵ mes. Eighty-eight paƟ ents 
(45%) visited a private healthcare provider when fi rst seeking healthcare. The mean paƟ ent age 
was 39 years old (14.1 SD, range 16-77) and 104 (54%) paƟ ents were male. On a scale of 0-46, 
the mean SES score was 21 (5.1 SD, range 9-38), which correspondents with middle class. More 
details on paƟ ent characterisƟ cs can be found in Appendix 1.
Determinants of paƟ ent delay 
The median paƟ ent delay was 14 days (range 0-146), with a mean of 19.1 days (1.52 SD). PaƟ ents 
that visited a public healthcare provider when fi rst seeking healthcare had a median paƟ ent 
delay of 17 days (range 0-146); paƟ ents that visited a private healthcare provider had a median 
paƟ ent delay of 7 days (range 0-112). The paƟ ents generally had high intenƟ ons, favourable 
aƫ  tudes, subjecƟ ve norms in favour of visiƟ ng a healthcare provider, and posiƟ ve perceived 
behavioral control, with mean scores above 3.5 (Table 3.1). This means that paƟ ents had the 
intenƟ on to seek healthcare for coughing and perceived no barriers to perform this behavior. The 
direct measures were considered good by the Cronbach’s alpha scores.
 Univariate analyses showed that the factors in the extended version of the TPB (direct and 
indirect measures) were not signifi cantly associated with paƟ ent delay (Table 3.2). PaƟ ents that 
reported many symptoms (5-10) had a shorter paƟ ent delay compared to those that reported 
few (1-4) symptoms. The factors marital status, occupaƟ on, residence (urban/rural), highest 
educaƟ on, SES score, the use of self-medicaƟ on, the use of tradiƟ onal medicine, visiƟ ng a 
tradiƟ onal healer, or the serious symptom of haemoptysis were signifi cantly associated with 
paƟ ent delay.
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Table 3.1 | DescripƟ ve staƟ sƟ cs of the factors included in the extended version of the Theory of Planned 
Behavior. N=194 paƟ ents with a cough that lasted at least two weeks
Mean (range)a Cronbach’s Alphab
IntenƟ on 4.2 (1-5) -- c
Aƫ  tude 4.2 (1-5) 0.89
SubjecƟ ve norm 4.1 (1-5) 0.90
Perceived behavioral control 3.7 (1-5) 0.86
Knowledge score 9.1 (0-15) -- d
Perceived severity of symptoms 3.2 (1-5) 0.81
Perceived severity of TB 2.0 (1-5) 0.80
Perceived vulnerability of TB 2.4 (1-5) 0.96
Perceived sƟ gma 2.1 (1-5) 0.64
a A score below 3 is not in favour of the seeking healthcare for coughing, a score of 3 indicates a neutral posiƟ on, 
and a score >3 is in favour of seeking healthcare for coughing.
b The Cronbach’s alpha is a measure of the internal consistency of quesƟ ons that measure the same factor, and it 
indicates the validity of the measurement of that factor. Cronbach’s alpha ranges from 0 to 1, where an alpha > 0.60 
was considered saƟ sfactory, and an alpha > 0.80 was considered good.
c Not applicable because only one quesƟ on was asked.
d Not applicable because the factor measured diī erent aspects of the knowledge of TB, which do not need to be 
internally consistent with each other. 
The independent variables for the mulƟ variate analysis included gender, symptoms discussed 
with others, fi rst healthcare provider visited, reason for choosing that parƟ cular healthcare 
provider, and travel Ɵ me. Males had longer paƟ ent delays than females, but this eī ect was not 
signifi cant in the mulƟ variate analysis. PaƟ ents that visited a private healthcare provider during 
fi rst healthcare visit had a signifi cant shorter paƟ ent delay compared to paƟ ents visiƟ ng a public 
healthcare provider. Compared to discussing symptoms with a spouse, discussing symptoms with 
other family members was negaƟ vely associated with paƟ ent delay, resulƟ ng in shorter delay. 
In contrast, discussing symptoms with non-family members resulted in more delay (posiƟ ve 
associaƟ on). Among the reasons given for choosing a certain healthcare provider, menƟ oning 
travel distance and travel Ɵ me as reason for visiƟ ng a parƟ cular health care provider was 
signifi cantly associated with a shorter paƟ ent delay compared to menƟ oning quality of service. A 
travel Ɵ me longer than 14 min was associated with a longer paƟ ent delay (p=.054). 
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Table 3.2 | Ordinal regression of determinants of paƟ ent delay in individuals that sought health care for 
a cough that lasted >2 weeks in lung clinics in Jogjakarta province, Indonesia
Variable N Mean paƟ ent 
delay (days)
Crude OR*
(95% CI)
p-value Adjusted OR* 
(95%CI)
p-value
IntenƟ on score a, b
Low 161 18.6 1 --
High മ33 21.3 1.14 (0.59-2.20) 0.71
Aƫ  tude a 194 19.1 1.67 (0.92-3.00) 0.10
SubjecƟ ve norm a 194 19.1 0.73 (0.34-1.55) 0.41
Perceived behavioral control a, b
Low മ79 22.7 1 --
High 115 16.6 0.80 (0.48-1.33) 0.39
Perceived severity of 
symptoms a
194 19.1 1.12 (0.83-1.50) 0.45
Perceived severity of TB a, b
Low മ41 21.7 1 --
High 153 18.4 0.85 (0.46-1.56) 0.60
Perceived vulnerability for 
TB a, b 
Low മ94 18.2 1 --
High 100 20.0 1.19 (0.72-1.94) 0.51
Perceived sƟ gma b
Low 103 21.4 1 --
High മ91 16.5 1,29 (0,78-2,13) 0.31
Knowledge score 194 19.1 1.11 (0.95-1.28) 0.19
Age (decades) 194 19.1 1.11 (0.93-1.32) 0.27
Gender
Female മ90 13.9 1 -- 1 --
Male 104 23.6 2.39 (1.42-3.97) 0.001 1.58 (0.92-2.71) 0.10
OccupaƟ on
Others മ87 18.1 1 --
Private sector 107 19.9 1.16 (0.70-1.91) 0.56
Residence
Rural മ57 20.5 1 --
Urban 137 17.2 0.75 (0.43-1.30) 0.30
Highest educaƟ on 0.28
Elementary school or lower മ50 21.7 1 --
Junior High school മ37 13.5 0.62 (0.29-1.32) 0.22
Senior High school മ68 22.0 1.15 (0.60-2.19) 0.67
University മ39 15.9 0.69 (0.33-1.46) 0.34
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Variable N Mean paƟ ent 
delay (days)
Crude OR*
(95% CI)
p-value Adjusted OR* 
(95%CI)
p-value
Socio economic status
Lower class മ55 21.5 1 --
Upper class 139 18.1 0.84 (0.48-1.45) 0.52
Number of symptoms
1-4 മ85 15.4 1 --
5-10 109 22.0 1.57 (0.94-2.59) മ0.083
Discussed symptoms with <0.001 <0.001
Spouse 123 19.1 1 -- 1 --
Other family members മ47 14.2 0.45 (0.25-0.83) മ0.011 0.44 (0.23-0.85) മ0.014
Non-family members c മ24 28.5 3.00 (1.35-6.68) മ0.007 2.70 (1.19-6.16) മ0.018
First HP* visited d
Public system 106 23.6 1 -- 1 --
Private sector മ88 13.7 0.30 (0.18-0.51) <0.001 0.51 (0.29-0.90) മ0.020
Reasons for visiƟ ng that 
parƟ cular HP 
<0.001 <0.001
Quality of service മ82 24.0 1 -- 1 --
Travel distance/travel Ɵ me മ75 11.7 0.22 (0.12-0.40) <0.001 0.35 (0.18-0.67) <0.001
Other മ37 23.2 0.70 (0.35-1.41) 0.32 0.78 (0.38-1.61) 0.35
Travel Ɵ me to fi rst HP <0.001 മ0.054
0-14 min. മ69 12.0 1 -- 1 --
15-29 min. മ74 20.4 2.77 (1.52-5.05) 0.001 2.17 (1.17-4.04) മ0.014
30 > min. മ51 26.8 5.75 (2.92-11.4) <0.001 2.61 (1.18-5.74) മ0.017
*OR = odds raƟ o; CI = confi dence interval; HP = healthcare provider.
a Factors are coded in such a way that a high score is theoreƟ cally in favour of the behavior.
b Based on a median split of the conƟ nuous variable.
c Includes two paƟ ents who did not discuss their symptoms at all.
d The lung clinics, healthcare centers, and governmental hospitals were categorised as public systems. 
Determinants of visiƟ ng a DOTS clinic when fi rst seeking healthcare 
Of the 194 paƟ ents included in the study, 110 (57%) visited a DOTS healthcare provider when fi rst 
seeking healthcare. The majority of DOTS healthcare providers consisted of lung clinics (55%) and 
healthcare centers (34%). A tendency to visit a DOTS healthcare provider was associated with 
the quality of service as reason to choose a certain healthcare provider (p=.078, Table 3.3). The 
number of reported symptoms was not signifi cantly associated with visiƟ ng a DOTS clinic. Other 
factors that were not associated with visiƟ ng a DOTS healthcare provider when fi rst seeking 
healthcare included; age, use of self-medicaƟ on, and use of tradiƟ onal medicine. Having senior 
high school as highest educaƟ on seems to be signifi cant, but the factor highest educaƟ on as a 
whole was not signifi cant (p=0.18) and could not be kept in the mulƟ variate analyses. 
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Table 3.3 | LogisƟ c regression of determinants for visiƟ ng a DOTS clinic as the fi rst healthcare provider 
by paƟ ents with a cough that lasted > 2 weeks, who visited a lung clinic in Jogjakarta province, Indonesia.
Variable n / N (%) a Crude OR*
(95% CI)
p-value Adjusted OR* 
(95%CI)
p-value
IntenƟ on score b 110 / 188 (59) 0.57 (0.27- 1.18) 0.128
Aƫ  tude b, c 
Low 70 / 109 (64) 1 --
High 40 / 79 (51) 0.57 (0.32-1.03) 0.063
SubjecƟ ve norm b, c 
Low 93 / 146 (64) 1 --
High 17 / 42 (40) 0.39 (0.19-0.78) 0.008 0.25 (0.10-0.59) 0.002
Perceived behavioral control b 110 / 188 (59) 0.77 (0.48-1.25) 0.29
Perceived severity of symptoms b 110 / 188 (59) 0.73 (0.51-1.03) 0.072 0.57 (0.38-0.85) 0.006
Knowledge score 0.70
Low 21 / 37 (57) 1 --
Average 71 / 117 (61) 1.18 (0.56-2.49) 0.67
High 18 / 34 (53) 0.86 (0.34-2.19) 0.75
Gender
Female 47 / 88 (53) 1 --
Male 63 / 100 (63) 1.49 (0.83-2.66) 0.18
Highest educaƟ on  0.18
Elementary school or lower 24 / 49 (49) 1 --
Junior High school 21 / 35 (60) 1.56 (0.65-3.76) 0.32
Senior High school 45 / 66 (68) 2.23 (1.04-4.79) 0.039
University 20 / 38 (53) 1.16 (0.50-2.70) 0.74
Main occupaƟ on
Others 41 / 84 (49) 1 -- 1 --
Private sector 69 / 104 (66) 2.07 (1.15-3.73) 0.016 2.77 (1.38-5.53) 0.004
Residence
Rural 29 / 54 (54) 1 --
Urban 81 / 134 (60) 1.32 (0.70-2.49) 0.40
Socio economic status score 
(conƟ nuous)
110 / 188 (59) 0.98 (0.92-1.03) 0.42
Total number of symptoms 110 / 188 (59) 0.90 (0.78-1.05) 0.17
Discussed symptoms with others 0.16
Spouse 72 / 120 (60) 1 --
Other family members 21 / 44 (48) 0.61 (0.30-1.22) 0.16
Non-family members d 17 / 24 (71) 1.62 (0.62-4.20) 0.32
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Variable n / N (%) a Crude OR*
(95% CI)
p-value Adjusted OR* 
(95%CI)
p-value
Reasons for visiƟ ng that parƟ cular 
HP 
 0.078
Travel distance/travel Ɵ me 35 / 72 (49) 1 --
Quality of service 54 / 81 (67) 2.11 (1.10-4.06) 0.025
Other 21 / 35 (60) 1.59 (0.70-3.60) 0.27
Travel Ɵ me to fi rst HP (hr) 110 / 188 (59) 15.0 (4.1-54.7) <0.001 29.0 (6.4-132) <0.001
*OR = odds raƟ o; CI = confi dence interval; HP = healthcare provider.
a n = number of paƟ ents that visited a DOTS HP; N = total number of paƟ ents in this category.
b Factors are coded such that a high score is theoreƟ cally in favour of the behavior. 
c Based on a median split of the conƟ nuous variable.
d Includes two paƟ ents who did not discuss their symptoms at all.
MulƟ variate analyses showed a signifi cantly lower chance of visiƟ ng a DOTS healthcare provider 
when fi rst seeking healthcare among those reporƟ ng a posiƟ ve subjecƟ ve norm and perceiving 
their symptoms as serious. PaƟ ents visiƟ ng a DOTS clinic were signifi cantly more oŌ en employed 
in the private sector and reported a signifi cant longer travel Ɵ me. We also tested what eī ect 
paƟ ent delay would have on visiƟ ng a DOTS clinic by including it in the mulƟ variate analysis. 
PaƟ ent delay was signifi cantly and posiƟ vely associated with visiƟ ng a DOTS healthcare provider 
when fi rst seeking healthcare. PaƟ ent delay only minimally changed the eī ects of the other 
determinants.
3.4 | DISCUSSION 
The aim of our study was to assess the determinants of paƟ ent delay of paƟ ents suspected 
of TB (defi ned as a paƟ ent with a cough for at least two weeks) presenƟ ng at a lung clinic in 
Jogjakarta province, Central Java. This study was the fi rst to apply a theoreƟ cal framework to an 
invesƟ gaƟ on of paƟ ent delay determinants in TB. The median paƟ ent delay was 14 days, range 
0-145. A shorter paƟ ent delay was signifi cantly associated with choosing a private healthcare 
provider when fi rst seeking healthcare, reporƟ ng travel distance/travel Ɵ me as reason for 
choosing a certain healthcare provider when fi rst seeking healthcare, discussing the symptoms 
with family, and a short travel Ɵ me to the fi rst healthcare provider. The extended version of the 
TPB did not appear to oī er a further explanaƟ on of paƟ ent delay. VisiƟ ng a DOTS clinic when fi rst 
seeking healthcare was determined by a posiƟ ve subjecƟ ve norm towards seeking healthcare for 
coughing, perceiving their symptoms as severe, employment in the private sector, and a longer 
travel Ɵ me to the fi rst visited healthcare provider. 
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Some limitaƟ ons were inherent to our study design. First, paƟ ents who did not visit one of the 
lung clinics were not interviewed, including those that did not seek healthcare; this probably 
resulted in an underesƟ maƟ on of paƟ ent delay. Also, paƟ ents with TB that visited a lung clinic 
with a cough that lasted less than two weeks were not interviewed; which in turn could have 
resulted in an overesƟ maƟ on of paƟ ent delay. Second, the paƟ ents were asked about their beliefs 
regarding visiƟ ng a healthcare provider aŌ er they had performed this behavior. Had the paƟ ents 
been asked to recall their past beliefs regarding visiƟ ng a healthcare provider, there answers 
might have got altered by their current beliefs. Besides that, it is easier for a paƟ ent to state his 
current beliefs instead of recalling past beliefs. Therefore, we assumed that the current beliefs, 
although they may have been altered by performing the behavior, sƟ ll express the diī erences 
in beliefs associated with diī erences in paƟ ent delay. However, as the TPB assumes that a 
certain level of intenƟ on is needed before the paƟ ent performs the behavior, these diī erences 
in beliefs and intenƟ ons might have faded away in the process of healthcare seeking. To avoid 
these inherent limitaƟ ons, an alternaƟ ve study design would be to idenƟ fy paƟ ents suspected 
of TB at the household level. However, that would have required invesƟ gaƟ ng a prohibiƟ vely 
large populaƟ on in order to include an equivalent number of paƟ ents with a cough that lasted 
at least two weeks. In this study we were unable to directly determine reasons why people 
delayed. When paƟ ents where asked for reasons why they delayed, most of them stated it was 
because of the symptoms were not severe. The high rate of this answer while perceived severity 
of symptoms was not associated with the delay suggests that this might be a social desirable 
answer. These limitaƟ ons may partly explain why this study did not idenƟ fy any of the TPB factors 
as determinants of paƟ ent delay with the included number of paƟ ents. 
 In this study, the median paƟ ent delay was relaƟ vely short (14 days) compared to other 
studies conducted in both developing and developed countries that reported a median delay 
of over 20 days.[14-22] The relaƟ vely short paƟ ent delay found in this study may be due to the 
fact that the majority of the included paƟ ents lived in urban areas with an extended network 
of healthcare providers.[9,23-25] Thus, our study populaƟ on had good access to healthcare. 
Therefore, the generalisability of our study may be restricted to urban and sub-urban areas with 
a relaƟ vely accessible healthcare system. 
 The fi nding that discussing the symptoms with family was associated with shorter paƟ ent 
delay compared to discussing the symptoms to non-family members confi rmed the suggesƟ on 
by Watkins and Plant and RinƟ swaƟ  et al. that the opinions of people next to the paƟ ents 
have an important infl uence on their healthcare seeking behavior.[6,7] Studies conducted in 
Botswana,[26] South Africa,[16] and Malawi[27] also found a posiƟ ve relaƟ onship between 
advice from others and healthcare seeking behavior, but they did not analyse the associaƟ on with 
paƟ ent delay.[16,26,27] The posiƟ ve infl uence of the advice of family members on healthcare 
seeking behavior highlights the need for populaƟ on-wide educaƟ on programs to inform both 
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the high risk populaƟ on and their social environment on adequate healthcare seeking behavior 
for coughing more than 2 weeks. We found that choosing a public healthcare provider when fi rst 
seeking healthcare was associated with a signifi cantly longer paƟ ent delay. This fi nding was also 
reported in a study on TB conducted in South India.[14] A study conducted in Malawi also found 
that the distance to a healthcare provider and the quality of service were the main reasons for 
choosing a parƟ cular healthcare provider when fi rst seeking healthcare, but that study did not 
analyse the eī ect on paƟ ent delay.[27] Other studies conducted in Ethiopia and South India 
also found that travel Ɵ me or distance were signifi cant determinants of paƟ ent delay.[14,21] 
These results suggested that availability, parƟ cularly of public healthcare providers, should be 
the primary concern of policy makers.
 It is diĸ  cult to explain the fi nding that working in the private sector was signifi cantly 
associated with a higher probability of choosing a DOTS clinic when fi rst seeking healthcare. 
A possible explanaƟ on could be that people working in the private sector had higher incomes, 
which enabled access to beƩ er transportaƟ on and reduced the issue of distance to the clinic. 
Another explanaƟ on could be that people in the private sector were more likely to work in shiŌ s; 
thus, they were more likely to be free for morning visits to a DOTS healthcare provider, which 
were only open during the morning hours. Other studies found an associaƟ on between distance 
and choosing a DOTS healthcare provider in general, but those studies did not analyse the 
associaƟ on between distance and visiƟ ng a non-DOTS healthcare provider.[18,21] A qualitaƟ ve 
study conducted in Vietnam invesƟ gated specifi c reasons for choosing a private healthcare 
provider versus a healthcare provider connected to the NaƟ onal TB Program (NTP).[28] They 
found that paƟ ents perceived that the NTP provided good healthcare, but other qualitaƟ ve 
aspects were considered negaƟ ve (e.g. DOTS treatment regimes and longer waiƟ ng Ɵ mes). That 
might also have been the case in our study. We found that paƟ ents were more likely to visit a 
DOTS clinic when quality of service was their reason for choosing their fi rst healthcare provider; 
however, those paƟ ents exhibited a signifi cantly longer paƟ ent delay. This suggests that paƟ ents 
who valued quality of service above other characterisƟ cs in the healthcare provider experienced 
barriers to visiƟ ng the healthcare provider of their choice. One important barrier to visiƟ ng 
a DOTS healthcare provider seems to be the travel Ɵ me as people visiƟ ng a DOTS healthcare 
provider when fi rst seeking healthcare had a signifi cant longer travel Ɵ me. Therefore, to improve 
the uƟ lizaƟ on of the DOTS healthcare providers, the focus should be on improving accessibility. 
A posiƟ ve subjecƟ ve norm towards seeking healthcare for coughing was negaƟ vely associated 
with visiƟ ng a DOTS health care provider during fi rst healthcare seeking acƟ on. It suggests that 
important others give the paƟ ents the advice to visit a non-DOTS healthcare provider as fi rst 
healthcare visit. This fi nding further highlights the need not to target the high-risk populaƟ on 
only but also the people that are important to them, especially family members.
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Another major fi nding of our study was that none of the factors of the extended version of 
the TPB was signifi cantly associated with paƟ ent delay. This suggested that these factors were 
not relevant to the control of TB. Nevertheless, the role of psychosocial factors cannot be 
fully excluded, because we found that discussing the symptoms with others and the reasons 
of paƟ ents for choosing their fi rst healthcare provider were important determinants of paƟ ent 
delay. Thus, conclusions about the importance of psychosocial factors in determining paƟ ent 
delay must await future studies that idenƟ fy paƟ ents with suspected TB at the household level, 
before they visit a healthcare provider. 
 PaƟ ents that visited a private healthcare provider when fi rst seeking healthcare had a paƟ ent 
delay suĸ  ciently short to obviate the necessity of further decreasing the delay. In fact, a shorter 
delay may be counterproducƟ ve in the control of TB, because the diĸ  culty in recognising the 
early symptoms of TB could result in a longer system delay.[4] Early treatment of symptoms 
without a proper diagnosis could lead to inappropriate anƟ bioƟ c use, an increased delay in 
the diagnosis of TB and unnecessary uƟ lizaƟ on of the healthcare system. However, the public 
system had a considerably longer paƟ ent delay. Because most public healthcare providers are 
DOTS healthcare providers, this indicated that the DOTS healthcare system lacked accessibility. 
The best way to address this would be to increase the density of public and DOTS healthcare 
providers, because the travel Ɵ me to the healthcare provider was also an important determinant 
of paƟ ent delay. However, given the popularity of private healthcare providers and their high 
density in Jogjakarta province,[29] it might be more eī ecƟ ve to extend the DOTS strategy to the 
private sector. This was also suggested in a study that used a mathemaƟ cal model to esƟ mate the 
impact of diī erent strategies on tuberculosis mortality and treatment outcome.[30] Although 
Ahmad et al. concluded that acƟ vely fi nding cases would provide the best outcomes,[30] that 
strategy may be less cost eī ecƟ ve than other strategies, including involvement of the private 
sector in the DOTS strategy. Mahendradhata et al. conducted a study to evaluate the incremental 
cost-eī ecƟ veness of such an iniƟ aƟ ve in Jogjakarta province where private pracƟ Ɵ oners were 
engaged to refer paƟ ent suspected of TB to an healthcare center for DOTS-treatment.[29] They 
concluded that this strategy could be cost-eī ecƟ ve given a well funcƟ oning DOTS program. 
Nevertheless, extending the DOTS strategy to the private sector would involve some diĸ  culty. 
Some characterisƟ cs of the DOTS programs (e.g., supervised treatment) may confl ict with 
characterisƟ cs of private healthcare providers (e.g., fl exibility and privacy). Also, the broad 
variety of types of private healthcare providers poses a challenge for successfully extending the 
DOTS strategy to the private sector. Despite these challenges, some iniƟ aƟ ves are currently being 
implemented to involve the private sector in TB control. The results of our study support the 
usefulness of these eī orts. Yet some consideraƟ ons need to be made. A recent study conducted 
in Jogjakarta province showed that visiƟ ng a DOTS healthcare provider during fi rst healthcare 
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visit did not result in a shorter diagnosƟ c delay suggested that the focus fi rst need to be on 
strengthening the health system and improving diagnosƟ c quality within DOTS services.[31]
 We conclude that accessibility of the healthcare provider was the primary determinant of 
paƟ ent delay, and that psychosocial factors were not signifi cant determinants of this delay. Given 
the short reported paƟ ent delay when a private healthcare provider was chosen in fi rst seeking 
healthcare, we recommend that the major concern of policymakers should be improving the 
uƟ lizaƟ on of DOTS healthcare providers, parƟ cularly in the private sector.
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Appendix 1 | Seƫ  ng of the study performed in Yogyakarta province, Indonesia, 
to idenƟ fy paƟ ent delay determinants for paƟ ents with suspected tuberculosis 
and addiƟ onal paƟ ent characterisƟ cs
Seƫ  ng
Yogyakarta Province is a densely populated province in Central Java that is well developed 
compared to other parts of Indonesia. Of the 3.2 million inhabitants, approximately 44% live in 
rural areas.[1] The healthcare system consists of an extended network of healthcare providers 
including public, private, and tradiƟ onal healthcare providers. The DOTS strategy is widely 
implemented in the governmental health system, and recently, the private sector has also goƩ en 
involved.[1] Part of the public system includes fi ve governmental (fi rst line) clinics specialised in 
the treatment of lung diseases. These specialised services are established in urban and suburban 
areas, and they are visited by paƟ ents from Yogyakarta province and the surrounding provinces, 
including both urban and rural areas. The services of the lung clinics are only available during the 
morning hours.
AddiƟ onal paƟ ent characterisƟ cs
Most of the included paƟ ents (166, 86%) reported three or less healthcare seeking acƟ on or 
before. Of the included paƟ ents, 151 (78%) were from two lung clinics located in the city of 
Yogyakarta. The other 43 paƟ ents (22%) were interviewed in one of the other three clinics 
located in the suburban and rural areas of Yogyakarta province. A total of 137 paƟ ents (71%) 
resided in an urban area and 20 paƟ ents (10%) resided outside Yogyakarta province. The paƟ ents 
were rather well educated, only 4 (2%) paƟ ents had not aƩ ended any school, and 39 paƟ ents 
(20%) had a university degree. Half of the paƟ ents had used self-medicaƟ on, 62 (32%) had tried 
tradiƟ onal medicines, and 13 (7%) reported visiƟ ng a tradiƟ onal healer when seeking healthcare. 
None of the laƩ er 13 paƟ ents had visited a tradiƟ onal healer the fi rst Ɵ me they had sought 
healthcare.
 One third of the paƟ ents (60, 31%) visited a lung clinic when fi rst seeking healthcare; 52 
paƟ ents visited a private doctor (27%); and 37 visited a healthcare center (19%). The other 
paƟ ents visited a private clinic (14, 7%), a midwife or nurse (13, 7%), or a hospital (17, 9%). One 
paƟ ent visited a hospital in Japan.
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Appendix 2 | Conceptual framework for the extended version of the Theory of 
Planned Behavior for idenƟ fying paƟ ent delay determinants for paƟ ents with 
suspected tuberculosis in Yogyakarta province, Indonesia
The Theory of Planned Behavior (TPB) is a social cogniƟ ve model used to idenƟ fy beliefs and 
cogniƟ ons that underlie the intenƟ on to perform a certain behavior. The model assumes that the 
intenƟ on to perform a certain behavior is a direct proxy of the behavior and that this intenƟ on 
is determined by three major factors: (1) a favourable or unfavourable aƫ  tude of the paƟ ent 
toward the behavior, (2) the subjecƟ ve norm, a measure of the social pressure associated with 
performing the behavior, which is perceived by the paƟ ent, and (3) the perceived behavioral 
control, or the extent to which the paƟ ent thinks he/she is capable of performing the behavior. 
Each of these three factors can be measured directly and indirectly. For example, the aƫ  tude 
of an individual toward the behavior can be measured directly by asking the individual whether 
he/she perceives the behavior to be pleasant, good, benefi cial etc. and indirectly by measuring 
the paƟ ent’s behavioral beliefs. However, individual beliefs do not have equal importance in 
infl uencing the behavior; thus, each belief should be weighted according to the outcome 
evaluaƟ on of that belief. In the same way, the subjecƟ ve norm can be assessed indirectly by 
assessing the paƟ ent’s percepƟ on of what important other people think about the behavior 
(normaƟ ve beliefs), weighted by the paƟ ent’s moƟ vaƟ on to comply with the wishes of these 
important others (moƟ vaƟ on to comply). Perceived behavioral control is composed of the 
paƟ ent’s beliefs about the presence of certain barriers (control belief strength), weighted by the 
paƟ ent’s percepƟ on of being able to control those barriers (control belief power). 
 Despite the extensive body of literature on the determinants of paƟ ent delay in paƟ ents 
with TB and those with suspected TB,[1,2] no studies could be idenƟ fi ed that have applied a 
theoreƟ cal framework to invesƟ gate the percepƟ ons and cogniƟ ons that underlie paƟ ent delay. 
Several studies have emphasized the use of the TPB as a theoreƟ cal framework for explaining 
paƟ ent delay for other diseases.[3,4] One study applied the TPB to explain variaƟ ons in help-
seeking intenƟ ons for symptoms of breast cancer.[5] Their work suggested that aƫ  tude and 
perceived behavioral control were signifi cantly higher in subjects who intended to seek 
healthcare promptly compared to potenƟ al delayers. Compton and Esterberg performed a pilot 
study to examine associaƟ ons between the three central constructs of the TPB and treatment 
delay for a fi rst episode of non-aī ecƟ ve psychosis.[6] Although that study focused on treatment 
delay, rather than paƟ ent delay, and they interviewed relaƟ ves, rather than the paƟ ents, the 
study design was similar to the present study. They found that perceived behavioral control and 
a perceived sƟ gma were signifi cantly inversely associated with treatment delay. Those studies 
suggested that the TPB could be applied as a theoreƟ cal framework for describing paƟ ent delay 
in general.
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Although the TPB has not been applied before in the context of TB, the literature has suggested 
that the factors of the TPB may be able to explain variaƟ ons in paƟ ent delay for paƟ ents with 
suspected TB. Some studies have suggested that beliefs about geƫ  ng healthcare had an eī ect 
on the healthcare seeking behavior of paƟ ents with TB and suspected TB. Watkins and Plant, 
and RinƟ swaƟ  et al. pointed out the infl uence of important other people on healthcare seeking 
behavior, and also menƟ oned several external constraints that may infl uence healthcare seeking 
behavior.[7,8] 
 To enhance the predicƟ on of human behavior, the TPB can be extended with measures 
specifi cally associated with paƟ ent delay. Based on a review of the literature, we extended the 
model with two factors from the Health Belief Model (HBM); the perceived vulnerability for TB, 
or the perceived chances of acquiring TB, and the perceived severity of TB, or the perceived 
seriousness and consequences of TB.[9-11] The TPB was further extended with the knowledge of 
TB,[7,12-14] perceived severity of symptoms,[7,9,15] and perceived sƟ gmaƟ saƟ on of TB.[7,16] 
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Appendix 3 | Outline of the quesƟ onnaire for idenƟ fying paƟ ent delay determi-
nants for paƟ ents with suspected tuberculosis in Yogyakarta province, Indonesia
The quesƟ onnaire included socio-demographic data (name, age, residence, civil status, religion, 
educaƟ on, and primary occupaƟ on). The socio-economic status (SES) was esƟ mated by assessing 
home ownership, home building materials, drinking water and energy sources, and property 
(car, motorcycle, bicycle, cable TV, DVD player, non-cable TV, VCD player, radio, air condiƟ oner, 
washing machine, or refrigerator). These items were scored according to their economic value. 
Based on the cumulaƟ ve score (range 0-46), we classifi ed the paƟ ents as either lower (score < 
18) or upper class (score >18). PaƟ ent residences were categorised as urban or rural, based on 
data from the naƟ onal government.[1] The duraƟ on of paƟ ent delay (in days) was measured 
by asking the paƟ ent when the symptoms started and the date of the fi rst healthcare visit. 
AddiƟ onal quesƟ ons assessed other symptoms (in addiƟ on to coughing) that prompted the 
fi rst decision to seek healthcare, use of self-medicaƟ on, use of tradiƟ onal medicine, the type of 
healthcare provider fi rst visited, and the reasons for visiƟ ng that parƟ cular healthcare provider at 
that parƟ cular Ɵ me. Other informaƟ on was obtained concerning the visit, including the travelling 
Ɵ me and distance to the fi rst health care provider and the costs (in Indonesian Rupiah) expended 
in making the fi rst healthcare visit. 
 The items of the extended version of the TPB were mainly derived from a study by Watkins 
and Plant conducted in Bali, which explored the healthcare seeking behavior of paƟ ents with 
TB and suspected TB.[2] We also searched the literature to idenƟ fy other potenƟ al factors 
for determining paƟ ent delay. The behavior we were interested in studying was a visit to a 
healthcare provider to get treatment for coughing. The TPB items were assessed with quesƟ ons 
based on a 5-point scale. The quesƟ ons were posed to the paƟ ents by asking them to consider 
what they would do if they started coughing again. Thus, paƟ ents were asked about their current 
consideraƟ ons; they were not asked to recall the consideraƟ ons made when they fi rst visited a 
healthcare provider during the current episode of coughing.
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Factor
(number of itmes1)
Example Scale
IntenƟ on (1) The next Ɵ me you start coughing, you will make 
plans to visit a healthcare provider to get 
healthcare
1. strongly disagree
2. disagree
3. not disagree, not agree
4. agree 
5. strongly agree
Aƫ  tude (7) For you, visiƟ ng a healthcare provider to get 
healthcare when you start coughing is:
 – harmful-beneficial 
 – good-bad
 – unpleasant-pleasant
1. very harmful
2. harmful
3. not harmful, not benefi cial
4. benefi cial
5. very benefi cial
Behavioral beliefs (6) 2 If you visit a healthcare provider to get 
healthcare when you start coughing:
 – you will get the correct diagnosis
 – the coughing will be cured
1. very unlikely
2. unlikely
3. neither unlikely, nor likely
4. likely
5. very likely
Outcome evaluaƟ on 
(6) 2
 – Getting the correct diagnose is […] 3
 – Getting the coughing cured is […] 3
1. extreme undesirable
2. undesirable
3. neither undesirable or 
desirable 
4. desirable 
5. extreme desirable
SubjecƟ ve norm (6)  – You are expected to visit a healthcare provider 
to get healthcare when you start coughing
 – If you visit a healthcare provider to get health-
care when you start coughing, you will be 
supported by most people who have influence 
on you
1. strongly disagree
2. disagree
3. neither agree or disagree
4. agree 
5. strongly agree
NormaƟ ve beliefs (6) 4  – Your parents/family would approve of your visit 
to a healthcare provider to get healthcare when 
you start coughing
Your parents/family will visit a healthcare provider 
to get healthcare when they start coughing
1. strongly approve
2. approve
3. neither approve or 
disapprove
4. disapprove 
5. strongly disapprove
1. completely true
2. true
3. neither true or false
4. false 
5. completely false
MoƟ vaƟ on to comply 
(6) 4
 – What your parents/family think you should do 
is important to you
 – Doing what your parents/family do is important 
to you
1. not at all 
2. a bit 
3. average
4. much
5. very much
Perceived behavioral 
control (6)
Imagine that you started coughing again. You want 
to go to a healthcare provider to get healthcare for 
coughing but: 
 – you do not have enough money for visiting the 
healthcare provider. How confident are you that 
you can visit the healthcare provider?
 – you find out that the additional costs for 
travelling and food are very high. In this 
situation, you feel yourself […] 2 to visit the 
healthcare provider
1. very unconfi dent 
2. unconfi dent 
3. neither confi dent or 
unconfi dent
4. confi dent
5. very confi dent
1. very able
2. able
3. neither able, nor unable
4. unable
5. very unable
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Factor
(number of itmes1)
Example Scale
Control beliefs strength 
(5) 4
When you visit a healthcare provider to get 
healthcare when you start coughing:
 – you expect it will be time consuming 
 – you expect it will be easy to get to the health 
facility
1. strongly disagree
2. disagree
3. neither agree or disagree
4. agree 
5. strongly agree
Control beliefs power 
(5) 4
 – When it is time consuming to visit a healthcare 
provider it is […] 2 that you will visit a healthcare 
provider to get healthcare when you start 
coughing
 – When it is easy to get to the healthcare 
provider it will be […] 2 that you will visit a 
healthcare provider to get healthcare when 
you start coughing
1. much less likely 
2. less likely
3. the same chance 
4. more likely 
5. much more likely
Knowledge score (15) 6  – TB can be caused by smoking
 – TB can be transmitted by food
 – Coughing is a symptom of TB
1. true
2. false
3. don’t know
Perceived severity of 
symptoms (3)
When you visited a healthcare provider for the 
fi rst Ɵ me during this period of coughing to get 
healthcare for coughing:
 – your symptoms were life threatening 
 – your symptoms were serious
1. strongly agree
2. agree
3. neither agree or disagree
4. disagree 
5. strongly disagree
Perceived severity of 
TB (3)
 – Tuberculosis is a life threatening disease
 – Tuberculosis might lead to death if left 
untreated
1. strongly agree
2. agree
3. neither agree or disagree
4. disagree 
5. strongly disagree 
Perceived vulnerability 
for TB (3)
 – Your chances of getting TB are
 – You think that your risk of getting diagnosed  
with TB is
1. very low 
2. low
3. average
4. high
5. very high
1. very unlikely
2. unlikely
3. average
4. likely
5. very likely 
Perceived sƟ gma (8) Imagine that you are diagnosed with TB; what 
do people in the community think about you:
 – People in the community think that you are  
dirty 
 – People in the community think that you will 
not be allowed to work 
1. strongly disagree
2. disagree
3. neither agree or disagree
4. agree 
5. strongly agree
1 Number of quesƟ ons asked to assess factor. 
2 These factors are indirect measures of aƫ  tude.
3 The paƟ ents were asked to fi nish the sentence with the opƟ on that was most applicable to their situaƟ on.
4 These factors are indirect measures of subjecƟ ve norm.
5 These factors are indirect measures of perceived behavioral control.
6 The knowledge quesƟ ons covered the subject’s knowledge of the causes of TB, ways of transmiƫ  ng TB, curability 
of TB, and symptoms of TB.
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SUMMARY
Background: Care seeking behavior of individuals with symptoms of tuberculosis (TB) is a criƟ cal 
factor in early detecƟ on and treatment. Thorough understanding of determinants of the care 
seeking process will help TB program managers to improve TB case fi nding. The objecƟ ve of this 
study is to assess determinants of care seeking behavior in individuals with TB symptoms at the 
populaƟ on level. 
Methods: A cross secƟ onal survey was conducted. Adult individuals with cough longer than 
two weeks were interviewed. Data on sociodemographics, TB status, onset of TB symptoms, TB 
knowledge , type of health facility visited, and duraƟ on of each visit were collected. 
Results: In total, 746 respondents were interviewed. Approximately 10% of TB suspects had not 
yet sought care. Of those who had sought care, less than half presented directly to medical 
health care providers. Female gender and mulƟ ple symptoms were associated with care seeking 
acƟ on. The median duraƟ on of paƟ ent delay was 17 days. Male gender and unemployment were 
associated with longer delay in presentaƟ on. 
Conclusions: The paƟ ent delay of individuals with TB symptoms in Jogjakarta province is relaƟ vely 
short. Eī orts need to be focused on encouraging TB suspected individuals to seek appropriate 
services through health educaƟ on and quality improvement of health providers.
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4.1 | INTRODUCTION
Early detecƟ on and treatment are crucial determinants of successful tuberculosis (TB) control. 
Reducing diagnosƟ c delay shortens the infecƟ ous period and improves treatment outcome, 
which will lead to a signifi cant reducƟ on in transmission of TB in the community.[1,2] As TB 
control programs rely on passive case fi nding, care-seeking behavior of TB paƟ ents is a criƟ cal 
factor for early diagnosis. 
 Many similar studies on care seeking behavior among TB paƟ ents have been conducted.
[3-5] These reports found that paƟ ent delay, oŌ en defi ned as a duraƟ on from the onset of TB 
symptoms to the fi rst visit to a health care provider, is on average longer than 4 weeks in many 
developing countries; this is considered an acceptable duraƟ on of diagnosƟ c delay for smear-
posiƟ ve TB cases.[6] However, these were mostly facility based studies at TB control program-
aĸ  liated health faciliƟ es. Therefore the results may underesƟ mate paƟ ent delay, as many TB 
cases in developing countries are diagnosed and treated by private health providers.[7] Also, 
some paƟ ents are likely never diagnosed, and are thus missing enƟ rely. Despite evidence 
suggesƟ ng a signifi cant contribuƟ on of paƟ ent delay to overall diagnosƟ c delay,[3-5] only a 
limited number of studies have explored determinants of paƟ ent delay or the decision to iniƟ ate 
care-seeking acƟ on at the community level.[8-13] While the Ɵ me dependent nature of paƟ ent 
delay is variable, the above menƟ oned studies did not take this aƩ ribute into consideraƟ on when 
exploring determinants of paƟ ent delay.
 Several studies on care seeking behavior of TB paƟ ents were conducted in Indonesia.[14-16] 
However, these studies were all performed at TB control program-aĸ  liated health faciliƟ es, thus 
suī er from the same limitaƟ ons as many previous health facility-based studies on TB paƟ ents’ 
care seeking behavior. Our study aims to explore the determinants of care seeking behavior of 
individuals with TB symptoms at the populaƟ on level. We also quanƟ fy the magnitude of paƟ ent 
delay and its determinants. To this end, we did a cross secƟ onal survey in the community among 
individuals with TB symptoms.
4.2 | METHODS
Study seƫ  ng
Jogjakarta province is located in the central part of Java Island and has fi ve districts. The 
populaƟ on is approximately 3.5 million, with 44% living in rural areas. The demographic 
composiƟ on is predominantly adult, with 51% being 25-59 years old and 13% over 59 years old.
[17] The province has a well funcƟ oning health system consisƟ ng of approximately 2000 private 
pracƟ Ɵ oners, 117 health centers, 9 public hospitals, and 24 private hospitals. It has a relaƟ vely 
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well-established TB control program, implemented using the World Health OrganizaƟ on (WHO) 
endorsed Direct Observed Treatment Short-course (DOTS) strategy. The backbone of the local TB 
program is a network of all 117 health centers, 18 public and private hospitals, and 5 lung clinics. 
The esƟ mated TB incidence in the province in 2004 is 63/100 000.[18]
 
Data collecƟ on
We conducted a cross secƟ onal survey using a modifi ed WHO/Expanded Program on ImmunizaƟ on 
(WHO/EPI) rapid survey.[19,20] We selected three districts: Jogjakarta, Sleman, and Bantul to 
represent urban, suburban, and rural areas, respecƟ vely. FiŌ y communiƟ es (clusters) were 
randomly selected with probability proporƟ onate to populaƟ on size. In each cluster the fi rst 
household to be visited was randomly selected. The nearest household from the fi rst selected 
household was the next visited, and so on unƟ l 15 eligible respondents were recruited. Inclusion 
criteria were age 15 years or above, persistent cough for more than two weeks, and willingness 
to parƟ cipate. Exclusion criteria were reported chronic respiratory problems (asthma, chronic 
obstrucƟ ve pulmonary disease), not understanding the survey procedure or quesƟ ons, or refusal 
to parƟ cipate.
 Seven interviewers were trained to perform data collecƟ on. Interviews were conducted in 
the Indonesian language. A fi eld manager reviewed the results daily for validity of respondents’ 
responses. A re-interview was conducted if considered necessary. PaƟ ents were interviewed 
using a structured quanƟ taƟ ve quesƟ onnaire. 
 The quesƟ onnaire consisted of quesƟ ons on socio-demographics, TB status, onset of TB 
symptoms, knowledge of TB (cause, symptoms, transmission, and treatment), number and type 
of health faciliƟ es uƟ lized, duraƟ on between symptom onset to the fi rst care seeking acƟ on, and 
subsequent visits prior to the interview. Perceived accessibility (accessible distance, fl exibility of 
service Ɵ me, ease of transportaƟ on), aī ordability (price of service and transportaƟ on), service 
quality (good reputaƟ on, provider hospitality, strong medicine), and the role of signifi cant others 
(families, neighbours, and friends) in determining the fi rst health facility uƟ lized were also 
recorded. 
 We defi ned paƟ ent delay as duraƟ on between reported onset of the symptom to the reported 
fi rst medical health care provider visit, which was not necessarily the fi rst care seeking acƟ on.
[21] Medical health care providers consisted of private pracƟ Ɵ oners, health centers, hospitals, 
and lung clinics, while alternaƟ ve health providers consisted of tradiƟ onal medicine pracƟ Ɵ oners 
and local kiosks or pharmacies that sell over the counter (OTC) drugs. The alternaƟ ve health 
providers do not have access to TB diagnosƟ c faciliƟ es, thus visiƟ ng these providers will not lead 
to a confi rmed TB diagnosis.
 The interview results were double entered by research assistants and the two resulƟ ng fi les 
compared to evaluate for typing errors, missing data, and inconsistencies before analysis.
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StaƟ sƟ cal analysis
Data were analysed using SPSS for Windows version 16. LogisƟ c regression was used to analyse 
the determinants of suspected TB paƟ ents who iniƟ ated care-seeking acƟ on versus not iniƟ aƟ ng 
acƟ on. Second, it was used for those visiƟ ng medical health care providers among suspected 
TB paƟ ents starƟ ng the care seeking process versus visiƟ ng alternaƟ ve health providers. Cox 
proporƟ onal hazard model (survival analysis) was used to analyse determinants of paƟ ent delay. 
We assumed that paƟ ents who had not yet visited a medical health care provider might later on 
visit one. Therefore, we took the duraƟ on of care seeking process or illness of these individuals 
into consideraƟ on in the survival analysis as right censored at the point of interview. Factors were 
fi rst tested univariately. Factors with P values <0.20 were included in the mulƟ variate model and 
entered using the backward LR method. Factors with P values <0.05 were maintained in the fi nal 
model. DuraƟ on of paƟ ent delay was presented as median with inter-quarƟ le range (IQR). The 
median of paƟ ent delay was calculated using the Kaplan-Meier survival method. 
Ethical consideraƟ on
Prior to recruitment, wriƩ en consent was obtained from all respondents or their guardian in case 
of respondents aged 15-18 years. Respondents were recommended to have a sputum smear 
examinaƟ on at the nearest health center following the interview process. The study received 
ethical approval from the ethical commiƩ ee of the Faculty of Medicine, Gadjah Mada University.
4.3 | RESULTS
Of those individuals who were idenƟ fi ed as having symptoms suspected for TB, all agreed to 
parƟ cipate. A total of 746 individuals with cough for more than two weeks were interviewed 
(Table 4.1). Approximately 62% of respondents were female, 44.5% were sixty years old and older, 
70.1% were married, and 67.3% had an elementary or lower educaƟ on level. More than one-
third of respondents were unskilled labourers, 20.1% were self-employed, 9.2% unemployed, 
and 26.1% were housewives. The majority of respondents were not poor and lived either in rural 
or suburban areas. Of the 746 respondents, 11.3% (n=84) were not (yet) seeking care, 40.7% 
(n=304) went directly to medical health care providers, mostly at health centers, and 48% (n=358) 
went directly to alternaƟ ve health providers, mostly procuring OTC at drug stores or local kiosks.
 Table 4.2 shows the determinants of care seeking acƟ on. Being female and having mulƟ ple 
symptoms were the only factors associated with seeking care (OR 2.90, 95% CI 1.78-4.72 and 
OR 1.43, 95% CI 1.16-1.75, respecƟ vely). InteresƟ ngly, educaƟ onal status and knowledge about 
TB did not correlate with the decision to seek care. Of those who did not seek care (n=84), 62% 
reported mild symptoms, and 19% reported the fi nancial burden as the main reason for not 
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seeking care. No individuals expressed sƟ gmaƟ zaƟ on as the reason for not seeking care (data not 
shown).
Table 4.1 | Socio demographic characterisƟ cs of the study populaƟ on and the fi rst care seeking acƟ on
Variable n (%)
Total 746 (100)
Sex
Male 283 (37.9)
Female 463 (62.1)
Age group
15-29 years 126 (16.9)
30-44 years മ51 (6.8)
45-59 years 230 (30.8)
60-74 years 237 (31.8)
>74 years 102 (13.7)
Marital status
Not married മ45 (6.0)
Married 523 (70.1)
Divorced/widowed 178 (23.9)
EducaƟ onal status
No educaƟ on 232 (31.1)
Primary school 270 (36.2)
Junior high school 101 (13.5)
High school 116 (15.5)
College/university മ26 (3.5)
Missing മമ1 (0.1)
Employment status
Unemployed മ69 (9.2)
Student മ12 (1.6)
Housewife 195 (26.1)
ReƟ red മ18 (2.4)
Unskilled labor 267 (35.8)
Self employed/business owner 150 (20.1)
Other മ35 (4.7)
Socio-economic status
Poor 159 (21.3)
Not poor 587 (78.7)
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Variable n (%)
District
Urban 177 (23.7)
Semi urban 286 (38.3)
Rural 283 (37.9)
First care seeking acƟ on
Medical health providers
Private doctor/paramedic/clinic 139 (18.6)
Health center 148 (19.8)
Hospital/Lung clinics മ17 (2.3)
AlternaƟ ve health providers
Pharmacy മ50 (6.7)
Drug store/local kiosk 234 (31.4)
TradiƟ onal medicine മ74(9.9)
No acƟ on മ84 (11.3)
Of those who sought care (n=662), 45.9% (n=304) uƟ lized medical health care providers as 
the fi rst care seeking acƟ on (Table 4.3). Older age (OR 1.38, 95% CI 1.23-1.56), employment 
status, and perceived good quality of health care providers (OR 4.72, 95% CI 3.12-7.14) were 
signifi cantly associated with direct visit to medical health care providers, while recommendaƟ on 
from signifi cant others (OR 0.59, 95% CI 0.37-0.94) was signifi cantly associated with visiƟ ng 
alternaƟ ve health providers as the fi rst care seeking acƟ on. Marital, educaƟ on, socioeconomic, 
urban-rural status, and knowledge of TB were not associated with fi rst care seeking acƟ on being 
with medical health care providers. 
 Of those who sought care (n=662), only 55.0% (n=410) eventually visited medical health care 
providers at the Ɵ me of interview (Table 4.4). The median duraƟ on of paƟ ent delay was 17 days; 
the lower limit of the IQR was 7 days. The upper limit was unknown, as approximately 45% of the 
respondents had not yet visited medical health providers at the Ɵ me of interview and were right 
censored. Many of these cases were censored above the median value (Figure 4.1), but most 
had iniƟ ated their care seeking process with alternaƟ ve providers. Being male (HR 0.66, 95% CI 
0.51-0.86), a student (HR 0.28, 95% CI 0.09-0.93), and self-employed (HR 0.60, 96% CI 0.39-0.92) 
were signifi cantly associated with longer paƟ ent delay. The median duraƟ on of paƟ ent delay 
among males was considerably longer than females (52 versus 14 days, respecƟ vely). Having 
good knowledge of TB did not lead to shorter paƟ ent delay. Age, marital status, educaƟ on, 
socioeconomic status, and urban-rural status also did not correlate with duraƟ on of paƟ ent 
delay. 
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Table 4.2 | Determinant of TB suspect individuals who iniƟ ated care-seeking process aŌ er the onset of 
TB symptoms. N denotes TB suspect individuals and n represents TB suspects who iniƟ ated care-seeking 
acƟ on. Missing data is reported but not included in the staƟ sƟ cal analysis.
Variable n/N % Univariate MulƟ variate (Backward LR)
OR 95% CI p OR 95% CI p
All 662/746 88.7
Sex
Male 235/283 83.0 1
Female 427/463 92.2 2.42 1.53-3.84 <0.001 2.90 1.78-4.72 <0.001
Age group (years) മ0.051
15-29 110/126 87.3 1
30-44 47/51 92.2 1.71 0.54-5.39 0.36
45-59 211/230 91.7 1.62 0.80-3.27 0.18
60-74 212/237 89.5 1.23 0.63-2.41 0.54
>74 82/102 80.4 0.60 0.30-1.22 0.16
Marital status 0.39
Not married 40/45 88.9 0.92 0.35-2.43 0.85
Divorced/widowed 153/178 86.0 0.71 0.42-1.17 0.17
Married 469/523 89.7 1
EducaƟ onal status 0.19
No educaƟ on 198/232 85.3 1
Primary school 243/270 90.0 1.55 0.90-2.65 0.11
Junior high school 89/101 88.1 1.27 0.63-2.58 0.50
High school 109/116 94.0 2.70 1.15-6.23 മ0.023
College/university 23/26 88.5 1.32 0.38-4.63 0.67
Missing 0/1 മ0.0
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Variable n/N % Univariate MulƟ variate (Backward LR)
OR 95% CI p OR 95% CI p
Employment status മ0.008
Unemployed 55/69 79.7 1
Student മ9/12 75.0 0.76 0.18-3.20 0.71
Housewife 186/195 95.4 5.30 2.16-12.81 <0.001
 ReƟ red 15/18 83.3 1.27 0.32-5.02 0.73
Unskilled labor/
farmer
231/267 86.5 1.63 0.82-3.24 0.16
Self employed 136/150 90.7 2.47 1.11-5.53 മ0.027
Other* 30/35 85.7 1.53 0.50-4.70 0.46
Socio-economic status
Poor 137/159 86.2 1
Non poor 525/587 89.4 1.36 0.81-2.30 0.25
Urban-rural status മ0.064
Urban 165/177 93.2 1.75 0.88-3.50 0.11
Sub-urban 246/286 86.0 0.78 0.48-1.29 0.34
Rural 251/283 88.7 1
# of symptoms°
1 മ86/105 81.9
2 184/214 86.0
3 183/203 90.1
>3 209/224 93.3
# of symptoms 
(conƟ nuous)
1.37 1.13-1.66 മ0.002 1.43 1.16-1.75 0.001
TB Knowledge മ0.080
Good 184/206 89.3 1.36 0.79-2.35 0.26
Average 202/219 92.32 1.94 1.08-3.48 മ0.027
Low 276/321 86.0 1
*Other: Military/Police/Civil servant/Professionals/Private sector employees
°Symptom including: cough, cough with sputum, cough with blood, fever, shortness of breath, chest pain, weight lost
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Table 4.3 | Determinant of TB suspect individuals who selected medical health providers (private 
pracƟ Ɵ oners, health centers, hospitals, lung clinics) as their fi rst care seeking acƟ on. N denotes TB suspect 
who iniƟ ated care-seeking acƟ on and n represents TB suspects who visited medical health providers as 
their fi rst care seeking acƟ on. 
Variable n/N % Univariate MulƟ variate
(Backward LR)
OR 95% CI p OR 95% CI p
All 304/662 45.9
Sex
Male മ98/235 41.7 1
Female 206/427 48.2 1.30 0.94-1.80 0.11
Age group (years)
15-29 മ33/110 30.0
30-44 19/47 40.4
45-59 89/211 42.2
60-74 106/212 50.0
>74 57/82 69.5
Age (conƟ nuous in 
10 years)
1.32 1.20-1.47 <0.001 1.38 1.23-1.56 <0.001
Marital status മ0.051
Not married 14/40 35.0 0.68 0.34-1.33 0.26
Divorced/widowed മ82/153 53.6 1.45 1.01-2.10 മ0.047
Married 208/469 44.3 1
EducaƟ onal status മ0.069
No educaƟ on 108/198 54.5 1
Primary school 105/243 43.2 0.63 0.44-0.93 മ0.018
Junior high school 36/89 40.4 0.57 0.34-0.94 മ0.028
High school 46/109 42.2 0.61 0.38-0.98 മ0.039
College/university 9/23 39.1 0.54 0.22-1.30 0.17
Employment status <0.001 0.044
Unemployed 31/55 56.4 1 1
Student 2/9 22.2 0.22 0.04-1.16 0.08 0.88 0.15-5.21 0.89
Housewife 105/186 56.5 1.00 0.55-1.84 0.99 1.28 0.66-2.48 0.47
ReƟ red മ9/15 60.0 1.16 0.36-3.71 0.80 1.12 0.33-3.88 0.86
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Variable n/N % Univariate MulƟ variate
(Backward LR)
OR 95% CI p OR 95% CI p
Employment status (conƟ nued) <0.001 0.044
Unskilled labor/
farmer
102/231 44.2 0.61 0.34-1.11 0.11 0.78 0.41-1.49 0.46
Self employed മ45/136 33.1 0.38 0.20-0.73 മ0.003 0.54 0.27-1.09 0.09
Other 10/30 33.3 0.39 0.15-0.98 മ0.045 0.66 0.23-1.89 0.44
Socio-economic status
Poor 61/137 44.5 1
Non poor 243/525 46.3 1.07 0.74-1.57 0.71
Urban-rural status 0.70
Urban 72/165 43.6 0.85 0.57-1.25 0.40
Sub-urban 112/246 45.5 0.91 0.64-1.30 0.61
Rural 120/251 47.8 1
TB Knowledge 0.24
Good മ76/184 41.3 0.72 0.50-1.06 0.09
Average മ92/202 45.5 0.86 0.60-1.24 0.43
Low 136/276 49.3 1
Perceived accessibility 
of the selected health 
provider
Yes 163/368 44.3 1
No 141/292 48.3 1.17 0.86-1.60 0.31
Perceived aī ordability 
of the selected health 
provider
Yes 114/287 39.7 1
No 190/373 50.9 1.58 1.15-2.15 മ0.004
Perceived quality of 
the selected health 
provider
Yes 117/162 72.2 4.31 2.92-6.36 <0.001 4.72 3.12-7.14 <0.001
No 187/497 37.6 1 1
Signifi cant others 
recommendaƟ on
Yes മ41/108 38.0 0.67 0.44-1.03 മ0.066 0.59 0.37-0.94 0.027
No 263/552 47.6 1 1
*Other: Military/Police/Civil servant/Professionals/Private sector employees
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Table 4.4 | Result of Cox regression analysis of the determinants of the paƟ ent delay up to the fi rst visit 
to medical health providers. N denotes TB suspects involved in the study, n represents the number TB 
suspects’ who eventually visited medical health provider.
Variable n/N % of 
censored 
cases
Median
(in days)
Univariate MulƟ variate
(Backward LR)
OR 95% CI p HR 95% CI p
All 410/746 45.0 17.0
Sex
Male 129/283 54.4 52.0 0.64 0.52-0.79 <0.001 0.66 0.51-0.86 0.002
Female 281/463 39.3 14.0 1 1
Age group (years) 0.49
15-29 മ58/126 54.0 30.0 1
30-44 28/51 45.1 14.0 1.25 0.80-1.97 0.33
45-59 127/230 44.8 14.0 1.32 0.97-1.80 0.08
60-74 137/237 42.2 16.0 1.28 0.94-1.74 0.12
>74 മ60/102 41.2 14.0 1.30 0.90-1.86 0.16
Marital status 0.14
Not married 18/45 60.0 NA 0.64 0.39-1.02 0.06
Divorced/widowed 104/178 41.6 14.0 1.06 0.84-1.32 0.64
Married 288/523 44.9 16.0 1
EducaƟ onal status 0.92
No educaƟ on 135/232 41.8 14.0 1
Primary school 144/270 46.7 17.0 0.90 0.71-1.14 0.40
Junior high school 52/101 48.5 21.0 0.93 0.67-1.28 0.65
High school 68/116 43.1 17.0 0.96 0.71-1.28 0.77
College/university 13/26 50.0 14.0 0.84 0.47-1.48 0.54
Missing 0/1
Employment status <0.001 മ0.005
Unemployed 39/69 43.5 20.0 1 1
Student മ3/12 75.0 NA 0.37 0.11-1.20 മ0.096 0.28 0.09-0.93 മ0.037
Housewife 136/195 30.3 10.0 1.42 0.99-2.03 0.055 0.98 0.64-1.49 0.91
 ReƟ red 13/18 27.8 14.0 1.47 0.79-2.76 0.23 1.17 0.61-2.24 0.63
Unskilled labor/
farmer
135/267 49.4 23.0 0.87 0.61-1.25 0.45 0.73 0.50-1.06 0.10
Self employed മ67/150 55.3 38.0 0.77 0.52-1.15 0.20 0.60 0.39-0.92 മ0.020
Other* 17/35 51.4 82.0 0.83 0.47-1.47 0.53 0.76 0.43-1.34 0.34
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Variable n/N % of 
censored 
cases
Median
(in days)
Univariate MulƟ variate
(Backward LR)
OR 95% CI p HR 95% CI p
Socio-economic status
Poor മ83/169 47.8 28.0 0.88 0.69-1.12 0.29
Non poor 327/587 44.3 16.0 1
Urban-rural status 0.46
Urban 100/177 43.5 14.0 1.03 0.80-1.33 0.80
Sub-urban 150/286 47.6 21.0 0.89 0.72-1.12 0.32
Rural 160/283 43.5 14.0 1
TB Knowledge 0.55
Good 108/206 47.6 21.0 1.03 0.81-1.31 0.83
Average 127/219 42.0 14.0 1.14 0.88-1.47 0.32
Low 175/321 45.5 20.0 1
*Other: Military/Police/Civil servant/Professionals/Private sector employees
Figure 4.1 | The cumulaƟ ve distribuƟ on of TB suspects and the duraƟ on of paƟ ent delay (fi rst visit to 
medical health providers) in days. TB suspects who had not yet visited medical health providers at the 
Ɵ me of interview were right censored. DoƩ ed line is the median of the paƟ ent delay (17 days).
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4.4 | DISCUSSION
In the present study, 11.3% of individuals with TB symptoms did not seek medical care. Of those 
who sought care, 46.0% went directly to the medical health care providers and only 55.0% had 
visited medical health care providers at the Ɵ me of interview. Female gender and have mulƟ ple 
symptoms were associated with care seeking acƟ on. Older age and having a good perceived 
quality of service were the determinants of directly visiƟ ng medical health care providers. Male 
gender, being self-employed, and being a student were determinants associated with longer 
paƟ ent delay. The median duraƟ on of paƟ ent delay was 17 days. Many of the analyzed socio-
demographic determinants did not correlate with care-seeking acƟ on, direct visit to medical 
health care providers, or paƟ ent delay. InteresƟ ngly, even high educaƟ onal status and knowledge 
about TB did not correlate with any part of the care seeking process.
 This is one of only a few studies on care seeking behavior of individuals with TB symptoms 
at the community level. This is the fi rst study to analyze the real life situaƟ on, where some TB 
suspects had not (yet) sought care or visited medical health care providers, into consideraƟ on 
in the analysis of duraƟ on and determinants of paƟ ent delay. Our study has some limitaƟ ons. 
First of all, the WHO/EPI rapid survey method, despite being widely adopted to assess diī erent 
aspects of health seeking behavior,[22] has intrinsic shortcomings. In parƟ cular we did not use a 
formal household register as a sampling frame but rather generated an ad hoc sampling frame 
as detailed elsewhere.[19] In the case of non-response, call back is not usually conducted, which 
may lead to selecƟ on bias; for example, many young adult males might not be available during 
data collecƟ on process due to their role as the primary breadwinner for the household. However 
we tried to revisit the household if the reported individual with symptoms was not available 
during our visit. Studies suggested that if conducted properly, the rapid survey provides accurate 
results.[20,22] However, our fi ndings should be interpreted cauƟ ously in straƟ fi ed analysis, 
especially when geographical accessibility leads to selecƟ on bias.[22] It is fortunate that our 
study populaƟ on was easily accessible using available transportaƟ on modes. Second, our study 
was based on reported historical events, which are vulnerable to recall bias. To minimize this 
bias we only recruited individuals with symptoms present for 6 months or less before the Ɵ me 
of interview. Third, we collected self-reported data, which is vulnerable to social desirability 
bias. This may explain the zero non-response rates, in which only moƟ vated individuals reported 
their symptoms and were willing to be interviewed. Furthermore, in this Javanese seƫ  ng, where 
social harmony is the norm,[23] concealing actual situaƟ ons may be culturally preferable and 
refusing to parƟ cipate may be considered impolite. Despite the abovemenƟ oned limitaƟ ons, we 
have tried to minimize potenƟ al bias where possible and to obtain an adequate sample size; we 
believe that the study is sƟ ll largely valid. 
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The proporƟ on of TB suspects who did not take any acƟ on (11.2%) was quite low, and comparable 
to previous studies in Vietnam.[8,9] Studies in India and Philippines found a markedly higher 
rate of non-acƟ on ranging from 23% to 43%. The proporƟ on of TB suspects who went directly 
to medical health care providers (46.0%) was lower than in studies from India (88.0%-94.0%) 
but higher than the rate in the Philippines (25.4%).[10-13,24,25] Contrary to the current study, 
our previous analysis found that approximately 70% of paƟ ents with suspected TB fi rst visited 
medical health care providers.[15] However, the laƩ er was a facility based study and may suī er 
from self selecƟ on bias, i.e. most paƟ ents diagnosed in TB faciliƟ es were individuals who proceed 
directly to medical health care providers when they become ill. The current study, therefore, 
gives a more accurate esƟ maƟ on of the average TB paƟ ents’ fi rst care seeking acƟ on. 
 Care seeking behavior involves many complex interrelaƟ ng factors, such as socio-demographic 
and economic issues, psychosocial variables, and perceived quality and accessibility of health 
care providers, which are mostly context specifi c. Therefore, studies exploring the same factors 
may have diī erent fi ndings when performed in diī erent populaƟ ons. We found female gender 
to be associated with care seeking, as reported in studies from Vietnam.[8,9] However, studies in 
Ethiopia and India found no correlaƟ on between gender and care seeking.[10-13] A systemaƟ c 
review of care seeking behavior studies of diī erent illnesses also found mixed results.[26] Having 
mulƟ ple symptoms was also associated with care seeking. The number of symptoms may refl ect 
the severity of the disease. Many studies suggest that the reason for not seeking care was mostly 
due to a low perceived severity of symptoms.[9-13,27]
 Of those who sought care, older age, employment status, perceived good quality of service, 
and signifi cant others were associated with fi rst uƟ lizaƟ on of medical health providers. Similar 
studies in Ethiopia, Vietnam, and India found no associaƟ on between age and health provider 
preference.[9-13] One possible explanaƟ on for our study fi nding is that older people perceive 
their illness to be more sever and require more immediate medical care than younger persons. 
Studies in Africa and Indonesia also found a relaƟ onship between advice from signifi cant others 
and care seeking acƟ on.[28-30,14] One other study also found perceived quality of service as a 
determinant for selecƟ ng a medical health care provider at the fi rst visit.[28]
 We found that the median duraƟ on of paƟ ent delay was relaƟ vely short (17 days) compared 
to many previous studies in developing countries.[3-5] Furthermore, these studies were mostly 
conducted at TB-aĸ  liated faciliƟ es, thus creaƟ ng selecƟ on bias and likely underesƟ maƟ ng 
the delay. However our fi nding shows a high proporƟ on of individuals were censored (45%), 
suggesƟ ng that a considerable proporƟ on of suspected TB paƟ ents may have a very long paƟ ent 
delay. We also found that men had a considerable longer delay than women. This is in agreement 
with a study from South Africa,[31] while many studies showed no signifi cant associaƟ on.
[5,13,32,33] However, a systemaƟ c review of studies evaluaƟ ng diī erent diseases suggests that 
men are usually less likely than women to seek help from health professionals.[26] Being self-
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employed was also associated with longer paƟ ent delay. This may be due to the fact that self-
employed individuals work in informal sectors and earn their income on a daily basis. Thus, they 
waited unƟ l symptoms were signifi cant before pursuing care.
 Previous studies suggest that a lower level of educaƟ on and lack of TB knowledge would be 
associated with longer paƟ ent delay,[3,5] Our study, on the contrary, found that knowledge of TB 
did not correlate with care seeking or paƟ ent delay. As cough is a very prevalent illness in these 
areas, which may be aƩ ributed to the high prevalence of smoking in Indonesia (46.8% among 
adult males in 2008),[34] one possible explanaƟ on is that even people with proper knowledge of 
TB may expect their symptom to be due to a less-threatening illness. 
 We found a relaƟ vely short paƟ ent delay, no associaƟ on between TB knowledge and paƟ ent 
delay, and only gender and employment status as signifi cantly correlaƟ ng with longer delay. Thus 
improving general TB awareness does not seem to be an adequate strategy. In fact, a shorter 
paƟ ent delay can be counterproducƟ ve, as the early symptoms of TB may be diĸ  cult to recognize, 
which could result in a longer health system delay. However, with only 55.0% of suspected TB 
paƟ ents having visiƟ ng medical health care providers, results should be analyzed with cauƟ on. 
Our fi ndings, however, show that only 11.3% of paƟ ents with suspected TB did not (yet) seek care, 
and approximately 33% had visited alternaƟ ve health providers but not formal medical health 
care providers. Therefore, the challenge remains in determining how to modify the care-seeking 
behavior of suspected TB paƟ ents who used and remained under treatment from alternaƟ ve 
health providers to switch to medical health care providers. Furthermore, our previous model 
simulaƟ ons suggest that reducing the duraƟ on of paƟ ent delay and the proporƟ on of TB paƟ ents 
visiƟ ng alternaƟ ve health providers has a promising impact on prevenƟ ng TB death and increasing 
cure rates in this seƫ  ng.[35] 
 The absence of a signifi cant perceived barrier to accessing health care providers and 
recommendaƟ on from signifi cant others were the main reason for selecƟ ng health care providers. 
Thus program managers need to develop strategies and social markeƟ ng campaigns to promote 
the DOTS (direct observed treatment, short course) strategy branding in the community, with the 
primary message of benefi ts associated with early TB diagnosis, along with free and high quality 
TB diagnosis and treatment in TB-aĸ  liated faciliƟ es. Specifi c media channels or strategies need 
to be developed in order to reach male audiences.
 AddiƟ onal health system strengthening strategies are needed, especially to improve the 
diagnosƟ c capacity of health faciliƟ es providing DOTS services. This is important, as our previous 
study suggested that diagnosƟ c delay in this province may be associated with quality of service 
in DOTS faciliƟ es.[15] Furthermore our current study found that TB suspects considered a good 
quality of service as an important factor for selecƟ ng medical health care providers.
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We conclude that paƟ ent delay among TB suspects in Jogjakarta province is relaƟ vely short. 
Many socio-demographic determinants and knowledge of TB do not correlate with care seeking 
behavior or duraƟ on of paƟ ent delay. Eī ort needs to be focused on modifying the care-seeking 
behavior of suspected TB paƟ ents who stay with alternaƟ ve health services through specifi c 
health promoƟ on strategies together with improving quality of services among medical health 
care workers providing TB services. 
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Jogjakarta Province, Indonesia is related to the 
quality of services in DOTS faciliƟ es
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SUMMARY
ObjecƟ ves: Understanding determinants of care seeking paƩ ern and diagnosƟ c delay among TB 
paƟ ents diagnosed at DOTS faciliƟ es in Jogjakarta, Indonesia.
Methods: We conducted a cross secƟ onal survey among newly diagnosed TB paƟ ents in 89 DOTS 
faciliƟ es. We reconstructed their history of care seeking through retrospecƟ ve interviews. Data 
regarding socio-demographics determinants, onset of TB symptoms, type of health faciliƟ es 
visited, duraƟ on of each care seeking acƟ on were recorded.
Results: In total 253 TB paƟ ents were included in the study. The median duraƟ on of paƟ ents’ 
delay was 1 week and the total duraƟ on of diagnosƟ c delay was 5.4 weeks. The median number 
of visits was 4. Many of the paƟ ents’ socio-demographic determinants did not associate with 
the care seeking paƩ erns, and no socio-demographic determinants were associated with the 
duraƟ on of diagnosƟ c delay. More than 60% of TB paƟ ents started their care seeking processes 
outside DOTS faciliƟ es, however the number of visits in DOTS faciliƟ es was higher during overall 
care seeking process. Surprisingly, paƟ ent’s immediate visits to a DOTS facility did not correspond 
to shorter diagnosƟ c delay. 
Conclusion: DiagnosƟ c delay in Jogjakarta province was not associated with paƟ ents’ socio 
demographic factors, but mainly related with the exisƟ ng health system providing DOTS services. 
This suggests that strengthening health system and improving diagnosƟ c quality within DOTS 
services is now a more raƟ onale strategy than expanding the TB program to engage more 
providers.
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5.1 | INTRODUCTION
Indonesia has the fi Ō h largest number of new tuberculosis (TB) cases worldwide.[1] The Indonesia 
NaƟ onal TB Program (NTP) adopted the WHO direct observed treatment short course (DOTS) 
strategy in 1995 and met the global target in 2006.[1] However a considerable proporƟ on of TB 
paƟ ents obtain care from health providers outside NTP. This is due to inadequate DOTS faciliƟ es 
coverage and because many health providers (e.g. hospitals and private pracƟ Ɵ oners) are not 
linked to the TB program.[2,3] As a consequence, TB paƟ ents may not be treated or not treated 
early enough in accordance to the internaƟ onal standards of TB care (ISTC).
 An eī ecƟ ve TB control program requires early diagnosis and immediate treatment. DiagnosƟ c 
delay is strongly associated with a longer duraƟ on of infecƟ ousness, increases severity of the 
disease, higher need for hospitalizaƟ on and poor prognosis of disease outcome.[4-7] Both fi eld 
studies and mathemaƟ cal modelling suggest that reducing diagnosƟ c delay contributes to the 
reducƟ on in incidence, mortality rates and disease transmission in the community.[8,9]
 SystemaƟ c reviews on diagnosƟ c delay studies of TB paƟ ents showed that many similar 
studies had been conducted both in developed and developing countries.[7,10] However, most 
of these studies focussed on the determinants of paƟ ents, health system, or total duraƟ on of 
diagnosƟ c delays. Few studies explored the pathways of the care-seeking process of TB paƟ ents 
in the health systems,[11-13] with no informaƟ on regarding the determinants of paƟ ents’ 
individual movements through diī erent health care services during their care-seeking process. 
Understanding the care-seeking paƩ ern will help program managers to idenƟ fy the weak links in 
the diagnosƟ c process.
 In this study, we explored the pathways and determinants of the care-seeking behavior of 
confi rmed TB paƟ ents during their diagnosƟ c process in Jogjakarta province, Indonesia. We also 
assessed the magnitude of diagnosƟ c delay, and explored the associaƟ ons with previous care-
seeking acƟ ons. To this end, we interviewed newly diagnosed TB paƟ ents in DOTS faciliƟ es and 
recorded their care-seeking process from the onset of symptoms to the Ɵ me of diagnosis.
5.2 | METHODS
Study seƫ  ng and populaƟ on
The study was conducted in Jogjakarta Province, central Java, which has 3.2 million inhabitants, 
covers an area of 3185 km2, and has two urban and three rural districts. The province’s primary 
care consists of about 2000 private pracƟ ces and 117 public community health centers. Both are 
staī ed with doctors, midwives and nurses. This fi rst-level network is backed up by 9 public and 
24 private hospitals.
92  |  Chapter 5
The provincial TB control program relies on a network of all primary health centers, fi ve lung 
clinics and 18 public and private hospitals. This network is established to ensure that TB paƟ ents 
have access to a good system of monitoring and quality assurance for both diagnosis processes 
and treatment outcome.
Data collecƟ on
Our study was part of a TB program economic evaluaƟ on study in Indonesia.[14] The study 
received ethical approval from the ethical commiƩ ee of the Faculty of Medicine, Gadjah Mada 
University and an endorsement from the NTP manager. We included one urban (Jogjakarta 
municipality) and two rural areas (Kulonprogo and Gunung Kidul districts) in the study. PaƟ ents 
were recruited from all 89 DOTS faciliƟ es (public health center, hospital and lung clinic) in these 
areas. Between November 2006 and February 2007, consecuƟ ve new TB paƟ ents (smear posiƟ ve 
and negaƟ ve) aged 15 years or older, who consented to parƟ cipate in the study, were recruited. 
All paƟ ents recruited in the economic evaluaƟ on study in Jogjakarta province were included in 
our study. The sample size was adequate to reach precision of 5% at the 95% confi dence level 
for an expected frequency of 60% TB paƟ ents starƟ ng their care-seeking process outside DOTS 
providers. Upon receiving the paƟ ent’s consent, a TB worker arranged an interview schedule. 
The interview was conducted in the paƟ ent’s house or a health facility depending on the 
paƟ ent’s preference. Four interviewers were trained to perform data collecƟ on. Interviews were 
conducted in the Indonesian language. A fi eld manager reviewed the results daily for validity of 
respondents’ responses. A re-interview was conducted if considered necessary.
 PaƟ ents were interviewed using a structured quanƟ taƟ ve quesƟ onnaire. They were asked 
about socio-demographics (age, sex, occupaƟ on, marital status, socio-economic level), onset of 
TB symptoms, number and type of health faciliƟ es visited during the care-seeking process, Ɵ me 
from onset of symptoms to the fi rst care-seeking acƟ on (paƟ ent delay), and Ɵ me from consecuƟ ve 
visits to health faciliƟ es to TB diagnosis. Provider delay was defi ned as the cumulaƟ ve Ɵ me from 
the fi rst health provider visit unƟ l TB diagnosis. The total duraƟ on of diagnosƟ c delay was the 
sum of paƟ ent delay and provider delay. Socio-economic status of individuals was measured by 
the status of their households.[14-16]
 We constructed a full retrospecƟ ve history of TB paƟ ents’ care-seeking process from the onset 
of symptoms to the moment of diagnosis in DOTS faciliƟ es. Each care-seeking acƟ on, such as visit 
to health facility, buy over the counter (OTC) or tradiƟ onal (herbal) medicine was recorded as one 
visit. We divided the type of care providers into three categories i.e. AlternaƟ ve, Non-DOTS and 
DOTS services. The AlternaƟ ve services consisted of all non-modern western medicine health 
providers (e.g. tradiƟ onal healers) and self-medicaƟ on, both using tradiƟ onal or modern OTC 
medicine.[17] Non-DOTS services consisted of modern health faciliƟ es outside the TB program 
(e.g. private pracƟ Ɵ oners and hospitals); DOTS services consisted of all health providers involved 
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in the TB program. DOTS status was based on the current list of faciliƟ es involved in TB program 
in the Jogjakarta Province. If a paƟ ent visited a health facility outside Jogjakarta Province, facility 
involvement was verifi ed through contacƟ ng the local TB program oĸ  cer. If the status could not 
be verifi ed, we considered the facility as Non-DOTS. This only happened in two cases.
 The interview results were double-entered and the two resulƟ ng fi les compared to check for 
typing errors, missing data, and inconsistencies before analysis.
StaƟ sƟ cal analysis
Data were analysed using spss for Windows version 16. We used diī erent regression models to 
explore the associaƟ on between various factors with three types of outcomes. A Cox proporƟ onal 
hazard model (survival analysis) was used to assess determinants of duraƟ on of diagnosƟ c delay, 
whereas Poisson regression was used to analyse number of visits. LogisƟ c regression was used 
to analyse the dichotomous outcome of movement from a parƟ cular type of health services to 
DOTS services or an alternaƟ ve type. LogisƟ c regression was also used to analyse the proporƟ on 
of visits to the DOTS services resulƟ ng in diagnosis as a TB case. The unit of analysis of the fi rst 
and second regression models was the individual paƟ ent, whilst the unit of analysis in the logisƟ c 
regression models was a paƟ ent visit. Factors were fi rst tested univariately. Factors with P<0.20 
were maintained in the fi nal mulƟ variate model. DuraƟ on of paƟ ent delay, diagnosƟ c delay and 
number of visits are presented as median with inter-quarƟ le range (IQR).
5.3 | RESULTS
A total of 837 new TB paƟ ents were registered during the study period. Of those who were 
registered, 275 paƟ ents were interviewed; 56% were males. 74% were 15-54 years old, 56% 
lived in urban seƫ  ngs, 59% were diagnosed in hospitals or lung clinics, and 65% had sputum 
smear posiƟ ve pulmonary TB. No signifi cant diī erences were found in terms of gender, age 
group, type of diagnosƟ c faciliƟ es and type of TB cases between the TB paƟ ents who were 
recruited and those who were only registered. Only TB paƟ ents in urban areas were signifi cantly 
overrepresented (66% vs. 56%). Of the 275 respondents, 22 extra-pulmonary TB were excluded 
as they had signifi cantly longer diagnosƟ c delay suggesƟ ng a diī erent paƩ ern of care-seeking 
behavior.
 Figure 5.1 shows that slightly more paƟ ents (n=96) fi rst visited DOTS services than Non-DOTS 
(n=79) or AlternaƟ ve services (n=78). AŌ erwards, TB paƟ ents oŌ en repeatedly visited the same 
type of health services or moved to other services. Most TB paƟ ents went through diī erent 
types of health services before they were eventually diagnosed. However, most of the paƟ ents’ 
movement happened in the DOTS services. Furthermore, movements to DOTS services occurred 
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more oŌ en than movement from DOTS to other services. It is noteworthy that repeated visits 
within the same type of health services were not necessarily visits to the same health care 
providers (e.g. the same health centers, or hospitals) and the subsequent visits can be aƩ ributed 
to both provider and self-referral.
Figure 5.1 | PaƩ ern of TB paƟ ents’ care seeking process from the Ɵ me they started seeking care to 
diagnosis in DOTS faciliƟ es. Arrows represent all paƟ ents’ movements. The fi rst movement of a paƟ ent was 
the fi rst care seeking acƟ on aŌ er the onset of TB symptoms. The second movement was the movement 
from the health facility service visited on the fi rst care seeking acƟ on to a health facility service visited in 
the second care seeking acƟ on, and so on. These movements conƟ nued unƟ l TB diagnosis was eventually 
obtained. The movements occurred within the same type of health service (arrows within boxes) or 
between diī erent types of health services (arrows between boxes). Most individual paƟ ents had mulƟ ple 
visits within and between diī erent health services. 
The minimum number of health facility visits before TB diagnosis was one (n=4); the maximum, 17 
(n=1). All visits of the laƩ er paƟ ent were to DOTS faciliƟ es (data not shown). The median number 
of visits before diagnosis was 4 (IQR 3-6). The median paƟ ent delay was 1.0 week (IQR 0.4-2.0 
weeks). The distribuƟ on of the duraƟ on of diagnosƟ c delay was highly skewed, with a median 
of 5.4 weeks (IQR 2.8-11.5 weeks).  Table 5.1 shows the basic demographic characterisƟ cs of the 
study populaƟ on and the associaƟ on of these characterisƟ cs with diagnosƟ c delay and number 
of visits. Poor socioeconomic status was associated with a shorter diagnosƟ c delay (HR 1.31, 95% 
CI 1.01-1.71). However, this factor was not associated with number of paƟ ents’ visits.
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DuraƟ ons of diagnosƟ c delays were similar between paƟ ents who fi rst visited DOTS services and 
those who visited AlternaƟ ve or Non-DOTS services, even though TB paƟ ents who fi rst visited 
DOTS services had signifi cantly fewer visits than TB paƟ ents who were in AlternaƟ ve or Non-
DOTS services.
 There were no signifi cant diī erences between paƟ ents who fi rst visited DOTS and those who 
used other type of health faciliƟ es in term of sex, age, marriage, educaƟ on, employment and 
socioeconomic status (Table 5.2). TB paƟ ents who lived in urban area were more likely to visit 
DOTS services than those who lived in rural areas (OR 2.01, 95% CI 1.15-3.50).
 Table 5.3 shows that of all movements from AlternaƟ ve services, 37% (n=75) were to DOTS 
services. TB paƟ ents with poor socio economic status, living in urban areas and with longer 
duraƟ on of symptoms were more likely to move from AlternaƟ ve to DOTS services (OR 3.46, 95% 
CI 1.68-7.14; OR 2.28, 95% CI 1.12-4.63 and OR 1.07, 95% CI 1.03-1.11 respecƟ vely). TB paƟ ents 
with high school educaƟ on were less likely to move from AlternaƟ ve to DOTS services (OR 0.25, 
95% CI 0.08–0.74). Movement from Non-DOTS to DOTS services was more common (42%) (Table 
5.4). TB paƟ ents from urban areas and with a longer duraƟ on of symptoms were more likely to 
move from Non-DOTS to DOTS services (OR 1.79, 95% CI 1.12-2.85 and OR 1.05, 95% CI 1.02-1.09 
respecƟ vely).
 Table 5.5 shows how oŌ en visit of the TB paƟ ents to the DOTS services resulted in diagnosis 
(i.e. 253 Ɵ mes, once for every paƟ ent) or in a subsequent health care visit. Socio-demographic 
variables did not play a signifi cant role in determining whether paƟ ents were diagnosed or not 
when visiƟ ng the DOTS services. Only paƟ ents with more previous visits (OR 2.22, 95% CI 1.77-
2.77) were more likely to be diagnosed whilst in DOTS services.
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Table 5.2 | Determinants of TB paƟ ents who went to DOTS services as their fi rst care seeking acƟ on. N 
denotes TB paƟ ents, and n represents fi rst seeking acƟ on in DOTS services. Missing data is reported but 
not included in the staƟ sƟ cal analysis.
Variable n/N % Univariate
OR 95% CI P
All മ96/253 37.9
Sex
Male മ60/153 39.2 1 - -
Female മ36/100 36.0 0.87 0.52-1.47 0.61
Age group (years) 0.23
15-24 16/54 29.6 0.88 0.40-1.95 0.76
25-34 21/55 38.2 1.30 0.61-2.78 0.50
35-44 19/39 48.7 2.00 0.88-4.55 0.10
45-54 20/43 46.5 1.83 0.82-4.07 0.14
>54 20/62 32.3 1 - -
Marital status
Not married 25/73 34.2 0.80 0.45-1.41 0.44
Married മ71/180 39.4 1 - -
EducaƟ onal status 0.77
No educaƟ on മ8/20 40.0 1.02 0.34-3.09 0.97
Primary school 18/59 30.5 0.67 0.29-1.58 0.36
Junior high school 17/43 39.5 1.00 0.41-2.45 1.00
High school 38/93 40.9 1.06 0.49-2.29 0.88
College/university 15/38 39.5 1 - -
Employment status 0.94
Unemployed മ41/110 37.3 1 - -
Farmer/Unskilled labor 26/63 41.3 1.18 0.63-2.23 0.60
Skilled labor/Self employed 25/69 36.2 0.96 0.51-1.79 0.89
Other‡ മ4/10 40.0 1.12 0.30-4.21 0.87
Missing 0/1 മ0.0
Socio-economic status
Poor 30/93 32.3 0.68 0.40-1.16 0.16
Not poor മ66/ 160 41.3 1 - -
Urban-rural status
Urban മ71/163 43.6 2.01 1.15-3.50 0.014*
Rural 25/90 27.8 1 - -
‡Other: Military/Police/Civil servant/Professionals
* Only urban and rural status remained in mulƟ variate analysis
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Table 5.3 | Determinants of TB paƟ ents moved to DOTS services, when they were in AlternaƟ ve services. 
N denotes number of visit in AlternaƟ ve health services and n represents number of next visit to DOTS 
services. Missing data is reported but not included in the staƟ sƟ cal analysis.
Variable n/N % Univariate MulƟ variate
(Backward LR)
OR 95% CI p OR 95% CI p
All മ75/202 37.1
Sex
Male മ43/122 35.2 1 - -
Female 32/80 40.0 1.23 0.69-2.19 0.49
Age group (years) 0.09
15-24 23/48 47.9 1.40 0.63-3.16 0.41
25-34 10/36 27.8 0.59 0.23-1.49 0.26
35-44 12/25 48.0 1.41 0.53-3.74 0.49
45-54 11/45 24.4 0.49 0.20-1.21 0.12
>54 19/48 39.6 1 - -
Marital status
Not married 26/70 37.1 1.00 0.55-1.82 1.00
Married മ49/132 37.1 1 - -
EducaƟ onal status 0.036 0.017
No educaƟ on മ7/18 38.9 0.42 0.12-1.56 0.20 0.59 0.13-2.63 0.49
Primary school 16/34 47.1 0.59 0.19-1.82 0.36 1.02 0.30-3.51 0.97
Junior high school 20/51 39.2 0.43 0.15-1.24 0.12 0.53 0.17-1.64 0.27
High school 20/79 25.3 0.23 0.08-0.63 0.005 0.25 0.08-0.74 0.013
College/university 12/20 60.0 1 - - 1
Employment status 0.64
Unemployed 32/82 39.0 1 - -
Farmer/Unskilled labor 19/51 37.3 0.93 0.45-1.91 0.84
Skilled labor/Self employed 21/57 36.8 0.91 0.45-1.83 0.79
Other‡ 2/11 18.2 0.35 0.07-1.71 0.19
Missing 1/1 100.0
Socio-economic status
Poor 30/58 51.7 2.36 1.26-4.40 0.007 3.46 1.68-7.14 0.001
Not poor മ45/144 31.3 1 - - 1
Urban-rural status
Urban 51/121 42.1 1.73 0.95-3.15 0.072 2.28 1.12-4.63 0.023
Rural 24/81 29.6 1 - 1
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Table 5.3 | ConƟ nued
Variable n/N % Univariate MulƟ variate
(Backward LR)
OR 95% CI p OR 95% CI p
Number of previous visits
0-2 മ49/119 41.2
3-5 18/52 34.6
>5 മ8/31 25.8
Number of previous visits 
(conƟ nuous)
0.95 0.84-1.07 0.38
DuraƟ on of symptoms
0-3 weeks 23/80 28.8
4-7 weeks 18/51 35.3
8-11 weeks 15/35 42.9
12-15 weeks 6/12 50.0
>16 weeks 13/24 54.2
DuraƟ on of symptoms 
conƟ nuous (in weeks)
1.04 1.00-1.07 0.040 1.07 1.03-1.11 0.001
‡Other: Military/Police/Civil servant/Professionals
Table 5.4 | Determinants of TB paƟ ents moved to DOTS services, when they were in Non-DOTS services. 
N denotes number of visit in Non-DOTS services, and n represents number of next visit to DOTS services. 
Variable n/N % Univariate MulƟ variate
(Backward LR)
OR 95% CI P OR 95% CI p
All 130/313 41.5
Sex
Male മ75/182 41.2 1 - -
Female മ55/131 42.0 1.03 0.66-1.63 0.90
Age group (years) 0.60
15-24 26/60 43.3 1.07 0.54-3.10 0.85
25-34 32/66 48.5 1.31 0.68-2.53 0.42
35-44 21/56 37.5 0.84 0.42-1.69 0.62
45-54 18/52 34.6 0.74 0.36-1.52 0.41
>54 33/79 41.8 1 - -
Marital status
Not married 34/81 42.0 0.58 0.22-1.52 0.27
Married 96/232 41.4 1 - -
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Variable n/N % Univariate MulƟ variate
(Backward LR)
OR 95% CI P OR 95% CI p
EducaƟ onal status 0.19
No educaƟ on മ9/29 31.0 0.55 0.20-1.47 0.23
Primary school 34/70 48.6 1.14 0.53-2.46 0.73
Junior high school 14/48 29.2 0.50 0.21-1.19 0.12
High school മ54/124 43.5 0.93 0.46-1.89 0.85
College/university 19/42 45.2 1 - -
Employment status 0.063
Unemployed മ61/149 40.9 1 - -
Farmer/Unskilled labor 32/96 33.3 0.72 0.42-1.23 0.23
Skilled labor/Self employed 31/56 55.4 1.79 0.96-3.33 0.066
Other‡ മ6/12 50.0 1.44 0.44-4.68 0.54
Socio-economic status
Poor മ49/127 38.6 0.81 0.51-1.29 0.38
Not poor മ81/186 43.5 1 - -
Urban-rural status
Urban മ71/150 47.3 1.58 1.01-2.49 0.046 1.79 1.12-2.85 0.015
Rural മ59/163 36.2 1 - - 1
Number of previous visits
0-2 മ61/155 39.4 1.15
3-5 മ50/117 42.7 1.33
>5 19/41 46.3 1
Number of previous visits 1.06 0.96-1.19 0.22
DuraƟ on of symptoms
0-3 weeks മ48/122 39.3 1
4-7 weeks 36/93 38.7 0.97
8-11 weeks 17/51 33.3 0.77
12-15 weeks 12/24 50.0 1.54
>16 weeks 17/23 73.9 4.37
DuraƟ on of symptoms 
conƟ nuous (in weeks)
1.05 1.01-1.08 0.007 1.05 1.02-1.09 0.003
‡Other: Military/Police/Civil servant/Professionals
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Table 5.5 | Determinants of TB paƟ ents eventually diagnosed, when they were in DOTS services. N 
denotes number of visit in DOTS services, and n represents number of TB paƟ ents diagnosed in DOTS 
services. 
Variable n/N % Univariate
OR 95% CI P
All 253/714 34.2
Sex
Male 153/428 35.7 1 - -
Female 100/286 35.0 0.83 0.71-1.32 0.97
Age group (years) 0.96
15-24 മ54/152 35.5 0.99 0.63-1.56 0.95
25-34 മ55/149 36.9 1.05 0.66-1.65 0.84
35-44 മ39/120 32.5 0.86 0.53-1.41 0.56
45-54 മ43/120 35.8 1.00 0.62-1.63 1.00
>54 മ62/173 35.8 1 - -
Marital status
Not married മ73/198 36.9 1.09 0.78-1.53 0.62
Married 180/516 34.9 1 - -
EducaƟ onal status 0.61
No educaƟ on 20/53 37.7 1.37 0.70-2.69 0.36
Primary school മ59/160 36.9 1.32 0.80-2.18 0.27
Junior high school മ43/107 40.2 1.52 0.88-2.62 0.13
High school മ93/270 34.4 1.19 0.75-1.87 0.46
College/university മ38/124 30.6 1 - -
Employment status 0.73
Unemployed 110/305 36.1 1 - -
Farmer/Unskilled labor മ63/171 36.8 1.03 0.70-1.53 0.87
Skilled labor/Self employed മ69/211 32.7 0.86 0.60-1.25 0.34
Other‡ 10/24 41.7 1.27 0.54-2.95 0.58
Missing 1/3 33.3
Socio-economic status
Poor മ93/251 37.1 1.09 0.59-2.03 0.78
Not poor 160/463 34.6 1 - -
Urban-rural status
Urban 163/478 34.1 1 - -
Rural മ90/236 38.1 1.19 0.86-1.65 0.29
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Variable n/N % Univariate
OR 95% CI P
Number of previous visits
0-2 മ35/228 15.4
3-5 142/329 43.2
>5 മ76/157 48.4
Number of previous visits 
(conƟ nuous)
2.22 1.77-2.77 0.000*
DuraƟ on of symptoms 
(in weeks)
0-3 85/252 33.7
4-7 69/197 35.0
8-11 39/104 37.5
12-15 22/56 39.3
>16 38/105 36.2
DuraƟ on of symptoms 
conƟ nuous (in weeks)
1.00 0.99-1.02 0.69
‡Other: Military/Police/Civil servant/Professionals
*Only number of previous visits remained in mulƟ variate analysis
5.3 | DISCUSSION
Our study suggests that more than 60% of the paƟ ents started their care-seeking process 
outside DOTS service providers. The median of paƟ ents’ delay was 1.0 week, the median of 
diagnosƟ c delay and number of visits before diagnosis was 5.4 weeks and four visits. Many of the 
paƟ ents’ socio-demographic determinants were not associated with the care-seeking paƩ ern 
or the duraƟ on of diagnosƟ c delay, and no socio-demographic determinants were associated 
with the number of paƟ ent visits. More than 60% of TB paƟ ents started their care-seeking 
processes outside DOTS faciliƟ es, but the number of visits in DOTS faciliƟ es was larger during the 
overall care-seeking process. Surprisingly, a paƟ ent’s immediate visit to a DOTS facility did not 
correspond to shorter diagnosƟ c delay.
 Our study has three important limitaƟ ons. Firstly, it was based on reported historical events, 
which is vulnerable to recall bias. To minimize this bias we only recruited newly diagnosed TB 
paƟ ents. Secondly, we only interviewed paƟ ents who were diagnosed at DOTS faciliƟ es. This 
may give an underesƟ maƟ on of the duraƟ on of diagnosƟ c delay, as experiences of TB paƟ ents 
diagnosed at faciliƟ es outside the DOTS services were not taken into account. To minimize these 
limitaƟ ons required a prospecƟ ve follow up study of TB suspect idenƟ fi ed in the community 
unƟ l diagnosis either in DOTS or Non-DOTS services. However, idenƟ fying TB suspects without 
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providing access to proper diagnosƟ c faciliƟ es would raise ethical quesƟ ons, whilst providing 
access would interfere with the normal care-seeking behavior in their natural environment. 
Thirdly, measurement of the possible determinants in this study was limited to socio-
demographic variables, whilst other studies showed that the determinants of diagnosƟ c delay 
are more complex than merely socio-demographic characterisƟ cs, such as provider’s service 
quality and personal beliefs.[7,10] This limitaƟ on may explain partly why we found only few 
signifi cant results in our study.
 We found that the paƟ ents’ delay in our study (1 week) is shorter than in other studies in high 
endemic countries (between 2 and 9 weeks),[18-23] but it is similar to paƟ ents’ delay reported 
in Italy, New Zealand and Taiwan.[24-26] The reported total diagnosƟ c delay in our study (5.4 
weeks) is also relaƟ vely short compared to other studies in high endemic countries (8–19 weeks).
[4,18-23,27] However it is comparable to studies in Japan and United States,[29,30] which 
reported duraƟ ons of 6 and 5 weeks consecuƟ vely. This duraƟ on is close to the considered an 
acceptable duraƟ on for diagnosƟ c delay of smear-posiƟ ve TB cases of 4 weeks.[31] Jogjakarta is 
one of the provinces in Indonesia with a strong TB control program and a well-established health 
system. The NTP had piloted several TB intervenƟ on strategies in this province.[14,32] Further- 
more, several naƟ onal media campaigns have been launched to increase awareness about the 
TB program in Indonesia. These factors may explain the short paƟ ent delay and diagnosƟ c delay 
found in this study. Surprisingly, many of the socio-demographic determinants in our study 
were not associated with diagnosƟ c delay. In many other seƫ  ngs, being female,[20,21,30,33] 
old age,[4,21,26,28,34-36,39] low educaƟ on level,[26,30,34-38] being single [22,39] and low 
occupaƟ onal status [4,40] were associated with longer diagnosƟ c delay.
 Low socio-economic status was correlated with shorter duraƟ on of diagnosƟ c delay. This 
fi nding contrasted with other studies, whereby low socio-economic status is a risk for a longer 
duraƟ on delay.[4,18,19,21,35,41-45] InteresƟ ngly, the number of visits was similar between 
poor and non-poor TB paƟ ents. This suggests that the clinical presentaƟ on may be more severe 
in poor paƟ ents, so that they seek care earlier than the higher socio economic group. It is known 
that faster TB progression is related to poor nutriƟ onal status.
 Our study showed a short paƟ ent delay, a longer provider delay, a majority visits in DOTS 
faciliƟ es and only a greater number of visits associated with TB diagnosis. This indicates problem 
of early detecƟ on among health workers in DOTS faciliƟ es. Many; studies show that fi rst care-
seeking with private providers correlates with several unsuccessful consultaƟ ons, involving 
several providers, and thus a high risk of longer diagnosƟ c delay.[19,21,33,37,44,46] Our 
study, however, found similar duraƟ ons between TB paƟ ents who fi rst visited DOTS providers 
compared to those who fi rst visited private or alternaƟ ve providers. This is consistent with a 
previous study in the same seƫ  ng.[47] Although the average number of visits was signifi cantly 
smaller for paƟ ent who fi rst visited DOTS faciliƟ es, this diī erence (3 vs. 4.5 visits) is negligible for 
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the pracƟ ce of TB control. InteresƟ ngly, paƟ ents in urban areas were more likely to immediately 
visit DOTS faciliƟ es, which indicate beƩ er access to DOTS faciliƟ es in urban areas, as more DOTS 
providers are available (i.e. hospitals and lung clinics). However, paƟ ents in urban areas were not 
diagnosed faster, thus it amplifi es the problem of diagnosƟ c delay in DOTS services.
 StarƟ ng immediately with visiƟ ng DOTS faciliƟ es does not necessarily correlate with shorter 
duraƟ on of diagnosƟ c delay in Jogjakarta. One possible explanaƟ on is that many TB paƟ ents may 
have shopped around for care at various health faciliƟ es before a diagnosis of TB was made. 
RinƟ swaƟ  et al. suggested that many of the TB paƟ ents in this province were ‘shopaholics’.[48] 
Another explanaƟ on may be the expansion of DOTS in this province. In Jogjakarta, public and 
private hospitals were involved in the TB program since 2000 as part of public private mix (PPM) 
policy in Indonesia.[32] A hospital TB case load study in Java suggested that not every hospital 
involved in the TB program integrated the NaƟ onal TB program guideline into their services, 
and that there were complex but weak links within hospital’s diī erent outpaƟ ents units with TB 
unit.[49] Thus many outpaƟ ents with TB symptoms in the hospitals involved in a DOTS program 
do not have access to proper TB diagnosƟ c procedures and treatments. At health center level, 
TB diagnosis is poorly performed. Sakundarno et al. found that only 14% of sputum samples 
collected at health centers were of a good quality, and only 24% of TB suspects reported that 
how to produce sputum samples had been explained to them by health providers.[50] Another 
study reported that only 55% of lab technicians correctly idenƟ fi ed all posiƟ ve sputum smear 
slides, whilst only 40% of nurses at health centers had proper knowledge of TB causes.[51]
 As many TB paƟ ents in developing countries seek care from private providers, advocacy 
on engaging all providers in TB control is increasing.[52] In the current Stop TB Strategy, WHO 
endorses the engagement of all providers based on the PPM approach.[38] This is expected to 
improve case detecƟ on, minimize diagnosƟ c delay and therefore improve treatment outcomes. 
However, as previously menƟ oned, our study showed that fi rst contact with DOTS providers 
did not necessarily reduce diagnosƟ c delay, even though the majority of paƟ ents visits before 
diagnosis were to DOTS services. Thus, in a situaƟ on where PPM acƟ viƟ es have been established, 
as in Jogjakarta Province, the more extensive network of DOTS providers may become part of the 
problem. Probandari et al. highlighted that approximately 50% of TB paƟ ents treated in DOTS 
aĸ  liated hospitals were not recorded in the hospital TB DOTS register, suggesƟ ng that treatment 
was not in line with the ISTC guideline.[49]
 We conclude that diagnosƟ c delay in Jogjakarta province was not associated with paƟ ents’ 
socio demographic factors, but mainly related with the exisƟ ng health system providing DOTS 
services. This suggests that strengthening the health system and improving diagnosƟ c quality 
within DOTS services is now a more raƟ onal strategy than expanding the TB program to engage 
more providers.
106  |  Chapter 5
5.5 | ACKNOWLEDGEMENTS
The study received fi nancial support from the NTP, KNCV, WHO and USAID through the TBCTA 
and Indonesia Directorate General for Higher EducaƟ on, Ministry of EducaƟ on Scholarship. We 
acknowledge the support provided by the staī  of the parƟ cipaƟ ng health faciliƟ es, Theodorus 
Kusuma, KrisƟ ono and the data collecƟ on team as a whole. The authors also thank the NTP, KNCV 
and WHO Country RepresentaƟ ve for Indonesia for their technical support.
DiagnosƟ c delay among TB paƟ ents in Jogjakarta, Indonesia  |  107
5.6 | REFERENCES
1. WHO. WHO Report: Global tuberculosis control, a short update to the 2009 report. Geneva: WHO; 2009.
2. Elzinga G, Raviglione MC, Maher D. Scale up: MeeƟ ng targets in global tuberculosis control. The Lancet 
2004, 363:814-9.
3. Soemantri S, Lolong DS, Senewe FE, et al. Tuberculosis Prevalence Survey in Indonesia 2004. Jakarta: 
NaƟ onal InsƟ tute of Health Research and Development Ministry of Health – Republic of Indonesia; 2005.
4. Madebo T, Lindtjørn B. Delay in Treatment of Pulmonary Tuberculosis: An Analysis of Symptom DuraƟ on 
Among Ethiopian PaƟ ents, 1999. [hƩ p://www.medscape.com/viewarƟ cle/ 407989]. 
5. Godfrey-FausseƩ  P, Kaunda H, Kamanga J, et al. Why do paƟ ents with a cough delay seeking care at Lusaka 
urban health centers? A health systems research approach. Int J Tuberc Lung Dis 2002, 6:796-805.
6. Mahendradhata Y, Lambert M, Van Deun A, MaƩ hys F, Boelaert M, van der StuyŌ  P. Strong general health 
care systems: a prerequisite to reach global tuberculosis control targets. Int J Health Plann Manage 2003, 
18 Suppl 1:S53-65.  
7. Storla DG, Yimer S, Bjune GA. A systemaƟ c review of delay in the diagnosis and treatment of tuberculosis. 
BMC Public Health 2008, 8:15.
8. Grzybowski S, Styblo K, Dorken E. Tuberculosis in Eskimo. Tubercle 1976, 57:S1-S58. 
9. Dye C. Tuberculosis 2000-2010: control, but not eliminaƟ on. Int J Tuberc Lung Dis 2000, 4: S146-52.
10. Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary 
tuberculosis: a systemaƟ c review of literature. BMC Infect Dis 2009, 9:91.  
11. Kasse Y, Jasseh M, Corrah T, et al. Health seeking behavior, health system experience and tuberculosis case 
fi nding in Gambians with cough. BMC Public Health 2006, 6:143.
12. Selvam JM, Wares F, Perumal M, et al. Health-seeking behavior of new smear-posiƟ ve TB paƟ ents under a 
DOTS program in Tamil Nadu, India, 2003. Int J Tuberc Lung Dis 2007, 11:161-7. 
13. Wang WB, Jiang QW, Chen Y, Xu B. Pathways from fi rst health care seeking to diagnosis: obstacles to 
tuberculosis care in rural China. Int J Tuberc Lung Dis 2007; 11:386-91.
14. Johns B, Probandari A, Mahendradhata Y, Ahmad RA. An analysis of the costs and treatment success of 
collaboraƟ ve arrangements among public and private providers for tuberculosis control in Indonesia. 
Health Policy 2009, 93:214-24.
15. Vyas S, Kumaranayake L. ConstrucƟ ng socio-economic status indices: how to use principal components 
analysis. Health Policy Plan 2006, 21:459-68.  
16. Pantoja A, Floyd K, Unnikrishnan KP, et al. Economic evaluaƟ on of public-private mix for tuberculosis care 
and control, India. Part I. Socio-economic profi le and costs among tuberculosis paƟ ents. Int J Tuberc Lung 
Dis 2009, 13:698-704.  
17. Ahmad RA, Mahendradhata Y, Cunningham J, Utarini A, de Vlas SJ. Improving the naƟ onal TB control 
program in Indonesia: exploraƟ ons with a health systems model. BMC InfecƟ ous Disease 2009, 9:87.
18. Lawn SD, Aī ul B, Acheampong JW. Pulmonary tuberculosis: diagnosƟ c delay in Ghanaian adults. Int J Tuberc 
Lung Dis 1998, 2:635-40.  
19. Wandwalo ER, Mørkve O. Delay in tuberculosis case-fi nding and treatment in Mwanza, Tanzania. Int J 
Tuberc Lung Dis 2000, 4:133-8.  
20. Pronyk RM, Makhubele M.B, Hargreaves JR, Tollman SM, Hausler HP. Assessing health seeking behavior 
among tuberculosis paƟ ents in rural South Africa. Int J Tuberc Lung Dis 2001, 5:619-27.
21. Yamasaki-Nakagawa M, Ozasa K, Yamada N, et al. Gender diī erence in delays to diagnosis and health care 
seeking behavior in a rural area of Nepal. Int J Tuberc Lung Dis 2001, 5:24-31.
22. Demissie M, Lindtjorn B, Berhane Y. PaƟ ent and health service delay in the diagnosis of pulmonary 
tuberculosis in Ethiopia. BMC Public Health 2002, 2:23. 
23. Yimer S, Bjune G, Alene G. DiagnosƟ c and treatment delay among pulmonary tuberculosis paƟ ents in 
Ethiopia: a cross secƟ onal study. BMC Infect Dis 2005, 5112.
24. Calder L. Tuberculosis: reasons for diagnosƟ c delay in Auckland. N Z Med J 2000, 113:483-5.
108  |  Chapter 5
25. Chiang CY, Chang CT, Chang RE, Li CT, Huang RM. PaƟ ent and health system delays in the diagnosis and 
treatment of tuberculosis in Southern Taiwan. Int J Tuberc Lung Dis 2005, 9:1006-12.
26. Gaglioƫ   C, Resi D, Moro ML. Delay in the treatment of pulmonary TB in a changing demographic scenario. 
Int J Tuberc Lung Dis 2006, 10:305-9.
27. Pungrassami P, Hirunayapa J, Tunsawai V, Pongpanich S, Petchborisut O. The study of paƟ ent’s and doctor’s 
delay of tuberculosis case-detecƟ on in TB Center Zone 12 Yala. Thai J Tuberc Chest Dis 1993, 14:73-83.
28. Ouedraogo M, Kouanda S, Boncoungou K, et al. Treatment seeking behavior of smear-posiƟ ve tuberculosis 
paƟ ents diagnosed in Burkina Faso. Int J Tuberc Lung Dis 2006 10:184-7.
29. Sasaki Y, Yamagishi F, Yagi T, Yamatani H, Kuroda F, Shoda H. A study of paƟ ent’s and doctor’s delay in paƟ ents 
with pulmonary tuberculosis discovered by visiƟ ng doctors with symptoms in parƟ cular on doctor’s delay. 
Kekkaku 2000, 75:527-32.
30. Sherman L, Fujiwara P, Cook S, Bazerman L. PaƟ ent and health care system delays in the diagnosis and 
treatment of tuberculosis. Int J Tuberc Lung Dis 1999, 3:1088-95.
31. Lambert ML, Van der StuyŌ  P. Delays to tuberculosis treatment: shall we conƟ nue to blame the vicƟ m? Trop 
Med Int Health 2005, 10:945-46.  
32. IrawaƟ  SR, Basri C, Arias MS, et al. Hospital DOTS linkage in Indonesia: a model for DOTS expansion into 
government and private hospitals. Int J Tuberc Lung Dis 2007, 11:33-9.  
33. Needham DM, Foster SD, Tomlinson G, Godfrey-FausseƩ  P. Socio- economic, gender and health services 
factors aī ecƟ ng diagnosƟ c delay for tuberculosis paƟ ents in urban Zambia. Trop Med Int Health 2001, 
6:256-9.
34. Odusanya OO, Babafemi JO. PaƩ ern of delays among pulmonary tuberculosis paƟ ents in Lagos, Nigeria. 
BMC Public Health 2004, 4:18.
35. Kiwuwa M, Charles K, Harriet M. PaƟ ent and health service delay in pulmonary tuberculosis paƟ ents 
aƩ ending a referral hospital: a cross-secƟ onal study. BMC Public Health 2005, 5:122.    
36. Pirkis JE, Speed BR, Yung AP, Dunt DR, MacIntyre CR, Plant AJ. Time to iniƟ aƟ on of anƟ -tuberculosis 
treatment. Tuber Lung Dis 1996, 77:401-6.
37. RojpibulsƟ t M, Kanjanakiritamrong J, Chongsuvivatwong V. PaƟ ent and health system delays in the diagnosis 
of tuberculosis in Southern Thailand aŌ er health care reform. Int. J. Tuberc Lung Dis 2006, 10:422-8. 
38. WHO. The Stop TB Strategy: Building on and Enhancing DOTS to Meet the TB-Related Millennium 
Development Goals. Geneva: WHO; 2006. 
39. Steen TW, Mazonde GN. Pulmonary tuberculosis in Kweneng District Botswana: delay in diagnosis in 212 
smear-posiƟ ve paƟ ents. Int J Tuberc Lung Dis 1998, 2:627-34.
40. van der Werf MJ, Chechulin Y, Yegorova OB, et al. Health care seeking behavior for tuberculosis symptoms 
in Kiev City, Ukraine. Int J Tuberc Lung Dis 2006, 10:390-5.
41. Lienhardt C, Rowley J, Manneh K, et al. Factors aī ecƟ ng Ɵ me delay to treatment in a tuberculosis control 
program in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis 2001, 5:233-
9.  
42. Rajeswari R, Chandrasekaran V, Suhadev M, Sivasubramaniam S, Sudha G, Renu G. Factors associated with 
paƟ ent and health system delays in the diagnosis of tuberculosis in South India. Int J Tuberc Lung Dis 2002, 
6:789-95.  
43. Güneylioglu D, Yilmaz A, Bilgin S, Bayram U, Akkaya E. Factors aī ecƟ ng delays in diagnosis and treatment 
of pulmonary tuberculosis in a terƟ ary care hospital in Istanbul, Turkey. Med Sci Monit 2004, 10:CR62-7.
44. Xu B, Jiang QW, Xiu Y, Diwan VK. DiagnosƟ c delays in access to tuberculosis care in counƟ es with or without 
the NaƟ onal Tuberculosis Control Program in rural China. Int J Tuberc Lung Dis 2005, 9:784-90.
45. Okur E, Yilmaz A, Saygi A, et al. PaƩ erns of delays in diagnosis among paƟ ents with smear- posiƟ ve 
pulmonary tuberculosis at a teaching hospital in Turkey. Clin Microbiol Infect 2006, 12:90-2.
46. Lönnroth K, Thuong LM, Linh PD, Diwan VK. Delay and disconƟ nuity- a survey of TB paƟ ents’ search of a 
diagnosis in a diversifi ed health care system. Int J Tuberc Lung Dis 1999, 3:992-1000.  
DiagnosƟ c delay among TB paƟ ents in Jogjakarta, Indonesia  |  109
47. Mahendradhata Y, Syahrizal BM, Utarini A. Delayed treatment of tuberculosis paƟ ents in rural areas of 
Yogyakarta province, Indonesia. BMC Public Health 2008 8:393.
48. RinƟ swaƟ  N, Mahendradhata Y, Suharna, et al. Journeys to tuberculosis treatment: a qualitaƟ ve study of 
paƟ ents, families and communiƟ es in Jogjakarta, Indonesia. BMC Public Health 2009, 9:158.
49. Probandari A, Lindholm L, Stenlund H, Utarini A, HurƟ g AK, Missed opportunity for standardized diagnosis 
and treatment among adult Tuberculosis paƟ ents in hospitals involved in Public-Private Mix for Directly 
Observed Treatment Short-Course strategy in Indonesia: a cross-secƟ onal study. BMC Health services 
2010,10:113.
50. Sakundarno M, Nurjazuli N, JaƟ  SP et al. Insuĸ  cient quality of sputum submiƩ ed for tuberculosis diagnosis 
and associated factors, in Klaten district, Indonesia. BMC Pulmonary Medicine 2009, 9:16.  
51. Wahyuni CU, Budiono, Rahariyani LD et al. Obstacles for opƟ mal tuberculosis case detecƟ on in primary 
health centers (PHC) in Sidoarjo district, East Java, Indonesia. BMC Health Services Research 2007, 7:135.  
52. Uplekar M, Pathania V, Raviglione M. Private pracƟ Ɵ oners and public health: weak links in tuberculosis 
control. Lancet 2001, 358:912-6.

CHAPTER 6
DiagnosƟ c work-up and loss of 
tuberculosis suspects in Jogjakarta, Indonesia
Ahmad RA, MaƩ hys F, Dwihardiani B, RinƟ swaƟ  N, Vlas SJ, Mahendradhata P, 
Van der StuyŌ  P. 
SubmiƩ ed.
112  |  Chapter 6
SUMMARY
Background: Early and accurate diagnosis of pulmonary tuberculosis (TB) is criƟ cal for successful 
TB control. To assist the diagnosis of smear-negaƟ ve pulmonary TB, WHO recommended the 
use of diagnosƟ c algorithm. Our study aims to evaluate the implementaƟ on of the naƟ onal 
tuberculosis program diagnosƟ c algorithm in rouƟ ne health cares seƫ  ng in Jogjakarta, Indonesia. 
Methods: We prospecƟ vely documented the diagnosƟ c work-up of all new tuberculosis suspects 
unƟ l a diagnosis was reached. We used clinical audit forms to record chronologically each step. 
Data on paƟ ents’ gender, age, symptoms, type, dates and results of examinaƟ ons, and fi nal 
diagnosis were collected.
Results: 754 tuberculosis suspects were recorded. 43.5% of the tuberculosis suspects were lost 
during the diagnosƟ c work-up in the health centers against 0% in lung clinics. Of those who 
completed diagnosƟ c work-ups, 51.1% and 100.0% of TB suspects were diagnosed without 
following the naƟ onal tuberculosis diagnosƟ c algorithm in health centers and lung clinics 
respecƟ vely. However, the work-up in the laƩ er was generally conforming to internaƟ onal 
standard for tuberculosis care (ISTC). The diagnosƟ c delays were signifi cantly longer in health 
centers compared to lung clinics.
Conclusions: There is a need to revise the naƟ onal TB algorithm and to diī erenƟ ate it according 
to level of care. The high rate of paƟ ents lost in health centers need to be addressed through 
implemenƟ ng paƟ ent tracing and beƩ er program supervision.
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6.1 | INTRODUCTION
Early and accurate diagnosis of pulmonary tuberculosis (TB) is criƟ cal for beƩ er treatment 
outcome and reducƟ on of transmission.[1,2] TB diagnosis gold standard is bacilli culture in 
Löwenstein-Jensen (LJ) media, but it is diĸ  cult to provide in many resource poor seƫ  ng countries. 
Moreover, LJ culture takes 6-8 weeks, which limits the usefulness of culture as fi rst line diagnosƟ c 
test. Rapid cultures in liquid media provide faster result but are more expensive and prone to 
contaminaƟ on.[3] Therefore, the World Health OrganizaƟ on (WHO) and the InternaƟ onal Union 
Against Tuberculosis and Lung Disease (IUATLD) endorse sputum smear microscopy examinaƟ on, 
with at least, one sputum smear-posiƟ ve for diagnosis of smear-posiƟ ve TB.[4,5] For TB suspected 
paƟ ents, with negaƟ ve sputum results, the diagnosƟ c criteria for smear-negaƟ ve pulmonary 
TB encompasses at least two negaƟ ve smear sputum specimens, radiographic abnormaliƟ es 
consistent with acƟ ve pulmonary TB, no response to a course of broad-spectrum anƟ bioƟ cs, HIV 
status and a decision by a clinician to treat with a full course of anƟ -tuberculosis chemotherapy.
[4]
 WHO recommended the use of diagnosƟ c algorithms to diagnose smear-negaƟ ve pulmonary 
TB,[6] and many TB high endemic countries have adopted the algorithm approach.[7] But the 
eī ecƟ veness of the diagnosƟ c algorithms is infl uenced by local factors such as HIV prevalence, the 
adopƟ on of the algorithm at frontline health care services and the adherence of local clinicians 
to the algorithm.[8] Several studies have evaluated diagnosƟ c algorithms, mainly focusing on 
performance of the algorithm in diagnosing smear-negaƟ ve TB among HIV paƟ ents[8,9] or in 
specifi c seƫ  ng.[10-13] However, studies that evaluate the implementaƟ on and adherence to 
such algorithm in rouƟ ne seƫ  ngs are lacking but would help program managers to idenƟ fy and 
correct possible weaknesses in the diagnosƟ c process. This study evaluated the implementaƟ on 
of the naƟ onal TB diagnosƟ c algorithm in rouƟ ne health care seƫ  ng in Indonesia. 
6.2 | METHODS
Study seƫ  ng
Jogjakarta municipality is an urban area with approximately half a million populaƟ on. The TB 
control program in Jogyakarta municipality relies on a network of 18 public health centers, 2 lung 
clinics and 9 public and private hospitals. The health centers consist of 4 microscopy health centers 
(MHC), capable of performing smear microscopy and 14 satellite health centers (SHC) that collect 
sputum specimens from TB suspects, prepare smear slides and subsequently send the slides to 
the MHC for microscopy reading. The lung clinics have smear microscopy, chest radiography and 
VCT services. TB incidence in Jogyakarta municipality is esƟ mated at 63/100,000[14] and HIV 
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prevalence among TB paƟ ents is esƟ mated at 1.9%.[15] The TB diagnosis network is supported 
by an external quality assurance mechanism through quarterly cross-checks by the Provincial 
Health Laboratory, with technical assistance from the Microbiology Laboratory, Faculty of 
Medicine, Gadjah Mada University (FM GMU). 
Data collecƟ on and analysis
The study took place from November 2009 unƟ l May 2010 in the all public health centers and 
lung clinics in Jogjakarta municipality. 
 All TB suspects registered at health centers and lung clinics were included. The defi niƟ on of TB 
suspect from the NTP guideline was employed, in which paƟ ent with symptom of cough for more 
than two weeks is considered as TB suspect.[16] Their diagnosƟ c work-ups, defi ned as clinical 
and laboratory examinaƟ ons received, were prospecƟ vely documented. The diagnosƟ c work-up 
was started from the Ɵ me a paƟ ent was considered as TB suspect, to the Ɵ me when diagnosis 
was obtained. A clinical audit form to record chronologically, step-by-step, the diagnosƟ c work-
up was developed and tested prior to data collecƟ on. Data on paƟ ents’ gender, age, symptoms, 
type, dates, sequence and results of examinaƟ ons, and fi nal diagnosis were collected. PaƟ ents 
who did not return to their previous health facility and complete their diagnosƟ c work-up, were 
considered lost and not traced back. A trained nurse fi lled in the audit form in each facility. A fi eld 
coordinator conducted monthly supervision visit to check the completeness of data collected 
and to crosscheck with the paƟ ents’ clinical fi le and laboratory register. 
 We compared the actual diagnosƟ c work-up with the naƟ onal TB diagnosƟ c algorithm (Figure 
1-solid lines and boxes). All cases that did not match the standardized pathways were categorized 
as other pathways (Figure1-doƩ ed lines and boxes). 
 All data were double entered into a database checked for typing errors, missing data, and 
inconsistencies. Data were analyzed using SPSS for Windows version 16. LogisƟ c regression was 
used to analyze factors associated with paƟ ent lost, posiƟ vity of TB diagnosis among suspects 
who completed the diagnosis work-up, and smear posiƟ vity of TB cases. Factors were fi rst 
tested univariately. Factors with P<0.20 were maintained using backward LR approach in the 
mulƟ variate model. Chi square was used to assess the background characterisƟ cs of paƟ ents 
visited lung clinics and health centers. A median based test was used to assess diī erences in 
diagnosƟ c delay between lung clinics, MHC and SHC.
 Ethical clearance was obtained from the ethical commiƩ ee of FM GMU, Indonesia and the 
ethics commiƩ ee of the University of Antwerp, Belgium.
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6.3 | RESULTS
Seven hundred twenty four (724) paƟ ents were registered as TB suspects during the study. The 
majority, 76.5% (n=554) aƩ ended health centers and 23.5% (n=170) aƩ ended lung clinics (Figure 
6.2). The gender and age distribuƟ on of paƟ ents consulƟ ng at health centers and lung clinics was 
similar (data not shown). Of paƟ ents who consulted health centers, 43.5% (n=241) were lost, 
while none was lost in lung clinics. Of paƟ ents that completed diagnosƟ c work-up, the adherence 
to the naƟ onal TB diagnosƟ c algorithm was 0.0% in lung clinics, and 48.9% (n=153) in health 
centers. 
 Figure 6.1 shows a summary of the diagnosƟ c pathways in lung clinics and health centers. 
Most of the paƟ ents (n=502, 69.7%) started their diagnosƟ c work-up with sputum smear 
microscopic examinaƟ on, but only 21.1% (n=153) followed thereaŌ er the standardized algorithm 
and completed diagnosƟ c work-up. 
 One hundred thirty six of 461 (29.5%) suspects who fi rst received sputum smear examinaƟ ons 
but had negaƟ ve results followed later non-standardized pathways (second dashed line on the 
right of Figure 6.1), with 22.6% (n=104) were diagnosed as non-TB because were clinically beƩ er. 
Approximately 30% (n=218) of paƟ ents did not follow the naƟ onal algorithm from the start of 
diagnosƟ c work-ups. They started their diagnosƟ c work-up with chest radiography, anƟ bioƟ cs 
trial, or a combinaƟ on of these procedures with sputum smear microscopy. It is of note that all 
TB suspects, who were not lost to follow up, received a sputum smear microscopy examinaƟ on 
at one or the other point during their diagnosƟ c work-up.
 PaƟ ents were lost at every level of the diagnosƟ c work-up (Figure 6.1) and this already 
occurred at a very early stages. The highest frequency of lost occurred, however aŌ er a negaƟ ve 
1st set of sputum smears: in 44% (n=204) of the 461 smear-negaƟ ve paƟ ents. PaƟ ent lost was 
similar in males and females, but varied slightly among diī erent age group (Table 6.1). PaƟ ent 
lost was signifi cantly higher in SHC compared to MHC (OR 2.06, 95% CI 1.41-3.02, p<0.001). 
 Of those TB suspects who completed their diagnosis process, gender and type of health 
facility were associated with TB diagnosis. Only older age was associated with TB diagnosis (OR 
0.75, 95% CI 0.66-0.86, p<001). There were no signifi cant diī erences between paƟ ents who 
were diagnosed as TB smear-posiƟ ve and TB smear-negaƟ ve in terms of gender, age group and 
type of health facility where they were diagnosed, only sputum smear as the fi rst examinaƟ on 
was associated with TB smear posiƟ vity (OR 2.93, 95% CI 1.10-7.77), p<0.03) (data not shown). 
 The median duraƟ on of diagnosƟ c delay for smear-posiƟ ve, excluding the paƟ ents that 
dropped out, was 1 day in lung clinics and 4 days in MHC and 7.5 days in SHC. The median delay 
unƟ l diagnosis for smear-negaƟ ve TB and non-TB case was also longer in the SHC compared to 
the delay in both MHC and lung clinics. The median tests showed that there were signifi cantly 
longer duraƟ on of diagnosƟ c delays in satellite, MHC compare to lung clinics among smear-
posiƟ ve, smear-negaƟ ve and non-TB paƟ ents (Table 6.2). 
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Figure 6.2 | Adherence to the naƟ onal TB diagnosƟ c algorithm and outcomes of diagnosƟ c work-ups in 
lung clinics and health centers.
Table 6.1 | Determinants of paƟ ent lost among 554 TB suspects in health centers in Jogjakarta municipality.
Variable n/N % Univariate
OR 95% CI P
All 241/554 43.3
First step work-up
Sputum smears microscopy 215/497 43.3 1
Others e 22/53 41.5 0.93 0.52-1.65 0.81
Nothing± 4/4 100.0
Sex
Male 115/262 43.9 1.03 0.74-1.44 0.86
Female 126/292 43.2 1
Age group (years) 0.10
18-25 28/81 34.6 0.70 0.39-126 0.23
26-35 40/88 45.5 1.10 0.62-1.94 0.74
36-45 47/89 52.8 1.48 0.84-2.59 0.18
46-55 45/92 48.9 1.26 0.72-2.21 0.41
56-65 34/95 35.8 0.74 0.42-1.29 0.29
>65 മ47/109 43.1 1
Type of health facility
MHC 53/168 31.5 1
SHC 188/386 48.7 2.06 1.41-3.02 മ<0.001*
e Chest X-ray, anƟ bioƟ cs or combinaƟ on of X-ray, anƟ bioƟ cs with/without sputum smears
±Suspects who were directly lost before any examinaƟ on performed. Not included in the staƟ sƟ cal analysis.
*Only type of health facility remained in mulƟ variate analysis.
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Table 6.2 | DuraƟ on of diagnosƟ c delay (in days) according to the diagnosƟ c outcome for TB suspects 
who completed the diagnosƟ c work-up
 Lung clinics MHC SHC P value
n Median (IQR) n Median (IQR) n Median (IQR)
TB smear-posiƟ ve മ27 1 (1-1) 16 മ4 (2-7) 26 7.5 (5 – 12) <0.001
TB negaƟ ve മ12 2 (1-4) 4 10 (5-88) 8 13.5 (5 – 14) മ0.006
Non-TB 131 2 (1-4) 95 മ8 (5-15) 164 11 (8 – 11) <0.001
IQR= inter-quarƟ le range
6.4 | DISCUSSION
This is one of a few studies, focusing on the process of diagnosƟ c work-up in DOTS faciliƟ es. Our 
study found that all diagnosis work-ups in lung clinics and 51% in health centers did not comply to 
the standardized naƟ onal algorithm. There were no paƟ ent losts in lung clinics, however 43.5% 
of paƟ ents lost was found in health centers. We also found longer duraƟ on of diagnosƟ c delay in 
health centers compared to lung clinics.
 Some limitaƟ ons of our study need to be taken into account. First, we limited ourselves to the 
lung clinics and health centers, therefore TB diagnosƟ c work-ups at DOTS aĸ  liated hospitals were 
not documented. However, the hospitals diagnosƟ c infrastructure and technical capacity are 
similar to the lung clinics, thus we expect the variaƟ on of diagnosƟ c pathways in these hospitals 
are comparable to lung clinics. Second, paƟ ents lost were not traced back, but this refl ects the 
actual performance of the health services. Third, culture examinaƟ on was not performed; since 
we did not aim to evaluate the eī ecƟ veness of the diagnosƟ c algorithm.
 Non-adherence to the standardized diagnosƟ c algorithm was high. One important reason 
was a non-TB diagnosis among paƟ ents with a negaƟ ve fi rst series of sputum smear result and 
showing clinical improvement. It is a reasonable clinical decision, however the exisƟ ng algorithm 
does not accommodate this opƟ on. If it is considered acceptable, the non-adherence in the 
health centers drops to 18.2% (n=57). Other studies in Ethiopia, and India also showed a high 
rate of non-adherence.[17-19] While, diī erent types of non-adherence exists e.g. sequence of 
examinaƟ ons, inadequate examinaƟ on or absence of recommended examinaƟ on.[17-19] We 
found that sequence of examinaƟ ons was the main reason for non-adherence. Most paƟ ents 
in lung clinics in parƟ cular, received mulƟ ple examinaƟ ons at the fi rst consultaƟ on, due to the 
availability of chest radiography. Also specialized chest doctors are more likely to rely on their 
clinical judgment than on the diagnosƟ c algorithm.
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PaƟ ents lost in health centers were surprisingly high. A study in Pakistan found lower proporƟ on 
of paƟ ent lost (13%).[20] We found that gender did not correlate with default rate, while a study 
conducted by Khan et al. found that male defaulted more frequently than female.[20] PaƟ ent 
lost in SHC was twice higher than in MHC. Several studies suggested that quality of services is 
a common reason for defaulƟ ng before iniƟ aƟ ng treatment.[20-22] One possible explanaƟ on 
in our study could be the substanƟ al longer duraƟ on of diagnosƟ c work-up in SHC. Another 
possibility is inadequate informaƟ on provided to the paƟ ents in SHC. A study in similar seƫ  ng 
in Java indicated that only 20% of the nurses in health centers provided adequate informaƟ on 
on providing sputum sample to TB suspects.[23] As paƟ ents were not traced, we did not know 
if they felt beƩ er or consulted other health services. For the laƩ er cases, as the subsequent 
consultaƟ ons were all self-referral, we, therefore, did not consider that as part of the TB 
diagnosƟ c work-ups under the study. There is also a possibility of self-selecƟ on i.e. paƟ ents with 
minor symptoms went to the SHC while more severe paƟ ents might prefer to go to the MHC or 
lung clinics, and the laƩ er may also be more moƟ vated to adhere to health providers’ orders.
 The diagnosƟ c delays are signifi cantly longer in SHC and MHC compared to lung clinics. 
This depends most probably on the diagnosƟ c capacity available, which infl uence the Ɵ ming 
of diī erent examinaƟ ons prescribed. All faciliƟ es and skills required to perform smear-negaƟ ve 
TB diagnosis are readily available in lung clinics, while SHC need to send the sputum smears 
to the referral MHC and wait for the reporƟ ng back of the results. Also in case of prescripƟ on 
of chest radiography by the health centers, most paƟ ents need to be referred to higher-level 
hospitals or lung clinics, which causes further delay. Furthermore, lung clinics tend to perform 
mulƟ ple examinaƟ ons at the same contact. Although this pracƟ ce is not in line with the naƟ onal 
diagnosƟ c algorithm, it signifi cantly reduced the duraƟ on of diagnosƟ c work-up. 
 All diagnosis at the lung clinics were made without complying with the naƟ onal diagnosƟ c 
algorithm, but this considerably reduced the delay to diagnosis and prevented paƟ ents lost. 
Getahun et al. have argued that the health service delay introduced by applying TB diagnosƟ c 
algorithm in a linear fashion could be life threatening parƟ cularly among HIV posiƟ ve paƟ ents, 
as it needs 11-34 days to establish the diagnosis of smear-negaƟ ve pulmonary TB under the 
most opƟ misƟ c scenarios.[7] The Stop TB Partnership endorsed an internaƟ onal standard of 
tuberculosis care (ISTC) since 2006. The ISTC acknowledges many situaƟ ons in which the level 
of care can, and should, go beyond what is specifi ed in the ISTC.[24] While the standardized 
diagnosƟ c algorithms are developed to improve TB diagnosis sensibility and specifi city among 
health providers within TB control program, the purpose of the ISTC is to provide guidelines, 
which are more suitable for all pracƟ Ɵ oners and allows some degree of fl exibility. The standard 2 
and 4 of the ISTC recommend that all paƟ ents suspected of having pulmonary TB and all person 
with chest radiographic fi ndings suggesƟ ve of tuberculosis should have sputum specimens 
submiƩ ed for microbiological examinaƟ on. The ISTC also acknowledges the fact that no single 
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provider commonly follows the steps in the TB diagnosƟ c algorithm in a sequenƟ al fashion. The 
algorithm should, therefore, be viewed as presenƟ ng an approach to diagnosis that incorporates 
the main components of, and a framework for, the diagnosƟ c evaluaƟ on. Furthermore the 
approach outlined in the algorithm may be quite costly to the paƟ ent and deter her/him from 
conƟ nuing with the diagnosƟ c evaluaƟ on. Therefore the ISTC recommends that applicaƟ on of 
such an algorithm must be done in a fl exible manner.[25] Our study found that all TB paƟ ents 
who completed diagnosƟ c work-up, both in lung clinics and health centers, received sputum 
examinaƟ on at certain point during their diagnosƟ c work-up, thus sƟ ll conforming to the ISTC 
recommendaƟ ons. Considering the diagnosƟ c capacity of lung clinics, applying ISTC is more 
suitable than following the standardized naƟ onal TB diagnosƟ c algorithm. A recent study 
also suggests that the performance of the WHO based diagnosƟ c algorithm for HIV negaƟ ve 
TB suspects is far from opƟ mal.[12] Another study among HIV posiƟ ve paƟ ents also suggests 
that chest radiography is the best next step aŌ er sputum examinaƟ on as the best fi rst step.
[9] Clearly, the Indonesia naƟ onal TB program (NTP) needs to reevaluate the current diagnosƟ c 
algorithm and current policy, taking into account possible scenarios at diī erent levels of care, 
new evidences and recent internaƟ onal policy recommendaƟ ons.
 Futhermore, the high rate of paƟ ents lost in health centers needs special aƩ enƟ on. Improving 
service quality through beƩ er communicaƟ on with paƟ ents may be the answer. However Khan et 
al. reported that even when paƟ ents were counseled, this did not reduce paƟ ents lost rate during 
diagnosƟ c work-up.[20] Faster diagnosƟ c technology may be a beƩ er answer. WHO has recently 
endorsed a new rapid molecular test for TB diagnosis following a successful evaluaƟ on in low-
income countries fi eld seƫ  ng.[26,27] The test provides a sensiƟ vity comparable to culture, but 
with results in less than 2 hours. However, considerable resources need to be invested and much 
Ɵ me will elapse before this new method will be generally implemented in Indonesian. Therefore, 
improving quality of service, implemenƟ ng paƟ ents tracing, oī er a diversifi ed naƟ onal algorithm 
and ensure beƩ er program supervision may be the best opƟ on for the moment.
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SUMMARY
IntroducƟ on: We aimed to establish HIV prevalence and uptake of unlinked anonymous tesƟ ng 
and Voluntary Counselling and TesƟ ng (VCT) among tuberculosis (TB) paƟ ents in Jogjakarta, 
Indonesia. 
Method: We introduced unlinked anonymous HIV tesƟ ng for TB paƟ ents aƩ ending DOTS services 
between April and December 2006. PaƟ ents were addiƟ onally oī ered VCT services. 
Results: Out of 1269 TB paƟ ents who were oī ered unlinked anonymous tesƟ ng, 989 (77.9%; 
95% CI 75.6-80.1%) accepted. HIV prevalence was 1.9% (95% CI 1.6-2.2%). HIV infecƟ ons were 
less frequently diagnosed among TB paƟ ents who aƩ ended public health center (OR 0.15; 95% CI 
0.03-0.70) rather than public hospital. They were more frequent in TB paƟ ents with a university 
educaƟ on background (OR 5.16; 95% CI 1.01-26.63) and a history of HIV tesƟ ng (OR 57.87; 95% 
CI 9.42-355.62). Of the 989 paƟ ents who accepted unlinked anonymous tesƟ ng, only 133 (13.4%; 
95%CI 11.5-15.7) expressed interest in VCT. Of these, 52 (39.1%; 95% CI 31.2-47.6) aƩ ended VCT. 
Interest was higher among students (OR 2.35; 95% CI 1.24-4.46) and those oī ered VCT by public 
health centers (OR 8.02; 95% CI 5.11-12.60). 
Conclusion: The HIV prevalence in Jogjakarta is higher than expected and needs to be monitored 
cauƟ ously. Unlinked anonymous HIV tesƟ ng is well accepted and can be implemented with 
modest addiƟ onal eī orts. Before adopƟ ng the WHO recommendaƟ on for linked confi denƟ al 
tesƟ ng, access to VCT services should be improved. 
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7.1 | INTRODUCTION
Indonesia’s NaƟ onal TB Control Program (NTP) has achieved the internaƟ onal targets for case 
detecƟ on (>70%) and treatment success rate (>85%) in 2006.[1] However, recent trends suggest 
the potenƟ al for a dual TB-HIV epidemic. The number of reported AIDS cases in Indonesia has 
increased 15 fold over the past ten years.[2] PaƟ ents with TB-HIV co-infecƟ on are reported 
from hospitals and jails in several provinces. Furthermore, TB is one of the leading opportunisƟ c 
infecƟ ons among hospitalized AIDS paƟ ents.[3]
 The World Health OrganizaƟ on (WHO) recommends HIV tesƟ ng among TB paƟ ents as a 
key component of the health sector’s response to the intersecƟ ng TB and HIV epidemics. HIV 
tesƟ ng among TB paƟ ents can serve as a pillar for integrated surveillance that is much needed to 
monitor the dual epidemic trend and to enable the development of sound prevenƟ on strategies.
[4] Moreover, it can facilitate referral for appropriate care, support and treatment for TB paƟ ents 
with HIV infecƟ ons.[5] 
 In view of the high HIV infecƟ on rates in some seƫ  ngs and the improved prospects for HIV/
AIDS treatment, an ethical debate has emerged surrounding HIV tesƟ ng among TB paƟ ents, 
parƟ cularly with regard to unlinked anonymous or “blinded” methods.[4] This led to linked 
confi denƟ al tesƟ ng through an ‘opt in’ approach, which has been oī ered in centers designated 
for voluntary counselling and tesƟ ng (VCT).[6] Recently however, WHO encouraged adopƟ on of 
provider-iniƟ ated linked confi denƟ al tesƟ ng and counselling (PITC).[7] In contrast to VCT, PITC is 
based on an ‘opt out’ approach in which the clinician iniƟ ates counselling when an individual is 
seeking medical care with signs or symptoms compaƟ ble with HIV infecƟ on.[6]
 UlƟ mately, decisions about whether and how to implement HIV tesƟ ng in TB paƟ ents, 
parƟ cularly in countries with low-level and concentrated epidemics like Indonesia, should be 
guided by an assessment of the local epidemiological context and the feasibility of alternaƟ ve 
tesƟ ng strategies. This study aimed to determine the HIV prevalence among TB paƟ ents in the 
diī erent types of health faciliƟ es in Jogjakarta, Indonesia, and to assess the feasibility of unlinked 
anonymous HIV tesƟ ng for rouƟ ne surveillance and ‘opt-in’ linked confi denƟ al HIV tesƟ ng as an 
entry point for integrated TB-HIV care.
7.2 | METHOD
Study context
Jogjakarta province is located in the central part of Java Island, has 3.2 million inhabitants and 
covers an area of 3185 square km. The province’s primary care oī er consists of some 650 private 
pracƟ ces and 117 public community health centers staī ed with doctors, midwives and nurses. 
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This fi rst-level network is backed up by 9 public and 24 private hospitals. The provincial TB control 
strategy involves all 117 public health centers, 5 chest clinics and 18 hospitals (public and private), 
linking them for monitoring of diagnosis and treatment outcomes as well as quality assurance for 
smear microscopy.[8]
 The province is currently facing a concentrated HIV epidemic, with 92 AIDS cases (2.3 per 
100.000 populaƟ on) reported as of 2006.[2] The HIV prevalence among the general adult 
populaƟ on in Jogjakarta is esƟ mated at 0.15-2.0%,[9] though much higher among high-risk groups: 
clients of commercial sex workers (0.69-1.19%); commercial sex workers (3.6-7.4%); prisoners 
(3.7-8.0%); and injecƟ ng drug users (29.0-52.9%).[2] HIV surveillance in the province is mainly 
based on rouƟ ne reporƟ ng of AIDS cases by hospitals and on annual seroprevalence surveys 
among risk groups. Voluntary Counselling and TesƟ ng (VCT) services have been established in 
four hospitals and one non-governmental organizaƟ on clinic in Jogjakarta municipality. These 
services are provided free of charge and can be reached from the surrounding districts within 45 
minutes by public transport. 
Study design
We piloted unlinked anonymous HIV tesƟ ng among TB paƟ ents aƩ ending Directly Observed 
Treatment, Short-course (DOTS) services in Jogjakarta province and addiƟ onally facilitated linked 
confi denƟ al tesƟ ng. The protocol was developed iteraƟ vely in consultaƟ on with key stakeholders 
and informed mainly by the WHO guideline on TB-HIV surveillance.[4]
 A minimum sample size of 916 was required based on the following assumpƟ ons: the WHO 
esƟ mate of percentage of HIV infecƟ on in TB cases in Indonesia (0.6%), a desired precision of 
0.05% (with ɲ= 5.0%), and an addiƟ onal to anƟ cipate 5% poor quality blood specimens.[10] Out 
of fi ve districts in the province, we selected three districts, which well represented urban, semi-
urban and rural seƫ  ngs. Within the three districts, we involved all 88 DOTS faciliƟ es: 68 health 
centers, 16 hospitals, and 4 chest clinics. We weighted the minimum sample size for each facility 
type to refl ect their contribuƟ ons per district to TB case fi nding in 2005.
 Between April and December 2006, consecuƟ ve new TB paƟ ents (smear posiƟ ve, smear 
negaƟ ve, extrapulmonary) and relapses, aged 15 and above, who gave informed consent were 
recruited into the study unƟ l the required sample size was reached. The TB case defi niƟ ons of 
the NTP guideline were employed.[11] The guideline prescribes diagnosis of smear posiƟ ve 
pulmonary TB on the basis of: (1) at least two posiƟ ve results out of three consecuƟ ve sputum 
samples; or (2) one posiƟ ve result out of three consecuƟ ve sputum samples complemented 
by chest X-ray indicaƟ ve of TB. Smear negaƟ ve pulmonary TB has to be diagnosed based on: 
(1) negaƟ ve results from all three consecuƟ ve sputum samples; (2) chest X-ray indicaƟ ve of 
TB; (3) no clinical improvement aŌ er empirical non-TB anƟ bioƟ c treatment; and (4) physician’s 
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judgment. Persons who were too ill to be counselled or unable to comprehend the procedure 
were excluded. 
 Eligible TB paƟ ents were recruited during their iniƟ al treatment visit and recorded in the 
TB register to avoid double enrollment. Specifi cally trained health workers oī ered TB paƟ ents 
unlinked anonymous HIV tesƟ ng and addiƟ onally the freely available hospital-based VCT 
services. Their interacƟ ons were guided by the content of a brochure covering basic knowledge 
of HIV transmission and the importance of HIV tesƟ ng that was subsequently oī ered to the 
paƟ ent. Access to anƟ retroviral treatment, as a possible benefi t of VCT, was to be explicitly 
menƟ oned. If the paƟ ent expressed interest in visiƟ ng the VCT services, the health worker made 
an appointment with the tesƟ ng center and provided a referral slip as well as a modest incenƟ ve 
to cover two return trips to the VCT centers with public transport. 
 Blood samples were transported from the TB faciliƟ es to the provincial laboratory. HIV was 
assessed in the provincial laboratory using Entebe HIV dipsƟ ck (HepaƟ ka Laboratories, Indonesia) 
and Determine HIV1/2 (Abbot Laboratories, Germany), according to a WHO standard algorithm 
already in use for annual HIV serosurveys in the province.[12] The provincial laboratory re-tested 
all posiƟ ve and 10% of the negaƟ ve HIV tests with VironosƟ ka HIV Uniform II AnƟ gen Ag/Ab 
(Biomerieux, France).
 The health workers who oī ered HIV tesƟ ng also administered on site a short quesƟ onnaire 
(available from the corresponding author), which was designed for this study, but with future 
adopƟ on for rouƟ ne recording and reporƟ ng in mind. The quesƟ onnaire idenƟ fi ed the health 
facility type, and collected informaƟ on on district, age, gender, educaƟ on, occupaƟ on, marital 
status of the paƟ ents, type and duraƟ on of TB symptom and history of HIV tesƟ ng. All data were 
double entered and checked for inconsistencies before analysis. Analysis was conducted using 
SPSS 15.0. (SPSS Inc, Chicago, IL, USA). In univariate analysis, diī erences between proporƟ ons 
were tested with Chi-square or Fisher Exact test. LogisƟ c regression analysis was performed to 
idenƟ fy independent determinants for a posiƟ ve HIV test and for interest in VCT. 
Ethical consideraƟ ons
Prior to recruitment, informed consent was obtained from all respondents or their guardian in 
case of paƟ ents aged 15 to 18 years. Whether or not a paƟ ent consented to parƟ cipate did not 
infl uence the standard of care he/she received. Respondents were encouraged, but never forced 
to consult VCT centers. The Jogjakarta provincial health oĸ  ce had suĸ  cient supply of Highly 
AcƟ ve AnƟ retroviral Treatment (HAART) regiments, which were freely available to paƟ ents 
taking up VCT. PaƟ ent’s anonymity was protected by applying unique codes in place of personal 
idenƟ fi ers on the data collecƟ on forms. 
 The study protocol was approved by the ethical review commiƩ ee of the Faculty of Medicine, 
Gadjah Mada University and endorsed by the relevant Indonesian health authoriƟ es.
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7.3 | RESULTS
In total, 1681 TB paƟ ents were registered by the parƟ cipaƟ ng DOTS services in the study districts 
(Figure 7.1). Among these, 1269 (75.5%) were invited to parƟ cipate in the study. The remaining 
412 (24.5%) were not invited due to exclusion criteria (26.5%), Ɵ me constraints within the facility 
(35.2%), and other reasons (38.3%). The predominant ‘other’ reason concerned the challenging 
condiƟ ons imposed by the severe earthquake that struck the study area in May 2006. 989 of 
the 1269 (77.9%; 95% CI 75.6-80.1%) invited paƟ ents accepted unlinked anonymous tesƟ ng and 
were all tested. There were no signifi cant diī erences between those that accepted or not in 
terms of gender, age and district. A signifi cant diī erence in acceptance rates was only observed 
with regard to the type of health facility where paƟ ents were recruited, with lower acceptance 
rates in hospitals compared with public heath centers (p<0.001).
Figure 7.1 | Acceptability of unlinked anonymous HIV tesƟ ng and voluntary counselling and tesƟ ng (VCT) 
among tuberculosis paƟ ents in Jogjakarta province, Indonesia in 2006. a Denominator = 1269 (oī ered 
unlinked anonymous tesƟ ng).
HIV surveillance among TB paƟ ents in Jogjakarta, Indonesia  |  129
HIV prevalence among all tested TB paƟ ents was 1.9% (95% CI 1.6-2.2%). There were no signifi cant 
diī erences between TB paƟ ents who were HIV posiƟ ve and those who were HIV negaƟ ve in 
terms of district, gender, age, occupaƟ on, marital/relaƟ onship status and TB paƟ ent categories 
(Table 7.1). The proporƟ on of HIV posiƟ ve TB paƟ ents were lower in health centers (OR 0.15; 
95% CI 0.03-0.70) or chest clinics (OR 0.19; 95% CI 0.05-0.82) than in public hospitals. It was 
higher in TB paƟ ents with University level educaƟ on background (OR 5.16; 95% CI 1.01-26.63). 
HIV infecƟ ons were also more frequently diagnosed in TB paƟ ents with a history of HIV tesƟ ng 
(OR 57.87; 95% CI 9.42-355.62). 
Table 7.1 | CharacterisƟ cs of TB paƟ ents and HIV test result in Jogjakarta province, Indonesia in 2006 
(N=987)*
Variable Total HIV posiƟ ve
n (%)
Univariate MulƟ variate
OR 95% CI OR 95% CI
All 987 19 (1.9) - - - -
District
Sleman 309 മ9 (2.9) 1 1
Jogjakarta 532 മ9 (1.7) 0.57 (0.23-1.46) 1.07 (0.30-3.77)
Bantul 146 മ1 (0.7) 0.23 (0.03-1.83) 0.94 (0.10-9.04)
Health facility where TB paƟ ent 
was diagnosed
Public hospital 232 11 (4.7) 1 1
Private hospital മ69 മ1 (1.4) 0.30 (0.04-2.33) 0.20 (0.19-2.15)
Health center 360 മ3 (0.8) 0.17 (0.05-0.61) 0.15 (0.03-0.70)
Chest clinic 322 മ4 (1.2) 0.25 (0.08-0.80) 0.19 (0.05-0.82)
Sex
Male 596 13 (2.2) 1 1
Female 390 മ6 (1.5) 0.70 (0.26-1.86) 0.52 (0.13-2.05)
Age group
15-24 years 222 മ6 (2.7) 1 1
25-34 years 249 മ7 (2.8) 1.04 (0.34-3.13) 0.93 (0.21-4.06)
35-44 years 147 മ4 (2.7) 1.03 (0.29-3.69) 1.21 (0.20-7.12)
>44 years 367 മ2 (0.5) 0.20 (0.03-1.09) 0.20 (0.23-1.59)
EducaƟ on level
No educaƟ on, elementary 
or junior high school
471 മ4 (0.8) 1 1
High school 370 മ8 (2.2) 2.58 (0.77-8.64) 2.86 (0.72-11.40)
University 146 മ7 (4.8) 5.88 (1.70-20.4) 5.16 (1.01-26.63)
130  |  Chapter 7
Table 7.1 | ConƟ nued
Variable Total HIV posiƟ ve
n (%)
Univariate MulƟ variate
OR 95% CI OR 95% CI
OccupaƟ on
Unemployed/informal 527 10 (1.9) 1
Student 117 മ4 (3.4) 1.83 (0.56-5.94) 0.36 (0.06-2.36)
Employed 203 മ2 (1.0) 0.51 (0.11-2.37) 0.25 (0.05-1.37)
Housewife 140 മ3 (2.1) 1.13 (0.30-4.17) 2.17 (0.36-13.20)
Married/in relaƟ onship 
No 302 മ8 (2.6) 1 1
Yes 682 11 (1.6) 0.60 (0.24-1.51) 1.51 (0.34-6.66)
History of HIV tesƟ ng 
No 962 15 (1.6) 1 1
Yes മമ8 മ4 (50.0) 63.1 (14.4-276.5) 57.87 (9.42-355.62)
PaƟ ent category 1 
Relapse/failure മ54 മ1 (1.9) 1 1
New/intensive phase 932 18 (1.9) 1.04 (0.14-7.97) 1.08 (0.09-13.04)
PaƟ ent category 2 
Pulmonary smear posiƟ ve 606 10 (1.7) 1 1
Pulmonary smear negaƟ ve/
Extrapulmonary
380 മ9 (2.4) 1.45 (0.54-3.89) 0.74 (0.90-13.04)
*PaƟ ents with indeterminate HIV test results and with missing values excluded 
Only 133 (13.4%; 95% CI 11.5-15.7%) of the 989 paƟ ents who accepted unlinked anonymous 
HIV tesƟ ng expressed interest to aƩ end VCT. Eventually, only 52 (4.1%; 95% CI 3.1-5.3%) of the 
1269 paƟ ents who were oī ered unlinked anonymous tesƟ ng actually aƩ ended VCT (Figure 
7.1). Between the three paƟ ent groups (those who expressed no interest for VCT; those who 
expressed interest but did not aƩ end VCT; and those who aƩ ended VCT), there were no 
signifi cant diī erences observed in terms of district, sex, educaƟ on, history of HIV tesƟ ng and 
paƟ ent categories (Table 7.2). TB paƟ ents were more interested for VCT if they were students 
(OR 2.35; 95% CI 1.24-4.46) or aged between 15-44 years old (OR 1.88; 95%CI 1.13-3.13) (Table 
7.3). They were also more interested if they had been oī ered the service by a public health 
center (OR 8.02; 95% CI 5.11-12.60).
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Table 7.2 | CharacterisƟ cs of TB paƟ ents and response to VCT oī er in Jogjakarta province, Indonesia in 
2006 (N=989)
Variable Total Response (%) P value
AƩ ended 
VCT
(n= 52)
Interested but did 
not aƩ end VCT
(n= 81)
Not interested 
in VCT
(n=856)
All 989 - - - -
District 0.31
Sleman 309 6.8 മ7.1 86.1
Jogjakarta 533 4.5 മ7.9 87.6
Bantul 147 4.8 11.6 83.7
Health facility oī ering VCT to TB 
paƟ ent
<0.001
Public hospital 228 3.1 മ3.5 93.4
Private hospital മ65 6.2 മ4.6 89.2
Health center 365 9.9 16.4 73.7
Chest clinic 331 1.5 മ3.0 95.5
Sex 0.53
Male 598 5.9 മ8.4 85.8
Female 390 4.4 മ7.7 87.9
Age group 0.05
15-24 years 222 6.3 12.2 81.5
25-34 years 250 6.0 മ8.4 85.6
35-44 years 147 3.4 മ9.5 87.1
>44 years 368 4.9 മ4.9 90.2
EducaƟ on 0.19
No educaƟ on, elementary 
or junior high school
473 4.6 മ6.6 88.8
High school 370 5.7 മ8.6 85.7
University 146 6.2 12.3 81.5
OccupaƟ on 0.02
Unemployed/informal 528 4.9 മ8.0 87.1
Student 117 8.5 14.5 76.9
Employed 204 4.4 മ8.8 86.8
Housewife 140 5.0 മ2.9 92.1
Married/in relaƟ onship 0.04
No 302 5.3 11.6 83.1
Yes 684 5.3 മ6.7 88.0
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Table 7.2 | ConƟ nued
Variable Total Response (%) P value
AƩ ended 
VCT
(n= 52)
Interested but did 
not aƩ end VCT
(n= 81)
Not interested 
in VCT
(n=856)
History of HIV tesƟ ng 0.56
No 964 മ5.1 മ8.2 86.7
Yes മമ8 12.5 12.5 75.0
PaƟ ent category 1 0.40
Relapse/failure മ54 മ9.3 മ7.4 83.3
New/intensive phase 934 മ5.0 മ8.2 86.7
Sex 0.94
Pulmonary smear posiƟ ve 606 മ5.4 മ8.3 86.3
Pulmonary smear negaƟ ve/
Extrapulmonary
382 മ5.0 മ8.1 86.9
Table 7.3 | Determinants of VCT interest among TB paƟ ents in Jogjakarta province, Indonesia in 2006 
(N=989)
Variable N (%interested 
for VCT)
Univariate MulƟ variate
OR 95% CI OR 95% CI
District
Sleman 309 (13.9) 1 1
Jogjakarta 533 (12.4) 0.87 (0.58-1.32) 1.24 (0.69-2.23)
Bantul 147 (16.3) 1.21 (0.70-2.01) 1.70 (0.97-2.99)
Health facility oī ering VCT to 
TB paƟ ents
Chest clinic/public hospital/
private hospital
624 (5.9) 1 1
Health center 365 (26.3) 5.66 (3.77-8.50) 8.02 (5.11-12.60)
Sex
Male 598 (14.2) 1 1
Female 390 (12.1) 0.83 (0.57-1.21) 0.70 (0.46-1.06)
Age group 
>44 years 340 (9.4) 1 1
15-44 years 647 (15.5) 1.76 (1.15-2.68) 1.88 (1.13-3.13)
EducaƟ on level
No educaƟ on, elementary 
school or junior high school
473 (11.2) 1 1
High school or University 516 (15.5) 1.45 (1.00-2.11) 1.40 (0.90-2.17)
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Variable N (%interested 
for VCT)
Univariate MulƟ variate
OR 95% CI OR 95% CI
OccupaƟ on
Employed/unemployed/ 
housewife
872 (12.2) 1 1
Student 117 (23.1) 2.17 (1.35-3.49) 2.350 (1.24-4.46)
Married/in relaƟ onship
No 302 (16.9) 1 1
Yes 684 (12.0) 0.67 (0.46-0.98) 1.35 (0.79-2.29)
7.4 | DISCUSSION
This is one of the rare TB-HIV co-infecƟ on prevalence studies carried out in a seƫ  ng with a low 
prevalence -or concentrated epidemic- of HIV. Our study is also the fi rst to document TB paƟ ents’ 
interest in VCT in such a seƫ  ng and to establish the acceptability of unlinked anonymous HIV 
tesƟ ng in Indonesia. 
 We limited our study populaƟ on to those aƩ ending DOTS TB services, as these services 
detected 73% of TB cases in 2006.[1] While one could expect diī erences between DOTS paƟ ents 
and those TB paƟ ents managed in non-DOTS services in terms of socio-economic status, most of 
the TB suspects aƩ ending non-DOTS services in the study area are eventually being referred to 
DOTS services.[13] Some of the TB paƟ ents aƩ ending DOTS services were not invited to parƟ cipate 
due to operaƟ onal reasons and of those invited, some refused. However, a comparison of tested 
and not tested paƟ ents shows no diī erences in paƟ ent profi le. 
 The acceptance rate of unlinked anonymous HIV tesƟ ng among our TB paƟ ents is high (77.9%). 
There exist no comparable data on unlinked anonymous tesƟ ng uptake among TB paƟ ents as 
other studies uƟ lized VCT as entry point.[14-18] Studies in another target populaƟ on, women 
aƩ ending antenatal clinics in Uganda,[19] observed on the one hand a low uptake of unlinked 
anonymous tesƟ ng (27%) and on the other hand a high uptake of VCT (73%). In seƫ  ngs where 
HIV is generalized, one can expect more demand for VCT services than for unlinked tesƟ ngs 
that does not lead to any direct individual benefi t. Moreover, many other diī erences across 
seƫ  ngs such as coverage and eī ecƟ veness of VCT campaigns, service quality and accessibility, 
and availability of HAART can infl uence uptake. Notwithstanding, our fi ndings support the use of 
an unlinked anonymous HIV surveillance strategy among TB paƟ ents in Indonesia, where HIV has 
not gained high visibility. It could be introduced with relaƟ vely modest addiƟ onal inputs: one day 
of training for health workers, specimen collecƟ on kits and linkage to the provincial laboratory. 
This should be accompanied by promoƟ on for VCT in the now exisƟ ng centers, which raises 
issues that will be discussed further on. 
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Due to methodological diī erences our prevalence result may not be directly comparable to 
results from other studies. Furthermore, HIV tesƟ ng in TB suspects, rather than in TB cases, 
would possibly return higher HIV prevalence rates. The diī erence could be marked in generalized 
HIV seƫ  ng where the diagnosis of TB is a challenge,[20] but it is probably negligible in Jogjakarta. 
At any rate, our data suggests that HIV prevalence among TB paƟ ents in Jogjakarta is signifi cantly 
higher than the naƟ onal (0.14-0.18%) and provincial (0.15-0.20%) esƟ mates for the general 
adult populaƟ on.[9,21] The prevalence we found in TB paƟ ents is close to HIV prevalence in 
risk populaƟ ons such as commercial sex workers and injecƟ ng drug users, which is between 
2.42-5.44% in the province.[9] It is also considerably higher than the esƟ mated HIV prevalence 
of 0.6% among all new adult TB paƟ ents in Indonesia.[22] This implies that the magnitude 
of co-infecƟ on in other Indonesian provinces with concentrated HIV epidemics could also be 
substanƟ ally higher than the naƟ onal average. This further implies that TB paƟ ents in Jogjakarta 
and similar seƫ  ngs in Indonesia should be considered as an important target group for HIV care 
and prevenƟ on. 
 PotenƟ al risk factors for HIV infecƟ on in TB paƟ ents that could easily and reliably be assessed 
were invesƟ gated, but in the interpretaƟ on one has to take into account possible (residual) 
confounding and endogenicity. Few were found to be signifi cant. This might however refl ect the 
study’s lack of power to detect moderate diī erences at the subgroup level. HIV prevalence was 
slightly higher among those aged 15-44 years in our study populaƟ on, but this was not staƟ sƟ cally 
signifi cant. A study in Ukraine did not idenƟ fy age as a risk factor,[16] while others did.[14,18,23] 
In our study, the proporƟ on of female TB paƟ ents infected with HIV is slightly lower than the 
male TB paƟ ents. This however was also not staƟ sƟ cally signifi cant. Other TB-HIV co-infecƟ on 
studies have reported no associaƟ on,[14,16,24] or that HIV infecƟ on was signifi cantly more 
frequent in males,[18,23] or in women.[17] We also observed a higher HIV prevalence among TB 
paƟ ents with higher educaƟ on levels. This is in line with the study conducted by Van der Werf et 
al. in Eritrea.[24] The above someƟ mes-contrasƟ ng fi ndings between studies indicate that the 
importance of demographic characterisƟ cs as risk factors for HIV infecƟ on in TB paƟ ents is largely 
context bound and related to the dynamics of the local HIV epidemiology.
 We fi nd no signifi cant diī erence in HIV rates between smear posiƟ ve and smear negaƟ ve 
TB paƟ ents. Studies in India documented that HIV prevalence was higher among smear posiƟ ve 
paƟ ents.[14,18] These confl icƟ ng results could be aƩ ributed to the diĸ  culty of diagnosing smear 
negaƟ ve TB, parƟ cularly in HIV paƟ ents.[25] HIV infecƟ on is most oŌ en found among TB paƟ ents 
with a history of previous HIV tesƟ ng in our study. This comes as no surprise, as those who had 
been interested in being tested in the past probably considered themselves at risk. HIV is also 
more oŌ en diagnosed among TB paƟ ents aƩ ending public hospitals. This indicates that public 
referral hospitals in major Indonesian towns could be a strategic entry point for integrated TB-
HIV care and surveillance. 
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Interest in VCT is very low in Jogjakarta. Studies in seƫ  ngs with generalized HIV epidemic reported 
much higher rates.[15-17] Only Jerene et al. in Ethiopia reported individual determinants of VCT 
interest in TB paƟ ents.[17] While some other studies were conducted in other sub-populaƟ ons, 
mainly pregnant women, beƩ er educaƟ on;[19,26] self perceived risk;[17,19] marital status;[26] 
and history of VCT uƟ lizaƟ on[26] were reported as predictors. We observe higher interest among 
TB paƟ ents who were students or young. This suggests that introducƟ on of VCT tesƟ ng strategy 
would be more fruiƞ ul if targeted to TB paƟ ents with these characterisƟ cs. 
 TB paƟ ents oī ered VCT in a public health center were notably much more likely to be 
interested. This points to the importance of structural condiƟ ons for eī ecƟ ve VCT. As health 
centers tend to see fewer TB paƟ ents than other faciliƟ es, health center workers have more Ɵ me 
to communicate on VCT services. The importance of structural factors for VCT interest was also 
noted in other studies on TB paƟ ents.[15,17] There is a need to ensure supporƟ ve condiƟ ons, 
parƟ cularly in hospitals, to move forward with integrated TB-HIV surveillance and care. 
 Finally, referral to VCT services in our study was organized in four central hospitals located 
in Jogjakarta municipality. PaƟ ents interested in VCT were oī ered incenƟ ves for transport. 
However, this may not have oī set the opportunity costs (e.g. being away from work) when 
travelling to VCT, waiƟ ng for the counsellor, undertaking the counselling and tesƟ ng process and 
returning for the results the next day. All this poses barriers to aƩ endance. It has, in parƟ cular, 
been shown that providing the result on the same day increases VCT uptake among clients of a 
sexually transmiƩ ed disease clinic and an AIDS informaƟ on center.[27,28] A strong eī ect of VCT 
locaƟ on on uptake was also observed in studies among groups other than TB paƟ ents.[29-31] 
Expansion of VCT sites into the decentralized DOTS services or establishing mobile VCT units to 
visit DOTS services may therefore provide substanƟ al leverage. 
7.5 | CONCLUSIONS
The HIV prevalence among TB paƟ ents in Jogjakarta, Indonesia is higher than expected and there 
is a clear need to cauƟ ously monitor the trend of co-infecƟ on in this and other provinces. We 
have demonstrated that acceptability of unlinked anonymous HIV tesƟ ng among TB paƟ ents is 
high, and that such surveillance schemes can be implemented in low prevalence seƫ  ngs without 
much addiƟ onal eī ort. However, if Indonesian health authoriƟ es want to adopt the current 
WHO recommendaƟ on for linked confi denƟ al tesƟ ng, they must fi rst boost acceptance for this 
strategy among TB paƟ ents. This requires improving access and ensuring availability of Ɵ me, 
skills and faciliƟ es for VCT services. Taking into account the available resources, such a large 
undertaking should iniƟ ally be targeted at students diagnosed in referral hospitals and prioriƟ ze 
provinces with a more advanced HIV epidemic. Likewise, Ministries of Health in other countries 
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with emerging TB-HIV epidemics should not delay introducƟ on of HIV tesƟ ng among TB paƟ ents, 
aŌ er thoughƞ ully considering the appropriate tesƟ ng modaliƟ es.
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ABSTRACT
Background: HIV and HIV-TB co-infecƟ on are slowly increasing in Indonesia. WHO recommends 
HIV tesƟ ng among TB paƟ ents as a key response to the dual HIV-TB epidemic. Concerns over 
potenƟ al negaƟ ve impacts to TB control and lack of operaƟ onal clarity have hindered progress. 
We invesƟ gated the barriers and opportuniƟ es for introducing HIV tesƟ ng perceived by TB 
paƟ ents and providers in Jogjakarta, Indonesia. 
Methods: We oī ered Voluntary Counselling and TesƟ ng (VCT) to TB paƟ ents in parallel to a HIV 
prevalence survey. We conducted in-depth interviews with 33 TB paƟ ents, 3 specialist physicians 
and 3 disease control managers. We also conducted 4 Focus Group Discussions (FGDs) with 
nurses. All interviews and FGDs were recorded and data analysis was supported by the QSR N6® 
soŌ ware. 
Results: PaƟ ents’ and providers’ knowledge regarding HIV was poor. The main barriers perceived 
by paƟ ents were: burden for accessing VCT and fear of knowing the test results. SƟ gma caused 
concerns among providers, but did not play much role in paƟ ents’ aƫ  tude towards VCT. The main 
barriers perceived by providers were communicaƟ on, paƟ ents feeling oī ended, sƟ gmaƟ zaƟ on 
and addiƟ onal burden. 
Conclusion: IntroducƟ on of HIV tesƟ ng among TB paƟ ents in Indonesia should be accompanied 
by paƟ ent and provider educaƟ on as well as providing condiƟ ons for eī ecƟ ve communicaƟ on.
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8.1 | INTRODUCTION
Indonesia is criƟ cal to the global tuberculosis (TB) control eī orts and increasingly important in 
the global HIV control eī orts. The country ranks third in the world for TB burden.[1] The number 
of reported AIDS cases has increased by 15 fold in the past ten years.[2] The rapid increase of new 
HIV infecƟ ons in Indonesia makes the epidemic one of the fastest growing in Asia, even though 
the aggregate naƟ onal prevalence is as low as 0.16%.[3] By the end of 2007, there were 296 
Voluntary Counselling and TesƟ ng (VCT) clinics throughout Indonesia, in addiƟ on to 153 hospitals 
which provide free anƟ retroviral treatment.[3] PaƟ ents with HIV-TB co-infecƟ on are appearing 
in hospitals and jails across several provinces and TB is a leading opportunisƟ c infecƟ on among 
AIDS paƟ ents.[4] These trends suggest a potenƟ al of a dual HIV-TB epidemic, which many other 
developing countries, parƟ cularly in Sub-Saharan Africa are already facing.
 WHO Interim Policy on HIV-TB recommends HIV tesƟ ng among TB paƟ ents as an entry 
point for integrated HIV-TB care and surveillance.[5] However, scaling-up of this policy has been 
lagging.[6] Concerns over sƟ gmaƟ zaƟ on which may generate TB paƟ ents unwillingness to use 
HIV associated services (with potenƟ al negaƟ ve impact on TB case detecƟ on) and lack of detailed 
operaƟ onal guidelines are among the important barriers.[6,7] 
 AddiƟ onally, there is an ethical debate surrounding HIV tesƟ ng among TB paƟ ents, parƟ cularly 
with regard to the unlinked anonymous tesƟ ng method, in view of the improved prospects for 
HIV/AIDS treatment.[8] This led to linked confi denƟ al tesƟ ng through an ‘opt in’ approach, which 
has been oī ered in Voluntary Counselling and TesƟ ng (VCT) centers.[9] More recently, WHO 
encouraged the adopƟ on of provider-iniƟ ated linked confi denƟ al tesƟ ng and counselling (PITC).
[10] In contrast to VCT, PITC is based on an ‘opt out’ approach in which the clinician iniƟ ates 
counselling when an individual is seeking medical care with signs or symptoms compaƟ ble with 
HIV infecƟ on.[9]
 UlƟ mately, decisions about how to implement HIV tesƟ ng in TB paƟ ents, should be guided by 
an understanding of issues surrounding HIV tesƟ ng among TB paƟ ents from the local stakeholders’ 
perspecƟ ves.[11] Studies on groups other than TB paƟ ents suggest that knowledge, fear and 
access may consƟ tute important barriers to HIV tesƟ ng.[12-14] This study aimed to shed light on 
the issue through invesƟ gaƟ ng the barriers for introducing HIV tesƟ ng perceived by TB paƟ ents 
and providers in Jogjakarta, Indonesia.
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8.2 | METHOD
Study context
Jogjakarta province is located in the central part of Java island. It is divided into fi ve districts, 
has 3.2 million inhabitants and covers an area of 3,185 square km. The province’s primary care 
network consists of around 650 private pracƟ ces and 117 public community health centers 
staī ed with doctors, midwives and nurses. These fi rst line services are backed up by 9 public 
hospitals and 24 private hospitals. The backbone of NTP’s DOTS (Directly Observed Treatment, 
Short-course) program in Jogjakarta province comprises a network of the 117 public health 
centers, 5 chest clinics and 18 public and private hospitals.
 HIV prevalence among the general adult populaƟ on in Jogjakarta province is 0.15-2.0%.[15] 
It is much higher among high-risk groups, e.g. sex workers [4.6 (3.6-6.4)%]; injecƟ ng drug users 
[39.3(29.0-52.7%)]. VCT services have been established in four hospitals and one NGO clinic. The 
standard procedure in these VCT services, in accordance to WHO guidelines for seƫ  ngs with HIV 
prevalence ч10%,[16] requires three HIV tests (two rapid and one Enzyme Immunoassays test). 
PaƟ ents would have to return the next day to obtain all three test results. These VCT services are 
free of charge for all, including TB paƟ ents, through fi nancial support from the Global Fund to 
fi ght AIDS, TB and Malaria.
Study design
The study was conducted in parallel to a HIV prevalence survey among TB paƟ ents carried out 
between April and December 2006. The survey targeted TB paƟ ents aƩ ending all (88) public and 
private DOTS services in three out of fi ve districts in the province. TB paƟ ents in parƟ cipaƟ ng 
health faciliƟ es were oī ered unlinked anonymous HIV tesƟ ng for survey purpose and addiƟ onally 
free services of four hospital-based VCT centers. Nurses provided paƟ ents with standardized 
informaƟ on on HIV and VCT services aided by a brochure which was subsequently given to the 
paƟ ent. If the paƟ ent expressed interest, nurses made an appointment with a VCT center and 
provided an incenƟ ve to cover transport expenses to the center. Out of 1269 TB paƟ ents whom 
were oī ered unlinked anonymous tesƟ ng during the survey, 989 (77.9%) accepted.[17] The HIV 
prevalence was 1.9% (95% CI 1.6-2.2%).[17] Out of these 989 paƟ ents, 133 (13.4%) expressed 
interest in VCT but only 52 (39.1%) subsequently aƩ ended VCT. 
 The paƟ ents were asked whether they would be willing to be recruited for follow up in-depth 
interviews. We grouped the paƟ ents who accepted into four groups: (1) paƟ ents who refused 
unlinked anonymous tesƟ ng and expressed no interest in VCT; (2) paƟ ents who accepted unlinked 
anonymous tesƟ ng and expressed no interest in VCT; (3) paƟ ents who expressed interest, but 
did not aƩ end VCT; and (4) paƟ ents who aƩ ended VCT. Among 1269 paƟ ents oī ered unlinked 
anonymous tesƟ ng and VCT service during the parallel survey, 764 accepted to be interviewed. 
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Figure 8.1 presents the distribuƟ on of these consenƟ ng paƟ ents by the 4 paƟ ent categories. 
We aimed to purposively sample eight paƟ ents within each group, keeping in mind the type 
of health facility aƩ ended and addiƟ onally age, gender, educaƟ on and urban/rural residency. 
Appointments were made by nurses for the in-depth interviews of selected paƟ ents. 
Figure 8.1 | PaƟ ent fl ow.
We interviewed 33 paƟ ents: 6 paƟ ents for group 1; 16 paƟ ents for group 2; 2 paƟ ents for group 
3; and 9 paƟ ents for group 4. We faced diĸ  culƟ es recruiƟ ng paƟ ents for group 3 because the 
interview was perceived as a blaming aƩ empt since they had received an incenƟ ve to cover 
transport to VCT, but had not aƩ ended. The large number of paƟ ents in group 2 was due to 
the need to increase the number of interviews to make up for the limited informaƟ on collected 
from the fi rst 8 respondents related to their very poor knowledge about HIV/AIDS. PaƟ ents were 
interviewed on the basis of an in-depth interview guide on why they were interested or not 
interested in VCT and probed for factors that hinder or support VCT uptake, e.g. knowledge, 
aƫ  tudes, informaƟ on given by health providers regarding VCT.
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Barriers prevenƟ ng DOTS services providers to oī er VCT services were also explored. We 
invesƟ gated nurses’ percepƟ ons through four Focus-Group Discussions (FGDs) sampling the 
diī erent health facility types: (1) urban health centers; (2) rural health centers; (3) private 
hospitals; and (4) public hospitals and chest clinics. Within each group, we purposively selected 
nurses who were most involved in the oī ering HIV tesƟ ng among TB paƟ ents and represented 
faciliƟ es with variaƟ on of paƟ ents’ interest rate toward HIV tesƟ ng. Each group consisted of eight 
to nine nurses. We fi nally carried out three in-depth interviews with all the specialist physicians 
providing DOTS services in public and private hospitals and with the three district disease control 
managers. 
 The in-depth interviews and FGDs were conducted by the fi rst and second author. 
Data analysis
We recorded and fully transcribed all in-depth interviews and FGDs. Data analysis was supported 
using the QSR N6® soŌ ware (QSR InternaƟ onal Pty. Ltd., Melbourne, Australia, 2002). The analysis 
was inducƟ ve which implies that categories of analysis were not imposed a priori on the data but 
are idenƟ fi ed through the analysis process [18]. Transcripts imported into the soŌ ware database 
were scruƟ nized to idenƟ fy emerging and recurrent themes and a codebook was progressively 
established and structured. Text units were coded systemaƟ cally. Coding frequency permiƩ ed to 
idenƟ fy key issues and trends regarding percepƟ ons of paƟ ents and providers about barriers to 
HIV tesƟ ng. 
Ethical issues
We safeguarded confi denƟ ality of paƟ ents’ serostatus by unlinking HIV test results from our 
paƟ ents’ idenƟ Ɵ es. Informed consent was obtained from all respondents prior to data collecƟ on. 
All collected data were kept anonymous. Ethical approval for the qualitaƟ ve data collecƟ on 
and the HIV-TB prevalence survey was given by the ethical review commiƩ ee of the Faculty of 
Medicine, Gadjah Mada University, Indonesia. 
8.3 | RESULTS
PaƟ ents’ characterisƟ cs 
Table 8.1 presents the characterisƟ cs of the interviewed paƟ ents’ for the four categories. There 
were slightly more males then females among the paƟ ents. In general, they were predominantly 
aged between 20-40 years old, married, had secondary educaƟ on and were oī ered VCT services 
by a public care provider. The groups’ characterisƟ cs were in general similar with the excepƟ on 
of group 1 having slightly more old paƟ ents and group 4 having more paƟ ents aƩ ending public 
health faciliƟ es.
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Table 8.1 | CharacterisƟ cs of enrolled TB paƟ ents
PaƟ ents’
CharacterisƟ cs
PaƟ ents’ category* Total
N (%)
Group 1
N (%)
Group 2
N (%)
Group 3
N (%)
Group 4
N (%)
Gender
Male 4 (66.7) 8 (50.0) 1 (50.0) 5 (55.6) 18 (54.5)
Female 2 (33.3) 8 (50.0) 1 (50.0) 4 (44.4) 15 (45.5)
Age group
15-19 years old 0 (0.0) 0 (0.0) 1 (50.0) 1 (11.1) 2 (6.1)
20-29 years old 2 (33.3) 9 (56.3) 1 (50.0) 4 (44.4) 16 (48.5)
30-39 years old 0 (0.0) 8 (31.3) 0 (0.0) 1 (11.1) 6 (18.2)
40-49 years old 0 (0.0) 2 (12.5) 0 (0.0) 3 (33.3) 5 (15.2)
>49 years old 4 (66.7) 0 (0.0) 0 (0.0) 0 (0.0) 4 (12.1)
EducaƟ on
Primary 1 (16.7) 2 (12.5) 0 (0.0) 2 (22.2) 5 (15.2)
Secondary 3 (50.0) 11 (68.8) 0 (0.0) 4 (44.4) 18 (54.5)
TerƟ ary 2 (33.3) 3 (18.8) 2 (100.0) 3 (33.3) 10 (30.3)
Married
Yes 4 (66.7) 11 (68.8) 1 (50.0) 5 (55.6) 21 (63.6)
No 2 (33.3) 5 (31.3) 1 (50.0) 4 (44.4) 12 (36.4)
Health facility type
Public 3 (50.0) 11 (68.8) 2 (100.0) 8 (88.9) 24 (72.7)
Private 3 (50.0) 5 (31.3) 0 (0.0) 1 (11.1) 9 (27.3)
TOTAL 6 (100.0) 16 (100.0) 2 (100.0) 9 (100.0) 33 (100.0
*PaƟ ents category:
Group 1. Not accepƟ ng unlinked anonymous and not interested for VCT
Group 2. Accepted unlinked anonymous but not interested for VCT
Group 3. Accepted unlinked anonymous, expressed interest but did not aƩ ended VCT
Group 4. Accepted unlinked anonymous and aƩ ended VCT
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Factors infl uencing paƟ ents’ interests in VCT
Many of our respondents (22) were not interested to aƩ end VCT regardless of gender, age, 
educaƟ on and marital status. Most paƟ ents (24) had no negaƟ ve feeling towards the HIV test 
oī er, though some (9) clearly felt oī ended: 
“Frankly, that Ɵ me I was oī ended. From the beginning, it was already explained that HIV 
is transmiƩ ed by this and that, not all drug users get it, also not all ‘others’ [risk groups] 
get it. And then all the sudden they oī ered me HIV test?ਈ 23-year-old, male, university 
student, aƩ ended VCT
Knowledge of many respondents (11) on HIV was poor, ranging from those who had never heard 
of HIV to those who knew liƩ le. PaƟ ents with limited knowledge were less interested in VCT: 
“The problem is I don’t even know what HF [HIV] is. Is it a new disease? I am just a 
layperson, so I don’t know. It was my son who replied. [I told him] you should respond 
because you are the one who can answer.ਈ 52 year-old, male, employee, not interested 
in VCT
“Well what can I say? That HIV is not scary. It’s just another disease. It can be cured.ਈ 
29-year-old, female, employee, not interested in VCT
MisconcepƟ ons regarding transmission of HIV/AIDS were common:
“You can get infected through having a [sexual] relaƟ onship or through drugs or through 
smoking cigareƩ es, that’s all I know. I heard it before from stories, you know, on TV.ਈ 
26-year-old, male, unemployed, aƩ ended VCT
“I would imagine, that people who get infected by HIV are those who keep changing 
partners. If one doesn’t change partners and does not use illegal drugs, then probably 
[he/she] can’t get infected.ਈ 45-year-old, male, construcƟ on worker, aƩ ended VCT
Table 8.2 summarizes the relaƟ ons between main paƟ ents’ percepƟ ons and VCT interest. Many 
paƟ ents (16) did not report to perceive themselves at risk, or simply did not know enough to 
aƩ ribute risk (10):
“It’s just for a test. It’s not because one gets TB that one will get HIV. I’ve never done 
anything [wrong]. So I don’t mind and I am also looking for a new experience. I am 
confi dent that the result will be non-reacƟ ve. No worries whatsoever. I am sure, Insya 
Allah [God’s willing], as the doctor already know, that I won’t get it. I imagine if one gets 
it. Oh my God!ਈ 37-year-old, male, employee, aƩ ended VCT
Barrier for HIV tesƟ ng among TB paƟ ents in Jogjakarta, Indonesia  |  147
“I mean usually those who get HIV are those who like to go out at night, they like to…well, 
like commercial sex workers, they’re like that, so they must get it. I never go out at night. I 
hardly leave my house. How can I get HIV?ਈ 29-year-old, female, employee, aƩ ended VCT 
Table 8.2 | PaƟ ents’ percepƟ ons and interest for VCT
PaƟ ent’s percepƟ on Interested for VCT
At risk of being infected Yes majority
No minority
VCT entails benefi ts Yes roughly half
No small minority
HIV paƟ ents are sƟ gmaƟ zed Yes roughly half
No minority
Fear of knowing test result Yes small minority
No vast majority
Access to VCT is a burden Yes minority
No vast minority
A few paƟ ents (7) accepted that they could be at risk and were interested in VCT:
“I’ve never done anything wrong [risky], or had a [sexual] relaƟ onship with someone 
with HIV. I’ve never received blood transfusion, never. I don’t believe I can get HIV but, 
there’s a possibility I get it because of TB, they say that can make you get infected easily.ਈ 
45-year-old, male, construcƟ on worker, aƩ ended VCT
“No, I was already told [by the health worker] that from …from the lungs it can lead to 
HIV. So I already knew beforehand.ਈ 24-year-old, female, self-employed, aƩ ended VCT 
Nearly half of the paƟ ents (16) perceived a certain benefi t of HIV tesƟ ng, regardless of whether 
they reported to perceive themselves at risk or not. Many of these (9) expressed interest towards 
VCT: 
“Well, to be able to know [whether I get] AIDS or …HIV. I was not surprised [to be oī ered 
HIV tesƟ ng]. I wanted to be examined to see if I had other diseases.ਈ 26-year-old, male, 
unemployed, aƩ ended VCT 
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Some paƟ ents (10) perceived some sƟ gmaƟ zaƟ on towards people living with HIV in the society. 
Others (8) did not perceive sƟ gmaƟ zaƟ on, while the remaining parƟ cipants (15) had no opinion. 
Most of those who perceived sƟ gmaƟ zaƟ on (6) however were interested in VCT: 
“[They are] afraid to get infected, yes. Also afraid of … what else…Well, it’s a shameful 
and horrible disease. It’s terrifying. So I would be afraid to be isolated, to be treated as 
someone infecƟ ous, as someone who has a patheƟ c disease. If I can, I will just avoid such 
disease.ਈ 29-year-old, female, aƩ ended VCT
“Well, the problem is AIDS is... Well, it is a shameful disease. I don’t know… The problem 
is most people who get AIDS are those who do wrong things. People where I live, if they 
know, they will avoid you immediately.ਈ 17-year-old, female, student, aƩ ended VCT
Some paƟ ents (5) feared knowing the HIV test result and were not interested in VCT, or iniƟ ally 
expressed interest, but eventually changed their mind:
“Why did it go that far? Saying HIV was like this and that. That made me scared. It’s 
about psychology, I am sure I don’t have HIV, but I am not mentally ready. It’s enough 
that I got TB. If for instance I had to be tested for something like that [HIV], it could make 
things more complicated with so many problems…Oohhh!ਈ 23-year-old, male, student, 
not interested in VCT
“If they take my blood again, then they will test it, then if it turns out that I have that 
disease, it’s like being struck on the head, it’s a mental burden. What I am afraid of is that 
there is no cure yet, you die because of HIV. So if there’s no treatment you will just die.ਈ 
23-year-old male, student, iniƟ ally expressed interest, but did not aƩ end VCT
A number of paƟ ents (8) also perceived burden for accessing and uƟ lizing VCT. Most of these (6) 
were not interested in VCT.
“The process would become too cumbersome. When I think about it, it will just make 
the process longer and complicated. My intenƟ on to seek treatment was just to get my 
coughs cured.ਈ 25-year-old, male, self-employed, not interested in VCT 
“Well, at that Ɵ me I thought, if they can do it at that moment, I wouldn’t mind. I thought 
it would take too much Ɵ me. [I asked] how I would know the result. [They said] if I wanted 
to know I have to go there. How can I manage the Ɵ me?ਈ 51-year-old, male, employee, 
not interested in VCT
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Nurses’ percepƟ ons
Table 8.3 depicts the distribuƟ on of main issues perceived by nurses across diī erent type of 
health faciliƟ es. Most nurses considered their knowledge of HIV-TB insuĸ  cient: 
“At the least, the lab technician, TB worker, nurse and doctor should know about the 
HIV issue comprehensively. SomeƟ mes we go for training and bring home materials, but 
we don’t really read them. There are paƟ ents who really need informaƟ on on what is 
the relevance, goals. Yesterday there were two like that. At the end I had to read, I had 
to open the reference for them. The problem is we ourselves do not understand HIV 
comprehensively.ਈ Female, nurse, rural health center
Table 8.3 | Nurses’ percepƟ ons of barriers to introduce HIV tesƟ ng among TB paƟ ents*
PercepƟ on Health centers Hospitals and chest clinics
Rural Urban Public Private
‘Hard’ paƟ ents - - + ++
AddiƟ onal burden +/- +/- ++ ++
PaƟ ents oī ended - - ++ ++
SƟ gmaƟ zaƟ on + +/- +++ ++
Lack of facility + +++ +/- +
CommunicaƟ on diĸ  culty +/- +/- ++ +++
* “+++” = criƟ cal; “++” = very important; “+” = “important”; “+/-“ = less important; “-“ = negligible
Nurses especially in the hospitals perceived that there are paƟ ents diĸ  cult to deal with, for 
instance skepƟ cal highly educated paƟ ents. Nurses in hospitals also more frequently perceived 
oī ended paƟ ents as an issue: 
“Once we had a paƟ ent who was a high school teacher. We discussed how TB is the 
leading opportunisƟ c infecƟ on for HIV. At the end it became confusing because the 
theory was not clear. At the end she refused. So how can we deal with paƟ ents who are 
highly educated?ਈ Female, nurse, rural health center 
“Even though we have explained this and that…but in the end it doesn’t seem to suĸ  ce. 
We really are not eī ecƟ ve.ਈ Female, nurse, public hospital 
“The majority reacts negaƟ vely [to the oī er]. PaƟ ents feel they have never done any 
wrongdoings. PaƟ ents feel they could not get it. Especially the VIPs [Very Important 
Person ശ PaƟ ents in fi rst class wards]. All the VIPs refused.ਈ Female, nurse, private hospital 
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Lack of faciliƟ es was an issue perceived by nurses of all types of structures: 
“The room is sƟ ll mixed [with other paƟ ents]. So, if possible, a separate room, which 
would be beƩ er to give paƟ ent educaƟ on. It’s inconvenient for us to do it when there are 
other paƟ ents around.ਈ Male, nurse, public hospital 
“We don’t have a special room. Our place unƟ l now is semi-permanent, so mixed Maybe 
it wasn’t convenient to oī er the test to the paƟ ents under such condiƟ on.ਈ Female, 
nurse, rural health center
Nurses at all faciliƟ es perceived some burden due to having to oī er an HIV test, parƟ cularly with 
limited Ɵ me available:
“We don’t have enough staī , for our lung clinic. It’s just me and one assistant. If there are 
many paƟ ents we really don’t have Ɵ me, really too overwhelmed to oī er [HIV tesƟ ng]. 
We have more Ɵ me in the morning. Those paƟ ents who accepted the oī er are usually 
those who come in the morning.ਈ Female, nurse, private hospital 
Nurses in hospitals parƟ cularly perceived diĸ  culƟ es in communicaƟ on, mainly when it comes to 
paƟ ents who are ‘hard’ to deal with: 
“If they have detailed quesƟ ons we have diĸ  culty in explaining in details. We can handle 
general quesƟ ons, but university students ask a lot of quesƟ ons which are beyond our 
knowledge.ਈ Female, nurse, private hospital
SƟ gmaƟ zaƟ on of people living with HIV/AIDS within the community was perceived to be a barrier, 
parƟ cularly in hospitals:
“They had fear, what if they turn out to be [HIV] posiƟ ve? What would happen when 
they have to face the community. Some of them are community leaders.ਈ Female, nurse, 
private hospital
Strikingly, a few nurses’ comments suggested that some nurses sƟ gmaƟ ze people living with HIV: 
“We’re also worried, what if nurses get it too? It will [then] become very risky for [HIV-
negaƟ ve] paƟ ents. We need to isolate them if we can idenƟ fy them, but unƟ l now we 
don’t know who is posiƟ ve and who is not. Even if it’s [just] gonorrhoea and somebody 
[staī ] knows, everyone [staī s’ behavior] becomes diī erent.ਈ Female, nurse, public 
hospital
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PercepƟ ons of decision makers: specialists and disease control managers
Both specialists and disease control managers perceived paƟ ent-provider communicaƟ on and 
sƟ gmaƟ zaƟ on as important barriers to VCT uptake: 
“Yes, I’ve observed that some health workers really can’t talk, they can’t communicate. 
Really, it’s not that they don’t want to do it, but they simply don’t have the capacity to 
do it. So we can’t do anything, because they are all we got.ਈ Female, disease control 
manager, urban district
“What I liked about the program [introducing HIV tesƟ ng among TB paƟ ents] was that the 
TB paƟ ents got more aƩ enƟ on. There was a demand to the health worker to be able to 
communicate beƩ er. We basically have nurses and doctors who can communicate well, 
but the majority have limited communicaƟ on skills and it’s not just a maƩ er of educaƟ on, 
it’s also about personality.ਈ Male, disease control manager, rural district 
Specialists seemed to be more opƟ misƟ c, giving more emphasis on the managerial challenges 
than on the operaƟ onal: 
“The most important thing is that this is integrated at the top level. If this is sƟ ll under two 
diī erent naƟ onal programs then it will be diĸ  cult for policy making. If it’s integrated at 
the top level, [we] at the frontline just have to implement. But if at the top there are sƟ ll 
two heads, what can we do? It’s a sensiƟ ve issue, but that’s the reality.ਈ Male, senior lung 
specialist, public chest clinic and private hospital 
“The management system needs to be repaired. If we’re integraƟ ng TB and HIV, the 
management becomes more [crucial]. Especially that we’re involving two diī erent 
naƟ onal programs together. The fi nancing, the organizaƟ on…ਈ Male, junior lung specialist, 
teaching hospital and private hospital
They also perceived much less addiƟ onal burden: 
“I don’t feel any [signifi cant] addiƟ onal burden. As far as I’ve observed, care delivery was 
not disrupted. Of course there were some addiƟ onal things [tasks], but not so much.ਈ 
Male, senior lung specialist, public chest clinic and private hospital 
However, specialists strongly perceived lack of knowledge on HIV to be a major hindrance to 
introduce tesƟ ng, including among colleagues: 
“Even in this hospital, other specialists don’t really know [about HIV]. Internal medicine 
and dermatovenereology [specialists] know quite a bit, but others sƟ ll ask a lot of 
quesƟ ons. They only know it superfi cially.ਈ Male, internist, private and teaching hospital
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But both district control managers and specialists were not concerned with potenƟ al harms to 
the TB control program’s performance: 
“No, I am not worried, the paƟ ents were not obliged to be tested … and I’ve observed no 
reducƟ on of case reporƟ ng so far. Our paƟ ents were not running away.” Female, disease 
control manager, urban district
8.4 | DISCUSSION
Previous studies examining the moƟ vaƟ ons and deterrents to HIV tesƟ ng have been carried out 
mainly among groups other than TB paƟ ents, i.e.: pregnant women;[14,19] drug users; [12,20] 
poor populaƟ on;[21] and mulƟ ple risk groups.[13,22] Our study contributes to the evolving body 
of evidence on specifi c factors that infl uence introducƟ on of HIV tesƟ ng among TB paƟ ents. This 
study is limited by qualitaƟ ve research boundaries. Issues perceived by paƟ ents and providers 
were idenƟ fi ed. Although trends emerge, the respecƟ ve infl uence of each issue was not quanƟ fi ed. 
This could be documented through a quanƟ taƟ ve survey building on our fi ndings, which points 
out the key issues to be taken into account. We have focused on contrasts between paƟ ents 
who expressed and did not express interest for VCT because only two paƟ ents who expressed 
interest but did not aƩ end could be interviewed (group 3) and because we interviewed more 
paƟ ents who did not express interest but accepted unlinked anonymous (group 2). This means 
our fi ndings can be interpreted in terms of VCT uptake rather than interest. Although our fi ndings 
are context bound, generalizaƟ on can be considered to other provinces in Indonesia with similar 
socio-economic, HIV-TB epidemiology and health system characterisƟ cs. Some specifi c fi ndings 
may hold in similar seƫ  ngs in other countries.
Knowledge
Knowledge of TB paƟ ents on HIV and its transmission was strikingly poor with considerable 
misconcepƟ ons, parƟ cularly regarding transmission routes. Pregnant women in Hong Kong 
and China reportedly also had inadequate knowledge regarding HIV transmission.[14,23] Poor 
knowledge of HIV among the general populaƟ on in the US and pregnant women in Hong Kong 
is associated with poor uptake of HIV tesƟ ng.[14,22] In addiƟ on, our fi ndings suggest that 
knowledge of providers regarding HIV and HIV-TB is also insuĸ  cient. A similar lack of knowledge 
parƟ cularly regarding HIV tesƟ ng among physicians was documented in India.[24,25] The need 
for professional educaƟ on to precede VCT programs has also been further aĸ  rmed by a study 
among health workers in China.[23]
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SƟ gmaƟ zaƟ on
Our data suggests that sƟ gmaƟ zaƟ on of HIV is present in the Indonesian society. HIV/AIDS has 
been one of the most sƟ gmaƟ zed diseases of the last 20 years.[26] HIV-associated sƟ gma has 
remained a barrier to tesƟ ng among pregnant women in China.[23] Perceived sƟ gmaƟ zaƟ on 
among mineworkers in South Africa and urban inhabitants in Mali reportedly also deterred them 
from HIV tesƟ ng.[27,28] SƟ gmaƟ zaƟ on was also considered to be an important barrier to HIV 
tesƟ ng by nurses in our study. Our fi ndings further show that there are even nurses who also 
sƟ gmaƟ ze HIV paƟ ents. This is similar to the fi ndings from China in which 30% of health workers 
would not treat HIV paƟ ents.[23] However, our data suggests that sƟ gmaƟ zaƟ on did not play 
much role on paƟ ents VCT interest. Most likely this is because HIV/AIDS in our seƫ  ng is not yet a 
widespread disease with high visibility. Other factors outweigh sƟ gmaƟ zaƟ on when it comes to 
interest in VCT, e.g. a clear indicaƟ on of the risk for HIV infecƟ on, as eī ecƟ vely communicated by 
the care provider, coupled with paƟ ents’ concerns for their personal well-being. 
Perceived benefi t and risk
Perceived benefi t and risk showed considerable infl uence on VCT interest among our TB 
paƟ ents. Mineworkers in South Africa perceive HIV tesƟ ng to be more acceptable if anƟ retroviral 
therapy (ARVs) become more available.[27] Rates of HIV tesƟ ng tend to increase as perceived 
benefi ts increase. However, the most worrying HIV tesƟ ng barrier is that people do not perceive 
themselves at risk.[29] The main stated reason for refusal of HIV screening among TB paƟ ents 
in Tamilnadu, India was ‘no risk behavior’.[30] Some drug users in the US indeed did not test for 
HIV as they had not perceived themselves at risk.[12] PercepƟ on of not being at risk persists 
as a barrier to tesƟ ng in the US, despite self-report of high-risk behaviors.[13] We likewise 
encountered a similar tendency among our TB paƟ ents.
Fear of knowing the test result
Our fi ndings indicate that fear of knowing test result plays a role in VCT interest. Such fear 
has also been documented as a barrier among risk populaƟ ons in the US.[13] A survey among 
Indonesian drug users in Bali province documented that the most important reason for avoiding 
HIV tesƟ ng (55% respondents) was fear of posiƟ ve results.[20] A qualitaƟ ve study carried out 
more recently in the same risk populaƟ on aĸ  rmed the importance of fear of knowing the test 
result as a barrier.[31] 
Perceived burden for uƟ lizing VCT
In addiƟ on to transportaƟ on, our paƟ ents sƟ ll had to spend considerable Ɵ me waiƟ ng for the 
counselor to see them, undergo the counseling process, have their blood taken, return home and 
come back again the next day for the result. The length of the process, linked to the percepƟ on 
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of not being at risk, was enough to deter most paƟ ents. Our TB paƟ ents were oī ered transport 
incenƟ ves, but this did not help much. Other studies have documented similar observaƟ ons. Some 
Indonesian drug users refused tesƟ ng because of the long wait and complicated procedures.[20] 
Accessibility of the VCT centers has been shown to moƟ vate TB paƟ ents in India to undergo 
tesƟ ng for HIV.[30] Drug users in the US decided to test because the site was immediately 
available and they need not travel far.[12] 
CommunicaƟ on 
A main barrier from the providers’ side was related to communicaƟ on. Providers aƩ ributed this 
problem to diĸ  culƟ es to communicate on HIV issues, lack of Ɵ me and adequate faciliƟ es. The 
disease control managers stated that health workers hardly communicate with paƟ ents and that 
some health workers did not have proper communicaƟ on skills. PaƟ ent-provider communicaƟ on 
around HIV in resource-constrained seƫ  ng seemingly falls short of best-pracƟ ce standard.[25] 
 Our fi ndings addiƟ onally revealed that communicaƟ on was infl uenced by characterisƟ cs 
of the paƟ ent, provider and healthcare facility condiƟ ons. The worst case scenario occurs 
when a skepƟ cal highly educated paƟ ent comes into contact with a nurse worker with poor 
communicaƟ on skills in an overburdened hospital. This highlights the need for creaƟ ng the 
material condiƟ ons in the health services which make it easier for health workers to interact with 
paƟ ents. Indonesia’s health services were designed to cope with acute diseases and the exisƟ ng 
service delivery model is clearly not conducive to eī ecƟ ve VCT. HIV/AIDS is a complex chronic 
condiƟ on requiring long-term involvement, paƟ ent-centered approaches and paƟ ent-provider 
communicaƟ on starƟ ng from the point of HIV tesƟ ng oī er. 
 The magnitude of communicaƟ on problems idenƟ fi ed in this study was not evenly distributed 
across health facility types and was more prominent in hospitals especially private. These 
hospitals are overloaded with paƟ ents. They also see more paƟ ents who are challenging to deal 
with. All of these issues have to be managed under condiƟ ons of limited Ɵ me, staī  and faciliƟ es. 
8.5 | CONCLUSIONS
TB paƟ ents evidently experienced mulƟ ple barriers that can deter them for HIV tesƟ ng. The study 
highlighted that paƟ ents’ and providers’ knowledge regarding HIV was inadequate in our seƫ  ng. 
The main barriers to HIV tesƟ ng idenƟ fi ed were: fear, burden to access VCT and communicaƟ on 
problems. SƟ gma exists in society and caused concerns among providers, but did not seem to 
play much role in paƟ ents’ interest in VCT. 
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If the Ministry of Health intends to move forward with linked confi denƟ al HIV tesƟ ng among TB 
paƟ ents through VCT, provider’s and paƟ ent’s knowledge need to be improved simultaneously, 
the general healthcare system strengthened by providing the necessary condiƟ ons for eī ecƟ ve 
communicaƟ on and paƟ ent-provider interacƟ on and oī ering VCT at potenƟ al DOTS services that 
can provide results on the same day. The potenƟ al acceptability of the alternaƟ ve PITC model 
would be worth to explore further. However, it would clearly require even more demanding 
pre-condiƟ ons and thus should be reserved for seƫ  ngs with more advanced HIV epidemic. In 
any case, eī orts to understand and overcome specifi c local barriers must accompany eī orts to 
introduce HIV tesƟ ng among TB paƟ ents. 
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This chapter discusses the main fi ndings of the studies in contrast with the current literature and 
answers the research quesƟ ons. The policy implicaƟ ons of the studies are also highlighted.
9.1 | ANSWERS TO THE RESEARCH QUESTIONS
1. What are the paƩ erns of care-seeking behavior among TB suspects in Indonesia?
Our studies focused on four elements of the care-seeking process, namely: 1) quanƟ fying the 
number of TB suspects who did not (yet) seek care (Chapter 4); 2) evaluaƟ ng the determinants 
of any care-seeking acƟ on (Chapter 4); 3) evaluaƟ ng the paƩ ern of fi rst care-seeking acƟ ons 
and its determinants (Chapters 3 and 4); and 4) evaluaƟ ng paƟ ent delay and its determinants 
(Chapters 3 and 4). We found that approximately 11% of TB suspects did not (yet) seek care. 
Being female and having mulƟ ple symptoms was signifi cantly associated with any care-seeking 
acƟ on. Of those who sought care, 46% went directly to medical health providers. Being older 
and perceiving good quality of service were the determinants of directly visiƟ ng medical health 
providers, but recommendaƟ ons from signifi cant others was associated with a direct visit to 
alternaƟ ve providers. Only 55% of TB suspects had visited medical health providers at the Ɵ me 
of the study. The median paƟ ent delay in our studies was approximately 2 weeks. The extended 
version of the Theory of Planned Behavior (TPB) did not oī er an explanaƟ on as to why some TB 
suspects had longer paƟ ent delay. Being male, self-employed, or a student were determinants 
of long paƟ ent delay. VisiƟ ng private providers and discussing symptoms with a spouse were 
associated with shorter paƟ ent delay. InteresƟ ngly, TB knowledge was not associated with any 
part of the care-seeking process (Chapters 3 and 4).
 Care seeking by TB suspects is criƟ cal for the early detecƟ on of TB cases. However, care-
seeking behavior involves many complex inter-relaƟ ng factors, e.g., socio-demographic, 
economic, and psychosocial factors. It also involves perceived quality and the accessibility of 
health care providers, which are primarily context specifi c. Therefore, signifi cant determinants 
may diī er from one study seƫ  ng to another.[1] We found that gender is signifi cantly associated 
with care-seeking acƟ ons, whereas studies in India and Ethiopia have suggested otherwise.
[2-5] We confi rmed that signifi cant others play an important role in determining care-seeking 
behavior, which was previously found in studies of TB paƟ ents in Africa and Indonesia.[6-9] 
Previous studies suggested that the perceived quality of services is a determinant for selecƟ ng a 
medical health care provider at the fi rst visit.[10,11]
 We found that paƟ ent delay was relaƟ vely short compared to many previous studies in 
developing countries.[1,12,13] We also found that being male, a student, or self-employed 
were determinants of a signifi cantly longer delay. A systemaƟ c review of studies of diī erent 
diseases also suggested that men usually are less likely than women to seek the help of health 
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professionals.[14] Though other studies have suggested that TB knowledge is associated with 
paƟ ent delay,[1,13] our study suggested otherwise. One possible explanaƟ on is that, because 
cough is a very prevalent illness in these areas, even people with proper knowledge of TB may 
expect their symptoms to be due to a non-threatening illness and not TB. 
2. How eī ecƟ ve is the performance of the health system providing DOTS services?
In our assessment, we took fi ve elements of health system performance into account: 1) 
diagnosƟ c delay and its determinants (Chapter 5); 2) interacƟ on of TB paƟ ents with the health 
system during the care-seeking process prior to TB diagnosis (Chapter 5); 3) adherence to the 
naƟ onal TB diagnosƟ c guidelines (Chapter 6); 4) paƟ ent loss during diagnosƟ c work-up (Chapter 
6); and 5) duraƟ on of diagnosƟ c work-up in DOTS faciliƟ es (Chapter 6)
 We found that the median diagnosƟ c delay for TB paƟ ents who were diagnosed at DOTS 
faciliƟ es was 5.4 weeks. Our study suggested that more than 60% of the TB paƟ ents started 
their care-seeking acƟ ons in alternaƟ ve and private non-DOTS health sectors. However, the 
number of paƟ ent visits to DOTS health providers was highest during the overall care-seeking 
process. Moreover, whether paƟ ents immediately visited a DOTS facility did not correspond 
with a shorter diagnosƟ c delay. We also assessed the diagnosƟ c work-up at two types of DOTS 
health faciliƟ es: health centers and lung clinics. We found that 43.5% of TB suspects were lost 
during diagnosƟ c work-up at health centers, but none in lung clinics. None of the TB suspects in 
lung clinics and 49% in health centers were diagnosed according to the naƟ onal TB diagnosƟ c 
algorithm. We also found a signifi cantly longer duraƟ on for diagnosƟ c work-up in health centers 
compared to lung clinics. All TB suspects who completed diagnosƟ c work-ups underwent sputum 
smear microscopic examinaƟ on at some point during their diagnosƟ c work-up.
 Our study in Chapter 5 indicated the problem of early detecƟ on by health workers in DOTS 
faciliƟ es. Many studies show that starƟ ng care-seeking by visiƟ ng private providers correlates 
with mulƟ ple unsuccessful consultaƟ ons, involving mulƟ ple providers, and results in a high risk 
of longer diagnosƟ c delay.[15-18] However, we found that fi rst visiƟ ng private providers is not 
associated with longer diagnosƟ c delay. Even paƟ ents in urban areas, who have beƩ er access to 
DOTS faciliƟ es, were not diagnosed faster. One possible explanaƟ on is that many TB paƟ ents may 
have shopped around for care at various health faciliƟ es before a diagnosis of TB was made.[9] 
Another explanaƟ on may be the broader network of DOTS health providers aŌ er the expansion 
of hospital DOTS, in which more than 80% of hospitals in the province are involved, through the 
HDL project since 2000.[19] A hospital TB case load study in Java suggested that not all hospitals 
involved in the TB program integrated the naƟ onal TB program guidelines into their services, and 
that there are weak links between diī erent outpaƟ ent units and the TB unit within a hospital. 
This study also idenƟ fi ed that approximately 19% to 53% of all TB cases managed in the hospitals 
do not receive standardized diagnosis and treatment.[20] 
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At the health center level, our study showed that TB diagnosis was not adequately performed 
(Chapter 6). Many paƟ ents were lost during diagnosƟ c work-up without any trace-back eī ort. 
A study in Pakistan suggested that 5.2% of paƟ ents lost during diagnosƟ c work-up are smear-
posiƟ ve cases and, therefore, at high risk of spreading infecƟ on.[21] The fi ndings from our recent 
study also indicate that paƟ ents were not traced back because there is no clear policy for paƟ ent 
tracing when sputum results are negaƟ ve; thus, the TB program managers mainly focus on 
fi nding smear-posiƟ ve TB paƟ ents (data not yet published). 
 In addiƟ on, many health workers at health centers and lung clinics do not adhere to the 
naƟ onal diagnosƟ c algorithm, but their acƟ ons may be clinically jusƟ fi ed. For instance, a 
non-TB diagnosis for paƟ ents with a negaƟ ve fi rst series of sputum smears who show clinical 
improvement. This opƟ on is not available as a diagnosis end-point in the current diagnosƟ c 
algorithm. The non-adherence to the naƟ onal diagnosƟ c algorithm in lung clinics signifi cantly 
reduced diagnosƟ c delay compared to health centers and prevented paƟ ent loss. A recent study 
also suggested that the performance of the WHO-based diagnosƟ c algorithm for HIV-negaƟ ve TB 
suspects is far from opƟ mal.[22] Another study among HIV-posiƟ ve paƟ ents suggested that chest 
radiography is the best next step aŌ er sputum examinaƟ on.[23] Most importantly, however, is 
that the non-adherence in both types of faciliƟ es is sƟ ll in accordance with the internaƟ onal 
standard for tuberculosis care (ISTC) for TB diagnosis. 
3. Which improvement would benefi t the performance of the TB program the most?
In the fi rst research quesƟ on, we idenƟ fi ed relaƟ vely favorable care-seeking behavior by 
individuals suspected of having TB. We measured a short paƟ ent delay, with a small proporƟ on 
of TB suspects not (yet) seeking care and many TB suspects going directly to medical health 
providers. The fi ndings also indicated perceived good quality of service and recommendaƟ on 
from a signifi cant other as signifi cant determinants for selecƟ ng parƟ cular health providers. In 
the second research quesƟ on, we demonstrated inadequate performance of the health system 
providing DOTS services in TB diagnosis. There were more visits to DOTS providers compared to 
non-DOTS or alternaƟ ve providers during the enƟ re care-seeking process, and a high proporƟ on 
of paƟ ents were lost during diagnosƟ c work-up in DOTS faciliƟ es. These fi ndings demonstrate a 
clear need to strengthen the health system providing DOTS services. IntervenƟ ons that focus on 
improving community awareness and TB paƟ ent care-seeking behavior may be an addiƟ onal, 
but not necessarily essenƟ al, component of intervenƟ on strategies. Steen et al. argued that 
when the diagnosƟ c delay is primarily related to health services and not the paƟ ent’s knowledge 
and understanding of TB, as demonstrated in our studies, intervenƟ ons directed at paƟ ents will 
not be useful.[6] Therefore, intervenƟ ons that focus on strengthening the health system that 
provides DOTS services is likely to be more benefi cial than community-based intervenƟ ons that 
focus on modifying the care seeking behavior of TB suspects.
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The performance of the health system can be improved several ways. Our studies idenƟ fi ed 
criƟ cal points for improved TB case detecƟ on: 1) improving the quality of services at DOTS 
faciliƟ es; 2) implemenƟ ng paƟ ent tracing among paƟ ents who are lost during diagnosƟ c work-
up; 3) evaluaƟ ng the current diagnosƟ c algorithm and oī ering a diversifi ed naƟ onal algorithm 
that takes into account possible scenarios at diī erent levels of care; and 4) ensuring beƩ er 
program supervision.
 The 2006-2015 and 2011-2015 Global Plan to Stop TB recommends engaging all care providers 
as a strategy to improve the detecƟ on of TB cases. However, we argue that expanding DOTS 
services to involve more private providers may not be the best opƟ on in this seƫ  ng. We found 
no signifi cant diī erence in diagnosƟ c delay between those who fi rst visited private providers 
compared to DOTS providers. Furthermore, involving private providers may put addiƟ onal 
stress on the exisƟ ng health system, which already has diĸ  culty maintaining adequate program 
performance. A bigger network of providers also requires addiƟ onal resources to be eī ecƟ vely 
maintained. A previous study that evaluated the process of a PPM partnership between hospitals 
and the TB control program in Jogjakarta province suggested that the governance and partnership 
between hospitals involved in the HDL project and provincial TB control program declined aŌ er 
the project was integrated into the rouƟ ne TB control program due to lack of leadership, low 
personnel retenƟ on, and fi nancing problems.[24]
 Our fi ndings in Chapter 3 suggest the usefulness of involving private providers/pracƟ Ɵ oners 
given the popularity of private providers and their extensive availability in Jogjakarta province. 
Our model simulaƟ on (Chapter 2) also demonstrated that an intervenƟ on that enables private 
providers to refer more TB suspects to DOTS faciliƟ es will have greater treatment success and 
prevent incomplete treatment, which is a major risk factor for MDR-TB.[25] An economic study 
that evaluated program intervenƟ ons targeted at private pracƟ Ɵ oners in 2004 revealed that 
involving private pracƟ Ɵ oners could be cost eī ecƟ ve.[26] However, Mahendradhata found that 
the actual caseload per private health provider is notably low. Thus, despite the potenƟ al impact 
of further expanding DOTS services through private provider involvement, this intervenƟ on will 
only marginally impact TB case detecƟ on.[27] I will further discuss the implicaƟ ons of our study 
fi ndings on the TB control program in Indonesia in secƟ on 9.2. 
4. How will the HIV epidemic impact the TB program in Indonesia?
To assess the impact of the HIV epidemic on the TB program, we quanƟ fi ed the prevalence of HIV 
infecƟ on among TB paƟ ents. Then, we assessed the level of TB paƟ ent parƟ cipaƟ on in diī erent 
HIV tesƟ ng strategies and its determinants. Finally, we assessed the acceptance of HIV tesƟ ng 
among users and providers and idenƟ fi ed barriers and enablers for introducing a HIV tesƟ ng 
service into TB programs.
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We found that the HIV prevalence among TB paƟ ents (1.9%) is three Ɵ mes higher than previously 
esƟ mated by WHO/UNAIDS.[28] This fi nding indicates that the burden of TB-HIV co-infecƟ on 
might have more serious consequences to the TB program than previously expected. Because 
the burden of HIV among TB paƟ ents is considered low by WHO standards,[29] the impact of 
the HIV epidemic on the TB program is sƟ ll limited. However, eī orts are needed to set up a HIV 
surveillance system in the TB program to monitor the HIV trend among TB paƟ ents closely, so 
that a Ɵ mely and appropriate response can be ensured. The challenge is to select the appropriate 
HIV tesƟ ng and surveillance strategy that is acceptable to both TB paƟ ents and health providers. 
 Our study in Chapter 7 demonstrated that HIV tesƟ ng is widely accepted among TB paƟ ents, 
parƟ cularly when an unlinked anonymous tesƟ ng strategy in which all idenƟ fying paƟ ent data 
is omiƩ ed was employed. However, when paƟ ents were oī ered free access to VCT clinics, our 
studies found a disappoinƟ ngly low parƟ cipaƟ on rate (4.1%). Perceived addiƟ onal burden was 
the main reason for not visiƟ ng VCT centers, even when a transport incenƟ ve was provided. 
Previous studies also suggested that the limited number and spaƟ al coverage of exisƟ ng VCT 
centers in developing countries hampers the acceptability of such services.[30,31] IntroducƟ on 
of HIV tesƟ ng in a hospital seƫ  ng requires special consideraƟ on, parƟ cularly because hospitals 
have a high TB caseload and some of the hospitals also provide VCT services. A one-day test 
result and closer locaƟ on of the test have been shown to increase VCT uptake.[32-35] However, 
our fi ndings suggest that structural barriers (e.g., adequate private rooms for consultaƟ on, 
number of personnel, and communicaƟ on skills) exist in hospitals, prevenƟ ng eī ecƟ ve HIV 
tesƟ ng services. Thus, intervenƟ ons to minimize the exisƟ ng barriers need to be in place. In 
addiƟ on, the internal referral mechanism, which is currently weak in hospitals,[20] needs to be 
strengthened.
 Overall, our study has demonstrated that, with modest eī orts, TB-HIV surveillance can 
be performed in a low HIV prevalence and resource poor seƫ  ng such as Indonesia. However, 
without adequate preparaƟ on and careful planning, the introducƟ on of HIV tesƟ ng into the TB 
program may add an addiƟ onal burden to the health system that provides DOTS, which is already 
having diĸ  culty maintaining adequate performance.
 
9.2 | FURTHER IMPLICATIONS OF THE FINDINGS
Generalizability to Indonesia as a whole
Our studies may not be fully applicable to the wider context of the TB control program in 
Indonesia, as Jogjakarta has a diī erent epidemiological situaƟ on in terms of TB and HIV 
incidence and prevalence. Wide variaƟ ons exist in the health system characterisƟ cs and socio-
economic context across the country, which are relaƟ vely favorable for Jogjakarta province. To 
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this end, our fi ndings may best be generalized to a limited number of other Indonesian areas 
with a similar seƫ  ng: a relaƟ vely well funcƟ oning health system with a mix of public and private 
health providers, no parƟ cular geographical barriers to health service access, a populaƟ on with 
relaƟ vely good socio-economic and demographic status, and a concentrated HIV epidemic, 
such as in Java and Bali islands. In the future, the study fi ndings may become more relevant for 
Indonesia as a whole, when the general situaƟ on in the country improves. This would also apply 
to other similar low and middle-income countries with a high TB burden in Asia.
 Other aspects also hinder the generalizaƟ on of our study fi ndings to a broader health system 
context. First, our studies focus on the performance of frontline health providers, but the 
health system structure is more complex. The WHO health system framework defi ned health 
systems as building blocks of government stewardship, fi nancing, human resource management, 
pharmaceuƟ cal management, service fi nancing, and delivering services. These building blocks 
have four core funcƟ ons, i.e. stewardship, creaƟ ng resources, fi nancing, and delivering services.
[36] Our studies focus mainly on the funcƟ on of delivering the services of the health system. The 
stewardship, resources creaƟ on, and fi nancing funcƟ ons of the health system in the TB program 
in this seƫ  ng have been studied elsewhere.[20,26,37,38] These studies generally suggest that 
PPM intervenƟ on can be cost eī ecƟ ve but requires a specifi c processes and context in which 
the processes of the public-private partnership are not adequately managed. Secondly, data on 
health system performance were only gathered in DOTS services. Despite the fact that private 
non-DOTS providers detect and treat TB paƟ ents, gathering data on their performance was 
diĸ  cult due to a strong aƫ  tude among private health providers regarding paƟ ent privacy. Our 
eī ort to collect data from private non-DOTS providers during the study in Chapter 5 only resulted 
in interviews with fi ve TB paƟ ents. However, many studies have suggested that the performance 
of non-DOTS service providers in general is worse than DOTS service providers.[8,10,15,18]
Strengthening vs. expanding DOTS services: A trade-oī  between equity and 
quality?
Our studies demonstrate that there is a clear need to conƟ nuously strengthen the health system 
providing DOTS, even aŌ er the successful implementaƟ on of a PPM intervenƟ on. Our studies 
confi rm previous studies that demonstrated that the health system in Jogjakarta province has 
had diĸ  culƟ es maintaining eī ecƟ ve performance aŌ er the hospital DOTS linkage (HDL) project 
was phased out.[20,37] Our study fi ndings suggest that the problem of detecƟ ng TB cases early 
lies in the more extensive, but not opƟ mally managed, network of DOTS health providers. Thus, 
a criƟ cal quesƟ on is whether equitable access to the TB service jusƟ fi es reduced quality.
 The Global Plan to Stop TB 2006-2015 endorsed a six-point strategy to achieve the TB related 
MDGs: 1) pursue high-quality DOTS expansion and enhancement; 2) address TB/HIV, MDR-TB, 
and the needs of poor and vulnerable populaƟ ons; 3) contribute to health system strengthening; 
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4) engage all care providers; 5) empower people with TB and communiƟ es through partnerships; 
and 6) enable and promote research.[39,40] This recommendaƟ on addresses the importance 
of intensifi ed eī orts towards case detecƟ on, which has been translated into expanding 
DOTS strategies to diī erent (both state and non-state owned) health providers through 
PPM approaches. Clearly, the current global strategy recognizes the importance of both the 
accessibility and quality of DOTS services. 
 The WHO policy on the PPM strategy is based on recognizing that the targeted service 
coverage cannot be achieved by replicaƟ ng exisƟ ng models for service delivery or focusing only 
on the public sector.[41,42] An increasing number of countries has implemented PPM acƟ viƟ es, 
from 13 in 2003 to 58 in 2008, and was supported by the Global Fund. Care providers involved 
in PPM vary by region depending on the preferred health provider used by TB paƟ ents as the 
fi rst point of care, e.g., semi-formal village doctors in Bangladesh, private pracƟ Ɵ oners in India 
and Indonesia, private hospitals in China and Indonesia, pharmacies in Cambodia, and prisons in 
many countries in Eastern Europe.[43] Studies have also demonstrated that diī erent models of 
PPM intervenƟ on strategies could be cost eī ecƟ ve.[26,38,44,45] However, the cost eī ecƟ veness 
of a PPM model is not universally applicable and is context-specifi c to the seƫ  ng in which it is 
implemented.[38] Furthermore, the overall PPM contribuƟ on to the new TB noƟ fi caƟ on rate 
varies, and in many countries the contribuƟ on is less than 20% of all noƟ fi caƟ ons.[43] Most 
importantly, under which condiƟ ons the scaling-up of PPM DOTS is more cost eī ecƟ ve than 
strengthening the exisƟ ng DOTS services is sƟ ll unclear.[46] 
 The PPM intervenƟ ons, like many other global iniƟ aƟ ves, are implemented primarily through 
external internaƟ onal fi nancial and technical assistance. For good project performance, a new ad 
hoc or parallel system is created, as the exisƟ ng system is considered to have liƩ le or no capacity, or 
is already overburdened with the exisƟ ng workload. The new system is staī ed with highly skilled 
professionals who work eĸ  ciently over the implementaƟ on period on a temporary basis. As a 
result, at the end of the project, the NTPs and technical agencies are able to demonstrate strong 
program performance upon project evaluaƟ on. AŌ er a transiƟ on period, the new intervenƟ on is 
integrated into the rouƟ ne TB control program and the operaƟ onal, managerial, and leadership 
responsibiliƟ es of the project are shiŌ ed to provincial or district TB program managers and their 
staī s. The rouƟ ne TB oĸ  cers, though having acquired new skills during the implementaƟ on of 
the project, may not be as resourceful and eĸ  cient as the professional staī  hired during the 
implementaƟ on period. Coupled with a lack of fi nancial capacity and the high staī  turnover at 
the district and provincial levels, the quality of the newly developed system cannot be sustained 
and may deteriorate.
 Ensuring the quality and consistency of health intervenƟ ons when delivered on a large scale 
can be challenging.[42] We agree with Mahendradhata and Probandari that health system 
strengthening should place strong emphasis on building the capacity of local health oĸ  ces 
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to be capable of their governance and leadership roles in the local health system.[24,46] This 
is also one of the key messages of health system strengthening endorsed by the WHO.[47] 
Governance is commonly weak in public-private partnerships,[24,48] which the Indonesia NTP 
needs to seriously take into account when further scaling up PPM intervenƟ ons naƟ onwide. 
Instead of rapidly scaling up PPM intervenƟ ons in order to achieve internaƟ onal, donor driven 
objecƟ ves at the expense of poor quality services, the NTP should carefully reconsider their 
current implementaƟ on strategy. Furthermore, instead of using a ‘one fi ts all’ policy for PPM 
implementaƟ on, the NTP should take into account the complexiƟ es of intervenƟ on at diī erent 
local health system levels. IntervenƟ on complexity is defi ned as the quality and quanƟ ty of 
non-fi nancial resources required to implement and sustain an intervenƟ on, which consists of 
four dimensions: the intervenƟ on itself; delivery characterisƟ cs; requirement for government 
capacity; and usage characterisƟ cs.[42,49] Private providers consist of diī erent insƟ tuƟ ons with 
diī erent ownership statuses, missions, organizaƟ onal structures, and complexiƟ es. In terms 
of delivery, intervenƟ ons diī er in their requirements regarding faciliƟ es, human resources, 
and other operaƟ onal issues. Furthermore, demands on the government vary, with some 
intervenƟ ons requiring more extensive government engagement in policy, service delivery, and 
regulaƟ on. Usage characterisƟ cs are related to the exisƟ ng demand, which can be measured from 
the care-seeking behavior of the TB paƟ ents. Understanding intervenƟ on complexiƟ es helps in 
the idenƟ fi caƟ on of resource constraints and strategies to overcome challenges to successful 
implementaƟ on.[42] 
 The WHO has developed guidelines for performing naƟ onal assessments and oī ers an 
implementaƟ on tool for PPM intervenƟ ons.[50,51] These guidelines provide a systemaƟ c, 
stepwise approach for naƟ onal assessments, planning, and implementaƟ on of PPM acƟ viƟ es. 
In our view, these guidelines do not oī er enough tools to assess the governance and leadership 
capacity of the exisƟ ng health system or to plan, implement, and monitor necessary measures 
for building or improving the exisƟ ng capacity. In order to take these guidelines one step further, 
there is a clear need to adapt the internaƟ onal perspecƟ ve of the guidelines into the local 
perspecƟ ve of the provincial and district health system contexts. There is also a clear need to 
evaluate the implementaƟ on of PPM acƟ viƟ es systemaƟ cally using scienƟ fi cally sound evaluaƟ on 
methods. The WHO PPM guidelines indeed oī er a toolkit for monitoring and evaluaƟ on, 
but do not provide methods for evaluaƟ on beyond rouƟ ne monitoring and evaluaƟ on using 
surveillance data. A rouƟ ne surveillance system can be a valuable resource for monitoring the 
implementaƟ on process and immediate program output. However, a more robust research 
method is needed to assess the intermediate or long-term health impact of the intervenƟ ons, 
as we have demonstrated in our studies (Chapters 5 and 6). Therefore, the NTP should allocate a 
reasonable porƟ on of the budget for systemaƟ c and rigorous evaluaƟ on studies.
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IntegraƟ ng HIV surveillance into TB programs: How to implement
Our study demonstrated that HIV tesƟ ng, parƟ cularly the unlinked anonymous method, is well 
accepted by TB paƟ ents and TB health providers. With the increasing rate of HIV prevalence 
in Indonesia, there is a clear need to introduce HIV tesƟ ng into the TB program naƟ onwide, 
parƟ cularly for cauƟ ous monitoring of the trend of co-infecƟ on, in order to have an adequate 
and Ɵ mely response to create public awareness, build poliƟ cal will, mobilize resources, and 
integrate service delivery when needed.
 RouƟ ne HIV tesƟ ng is the ideal policy opƟ on. It would provide HIV-posiƟ ve TB paƟ ents access 
to proper care, support, and treatment (CST). RouƟ ne HIV tesƟ ng together with proper CST not 
only improves the quality of the surveillance system, but also signifi cantly increases both the 
survival rate and the quality of life of co-infected paƟ ents. However, seƫ  ng up and running such 
services requires an investment of considerable resources to train personnel and set-up and run 
the services. Unfortunately, many resource poor countries do not have the necessary resources 
at their disposal. Also, not every DOTS facility (parƟ cularly in health centers) has a large enough 
TB caseload for rouƟ ne HIV tesƟ ng to be cost eī ecƟ ve. Referring TB paƟ ents to a nearby VCT 
clinic for HIV tesƟ ng may be an opƟ on, but at the expense of introducing access barriers, as 
demonstrated in our study.
 The more raƟ onal opƟ on would be to set up periodic surveys or senƟ nel surveillance. SenƟ nel 
surveillance is defi ned as a system by which “specifi c sites and populaƟ on groups are selected, 
a predetermined number of persons are rouƟ nely tested, and tesƟ ng is performed in a regular 
and consistent way”.[52] SenƟ nel surveillance usually applies an unlinked anonymous HIV tesƟ ng 
method to leŌ over blood specimens that were collected for other purposes and stripped of all 
idenƟ fying markers, with no informed consent required.[52] However, this would not apply to 
TB paƟ ents because no blood specimen is collected for diagnosƟ c purposes. In this situaƟ on, 
the WHO recommends an unlinked anonymous or linked test in which the specimen is coded 
and can be linked to a personal idenƟ fi er, with informed consent and free access to VCT.[53] A 
reasonable improvement for both the surveillance system and CST of HIV posiƟ ve cases would be 
to select hospitals and lung clinics, due to their high TB case loads, with well funcƟ oning TB and 
VCT services as senƟ nel sites and to oī er linked confi denƟ al tests to all TB paƟ ents. 
 In a seƫ  ng with high TB-HIV caseload, as in the Papua provinces, integraƟ ng TB-HIV cases under 
one roof should be considered. The raƟ onale for an integrated service is that TB paƟ ents have 
immediate VCT services, accelerated access to ART, reduced incidence of TB and opportunisƟ c 
infecƟ on among co-infected persons, early TB diagnosis for co-infected persons, and improved 
cure rates among TB paƟ ents. Such a service would facilitate integrated management of co-
infected persons and streamline the resources needed.[54] AddiƟ onally, good infecƟ on control 
measures need to be in place, parƟ cularly in faciliƟ es that provide integrated TB-HIV to prevent 
TB transmission between TB-HIV co-infected persons and HIV-posiƟ ve individuals without TB. 
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These eī orts are in line with the WHO’s three recommendaƟ ons for TB-HIV collaboraƟ on, 
parƟ cularly to prevent further transmission of TB among HIV paƟ ents: intensifi ed case detecƟ on; 
isoniazid prevenƟ ve therapy (IPT); and infecƟ on control (IC).[55] In the long run, collaboraƟ ve 
eī orts need to be integrated not only at the frontline health providers, but also at every level of 
TB and HIV control programs. 
Health system research: Beyond randomized control trials and cost eī ecƟ veness 
studies
Though all health intervenƟ ons have some degree of complexity, the health system intervenƟ on 
is oŌ en considered a relaƟ vely complex intervenƟ on.[56,57] In the fi eld of service delivery, 
intervenƟ ons can be considered parƟ cularly complex because they are delivered across diī erent 
levels of service providers, delivered in a new seƫ  ng, or when new tasks are performed by the 
staī  or current tasks are performed in a new context.[58] Two main methods are used to evaluate 
such intervenƟ ons: 1) a randomized controlled trial to evaluate the eĸ  cacy and eī ecƟ veness of 
the intervenƟ on or 2) economic evaluaƟ on to assess the cost eī ecƟ veness of the intervenƟ on. 
Though the randomized controlled trial is the gold standard for evaluaƟ ng intervenƟ ons, some 
have argued the appropriateness of this method for evaluaƟ ng complex intervenƟ ons because 
this approach does not provide informaƟ on on why and how the intervenƟ ons work.[56,57] 
A cost-eī ecƟ veness study also has limitaƟ ons in evaluaƟ ng complex intervenƟ ons. Most cost-
eī ecƟ veness studies are primarily used for evaluaƟ ng clinical intervenƟ ons, e.g., new drugs, 
surgery or screening, or for generalized applicaƟ on using aggregate data, whereas the outcomes 
of health system intervenƟ ons, such as PPM intervenƟ ons, are context specifi c and depend 
on private provider characterisƟ cs, stakeholder interacƟ ons, and the management of the 
intervenƟ on.[38] 
 Assessment of such complex intervenƟ ons should therefore shiŌ  from the randomized 
controlled trial to systems thinking and prospecƟ ve evaluaƟ on with plausibility rather than 
probability design.[59] Systems thinking allows the evaluaƟ on of the process and the context 
of the intervenƟ on to be an integral part of the evaluaƟ on of its eī ects.[56] Research quesƟ ons 
should shiŌ  from ‘whether PPM works’, to ‘how, why, in what circumstances, for whom, and to 
what extent’ PPM works.[58] The same thinking also applies to evaluaƟ on of the cost-eī ecƟ veness 
of an intervenƟ on. Many studies have shown that PPM intervenƟ ons are cost-eī ecƟ ve, but we 
need to shiŌ  the quesƟ ons to ‘in which context is the intervenƟ on cost-eī ecƟ ve’ and ‘how can 
the cost-eī ecƟ veness be improved’.[38] 
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 9.3 | CONCLUSIONS AND RECOMMENDATIONS
Conclusions
 – The care-seeking behavior of TB suspects in Jogjakarta province of Indonesia is relaƟ vely 
favorable.
 – The health system providing DOTS services in Jogjakarta province of Indonesia has diĸ  culty 
maintaining eī ecƟ ve performance in diagnosing TB cases.
 – Strengthening the health system providing DOTS is likely to be more eī ecƟ ve than modifying 
the care seeking behavior of TB suspects.
 – The HIV epidemic in Indonesia sƟ ll has a limited impact on the TB program, but the trend of 
HIV-TB co-infecƟ on needs to be monitored cauƟ ously for a Ɵ mely and appropriate response.
RecommendaƟ ons
 – To improve TB case detecƟ on in Indonesia, intervenƟ ons should focus on strengthening the 
health system providing DOTS.
 – The trend of the HIV epidemic among TB paƟ ents in Indonesia needs to be monitored 
cauƟ ously for a Ɵ mely and appropriate response.
 – Adapt the WHO guidelines for the PPM assessment and implementaƟ on acƟ viƟ es into local 
provincial and district system contexts in order to determine the right PPM strategies for 
diī erent provinces and districts. 
General Discussion  |  171
9.4 | REFERENCES
1. Storla DG, Yimer S, Bjune GA. A systemaƟ c review of delay in the diagnosis and treatment of tuberculosis. 
BMC Public Health 2008, 8:15.
2. Sudha G, Nirupa C, Rajasakthivel M, et al. Factors infl uencing the care-seeking behavior of chest 
symptomaƟ cs: a community-based study involving rural and urban populaƟ on in Tamil Nadu, South India. 
Trop Med Int Health 2003, 8:336-41.
3. Fochsen G, Deshpande K, Diwan V, Mishra A, Diwan VK, Thorson A. Health care seeking among individuals 
with cough and tuberculosis: a populaƟ on-based study from rural India. Int J Tuberc Lung Dis 2006, 10:995-
1000.
4. Yimer S, Holm-Hansen C, Yimaldu T, Bjune G. Health care seeking among pulmonary tuberculosis suspects 
and paƟ ents in rural Ethiopia: a community-based study. BMC Public Health 2009, 9:454.
5. Charles N, Thomas B, Watson B, Raja Sakthivel M, Chandrasekeran V, Wares F. Care seeking behavior of 
chest symptomaƟ cs: a community based study done in South India aŌ er the implementaƟ on of the RNTCP. 
PLoS One 2010, 5.
6. Steen TW, Mazonde GN. Ngaka ya setswana, ngaka ya sekgoa or both? Health seeking behavior in Batswana 
with pulmonary tuberculosis. Soc Sci Med 1999, 48:163-72.
7. Salaniponi FM, Harries AD, Banda HT, et al. Care seeking behavior and diagnosƟ c processes in paƟ ents with 
smear-posiƟ ve pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 2000, 4:327-32.
8. Pronyk RM, Makhubele MB, Hargreaves JR, Tollman SM, Hausler HP. Assessing health seeking behavior 
among tuberculosis paƟ ents in rural South Africa. Int J Tuberc Lung Dis 2001, 5:619-27.
9. RinƟ swaƟ  N, Mahendradhata Y, Suharna, et al. Journeys to tuberculosis treatment: a qualitaƟ ve study of 
paƟ ents, families and communiƟ es in Jogjakarta, Indonesia. BMC Public Health 2009, 9:158.
10. Lonnröth K, Thuong LM, Linh PD, Diwan VK. UƟ lizaƟ on of private and public health-care providers for 
tuberculosis symptoms in Ho Chi Minh City, Vietnam. Health Policy Plan 2001, 16:47-54.
11. Kiwuwa MS, Charles K, Harriet MK. PaƟ ent and health service delay in pulmonary tuberculosis paƟ ents 
aƩ ending a referral hospital: a cross-secƟ onal study. BMC Public Health 2005, 5:122.
12. Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary 
tuberculosis: a systemaƟ c review of literature. BMC Infect Dis 2009, 9:91.
13. Finnie RK, Khoza LB, van den Borne B, Mabunda T, Abotchie P, Mullen PD. Factors associated with paƟ ent 
and health care system delay in diagnosis and treatment for TB in sub-Saharan African countries with high 
burdens of TB and HIV. Trop Med Int Health 2011, 16:394-411.
14. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behavior: literature review. J Adv Nurs 2005, 
49:616-23.
15. Needham DM, Foster SD, Tomlinson G, Godfrey-FausseƩ  P. Socio- economic, gender and health services 
factors aī ecƟ ng diagnosƟ c delay for tuberculosis paƟ ents in urban Zambia. Trop Med Int Health 2001, 
6:256-9.
16. Yamasaki-Nakagawa M, Ozasa K, Yamada N, et al. Gender diī erence in delays to diagnosis and health care 
seeking behavior in a rural area of Nepal. Int J Tuberc Lung Dis 2001. 5:24-31.
17. Wandwalo ER, Mørkve O. Delay in tuberculosis case-fi nding and treatment in Mwanza, Tanzania. Int J 
Tuberc Lung Dis 2000, 4:133-138.  
18. Lönnroth K, Thuong LM, Linh PD, Diwan VK. Delay and disconƟ nuity- a survey of TB paƟ ents’ search of a 
diagnosis in a diversifi ed health care system. Int J Tuberc Lung Dis 1999, 3:992-1000.  
19. IrawaƟ  SR, Basri C, Arias MS, et al. Hospital DOTS linkage in Indonesia: a model for DOTS expansion into 
government and private hospitals. Int J Tuberc Lung Dis 2007, 11:33-9.
20. Probandari A, Lindholm L, Stenlund H, Utarini A, HurƟ g AK. Missed opportunity for standardized diagnosis 
and treatment among adult Tuberculosis paƟ ents in hospitals involved in Public-Private Mix for Directly 
Observed Treatment Short-Course strategy in Indonesia: a cross-secƟ onal study. BMC Health services 2010, 
10:113.
172  |  Chapter 9
21. Khan MS, Khan S and Godfrey-FausseƩ  P. Default during TB diagnosis: quanƟ fying the problem. Trop Med 
Int Health2009, 14:1437-41.
22. Soto A, Solari L, Gotuzzo E, Acinelli R, Vargas D and Van der StuyŌ  P. Performance of an algorithm based 
on WHO recommendaƟ ons for the diagnosis of s pulmonary tuberculosis in paƟ ents without HIV infecƟ on. 
Trop Med Int Health 2011; 16(4): 424-30.
23. Cain K P, McCarthy K D, Heilig C M, et al. An algorithm for tuberculosis screening and diagnosis in people 
with HIV. N Engl J Med 2010; 362 (8): 707-16.
24. Probandari AN. RevisiƟ ng the choice: To involve hospitals in the partnership for tuberculosis control in 
Indonesia. PhD Thesis. Umeå University, Department of Public Health and Clinical Medicine Epidemiology 
and Global Health 2010.
25. Caminero JA. MulƟ drug-resistant tuberculosis: epidemiology, risk factors and case fi nding. Int J Tuberc Lung 
Dis 2010, 14:382-90.
26. Mahendradhata Y, Probandari A, Ahmad RA, et al. The incremental cost-eī ecƟ veness of engaging private 
pracƟ Ɵ oners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia. Am J Trop Med Hyg 
2010, 82:1131-9.
27. Mahendradhata Y, Utarini A, Lazuardi U, Boelaert M, StuyŌ  PV. Private pracƟ Ɵ oners and tuberculosis case 
detecƟ on in Jogjakarta, Indonesia: actual role and potenƟ al. Trop Med Int Health 2007, 12:1218-24.
28. WHO. WHO Report 2006: Global Tuberculosis Control: Surveillance, Planning and Financing. Geneva: WHO; 
2006.
29. WHO. Guidelines for HIV Surveillance Among Tuberculosis PaƟ ents 2nd Ed. Geneva: WHO; 2004. WHO/
HTM/TB/2004.339
30. Raizada N, Chauhan LS, Khera A, et al. HIV seroprevalence among tuberculosis paƟ ents in India, 2006-2007. 
PLoS One 2008, 3:e2970.
31. Kanara N, Cain KP, Laserson KF, et al. Using program evaluaƟ on to improve the performance of a TB-HIV 
project in Banteay Meanchey, Cambodia. Int J Tuberc Lung Dis 2008, 12(3 Suppl 1):44-50.
32. Kassler WJ, Dillon BA, Haley C, Jones WK, Goldman A. On-site, rapid HIV tesƟ ng with same-day results and 
counseling. AIDS 1997, 11:1045-51.
33. Kassler WJ, Alwano-Edyegu MG, Marum E, Biryahwaho B, Kataaha P, Dillon B. Rapid HIV tesƟ ng with same-
day results: a fi eld trial in Uganda. Int J STD AIDS 1998, 9:134-8.
34. Wolī  B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. EvaluaƟ on of a home-based 
voluntary counselling and tesƟ ng intervenƟ on in rural Uganda. Health Policy Plan 2005, 20:109-16.
35. CorbeƩ  EL, Dauya E, Matambo R, et al. Uptake of workplace HIV counselling and tesƟ ng: a cluster-
randomised trial in Zimbabwe. PLoS Med 2006, 3:e238.
36. WHO. Everybody’s Business: Strengthening Health Systems to Improve Health Outcomes: WHO’s Framework 
for AcƟ on. Geneva: WHO; 2007.
37. Probandari A, Utarini A, HurƟ g AK. Achieving quality in the Directly Observed Treatment Short-course 
(DOTS) strategy implementaƟ on process: a challenge for hospital Public-Private Mix in Indonesia. Glob 
Health AcƟ on 2008;1.
38. Johns B, Probandari A, Mahendradhata Y, Ahmad RA. An analysis of the costs and treatment success of 
collaboraƟ ve arrangements among public and private providers for tuberculosis control in Indonesia. 
Health Policy 2009, 93:214-24.
39. WHO. The stop TB strategy. Building on and enhancing DOTS to meet the TB-related Millennium Development 
Goals. Geneva: WHO; 2006. WHO/HTM/STB/2006.37.
40. WHO. The Global Plan To Stop TB 2011-2015. Geneva: WHO; 2010.
41. Homsy J, King R, Balaba D, Kabatesi D. TradiƟ onal health pracƟ Ɵ oners are key to scaling up comprehensive 
care for HIV/AIDS in sub-Saharan Africa. AIDS 2004, 18:1723-5.
42. Mangham LJ, Hanson K. Scaling up in internaƟ onal health: what are the key issues? Health Policy Plan 2010, 
25:85-96.
General Discussion  |  173
43. Lal SS, Uplekar M, Katz I, Lonnroth K, Komatsu R, Yesudian Dias HM, et al. Global Fund fi nancing of public-
private mix approaches for delivery of tuberculosis care. Trop Med Int Health 2011, 16:685-92.
44. Floyd K, Arora VK, Murthy KJ, et al. Cost and cost-eī ecƟ veness of PPM-DOTS for tuberculosis control: 
evidence from India. Bull World Health Organ 2006, 84:437-45.
45. Sinanovic E, Kumaranayake L. Financing and cost-eī ecƟ veness analysis of public-private partnerships: 
provision of tuberculosis treatment in South Africa. Cost Eī  Resour Alloc 2006, 4:11.
46. Mahendradhata Y. PiloƟ ng new intervenƟ ons for tuberculosis control in Indonesia. PhD Thesis. Ghent 
University, Dept. of Public Health, Faculty of Medicine and Health Sciences 2009.
47. Adam T, Mookherji S, Campbell S, Reid G, Gilson L, de Savigny D. Systems thinking for health systems: 
Challenges and opportuniƟ es in real-world seƫ  ngs. InSystems thinking for health systems strengthening. 
Edited by de Savigny D and Adam T. Geneva: WHO; 2009.
48. Buse K, Harmer AM. Seven habits of highly eī ecƟ ve global public-private health partnerships: pracƟ ce and 
potenƟ al. Soc Sci Med 2007, 64:259-71.
49. Gericke CA, Kurowski C, Ranson MK, Mills A. IntervenƟ on complexity--a conceptual framework to inform 
priority-seƫ  ng in health. Bull World Health Organ 2005, 83:285-93.
50. WHO. A NaƟ onal SituaƟ on Assessment Tool to Help Countries Decide If and When They Should Implement 
PPM. Geneva: WHO; 2007.
51. WHO. Public-Private Mix for TB Care and Control Tool Kit. Geneva: WHO; 2009. WHO/HTM/TB/2010.12
52. WHO. Guidelines for HIV Surveillance among Tuberculosis PaƟ ents 2nd Ed. Geneva: WHO; 2004. WHO/HTM/
TB/2004.339
53. WHO. Guidelines for Using HIV TesƟ ng Technologies in Surveillance: SelecƟ on, EvaluaƟ on and ImplementaƟ on 
– 2009 update. Geneva: WHO; 2009.
54. Friedland G, Harries A, Coetzee D. ImplementaƟ on issues in tuberculosis/HIV program collaboraƟ on and 
integraƟ on: 3 case studies. J Infect Dis 2007, 196(Suppl 1):S114-23.
55. WHO.Three I’s MeeƟ ng, Intensifi ed Case Finding (ICF), Isoniazid PrevenƟ ve Therapy (IPT) and TB InfecƟ on 
Control (IC) for people living with HIV. Geneva: WHO; 2009. 
56. Peterson S. Assessing the scale-up of child survival intervenƟ ons. Lancet 2010, 375:530-1.
57. Whitworth J, Sewankambo NK, Snewin VA. Improving implementaƟ on: building research capacity in 
maternal, neonatal, and child health in Africa. PLoS Med 2010, 7:e1000299.
58. Shepperd S, Lewin S, Straus S, et al. Can we systemaƟ cally review studies that evaluate complex 
intervenƟ ons? PLoS Med 2009, 6:e1000086.
59. de Savigny D, Borghi J, Windisch R, Shiell A, Adam T. Systems thinking: Applying a systems perspecƟ ve 
to design and evaluate health systems intervenƟ ons.InSystems thinking for health systems strengthening. 
Edited by de Savigny D and Adam T. Geneva: WHO; 2009.

Summary  |  175
Summary
The objecƟ ve of this thesis is to idenƟ fy ways to improve tuberculosis case fi nding in Indonesia. 
To achieve the objecƟ ve, this thesis focuses on two major issues in TB control: 1) the interacƟ on 
of TB paƟ ents and individuals suspected to have TB with the health system providing TB services 
and 2) the impact of the emerging HIV epidemic on the naƟ onal TB control program. This thesis 
consists of 9 chapters, with 7 scienƟ fi c papers (Chapters 2-8), general introducƟ on (Chapter 1) 
and discussion (Chapter 9).
 In Chapter 1, we give a general introducƟ on to TB epidemiology, natural history, diagnosis, 
and treatment, and the WHO recommended DOTS strategy as the global TB control strategy. We 
also introduce the care seeking behavior theories and concepts and its importance to TB control. 
The Indonesian health system structure, the naƟ onal TB control program, and the health system 
model that we use as a theoreƟ cal framework are also discussed. The studies were conducted in 
Jogjakarta province, in central part of Java Island, Indonesia, with 117 public health centers, 24 
hospitals, and 5 lung clinics as the backbone of the TB program in this province. 
In this thesis, we address the following research quesƟ ons:
1. What are the paƩ erns of care seeking behavior among TB suspects in Indonesia?
2. How eī ecƟ ve is the performance of the health system providing DOTS services?
3. Which improvement would benefi t the performance of TB program the most?
4. How will the HIV epidemic impact the TB program in Indonesia?
In Chapter 2, we provide the theoreƟ cal framework of the interacƟ on between TB paƟ ents 
and health system. The framework is based on a mathemaƟ cal model of TB and health system 
developed by Erasmus MC. The model was adjusted to refl ect the health system in Indonesian 
context, in which alternaƟ ve sector, private providers (Non-DOTS) and public providers (DOTS) 
co-exist. The model mimics the journey of pulmonary TB paƟ ents through the health system, 
beginning with the onset of symptoms, followed by care seeking behavior. We used experts’ 
opinions to quanƟ fy model parameters, followed by a model simulaƟ ons exercise to describe 
the performance of the current TB control program in Indonesia. We subsequently explored the 
impact of potenƟ al case fi nding strategies. The model shows the potenƟ al eī ecƟ veness of acƟ ve 
case fi nding strategy in seƫ  ngs where access to DOTS faciliƟ es is limited.
 Chapters 3 and 4 discuss the care seeking behavior of TB suspects both in health faciliƟ es and 
in community seƫ  ngs. PaƟ ent delay and its determinants are explored. Chapter 3 aims to explore 
determinants of TB suspects’ care seeking behavior, using the theory of planned behavior (TPB) 
as a theoreƟ cal framework. A structured quesƟ onnaire, which consists of quesƟ ons regarding 
socio-demographics data, paƟ ent delay, health care seeking behavior and an extended version of 
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TPB, was developed. In total 194 TB suspect paƟ ents at 5 lung clinics in Jogjakarta province were 
interviewed. We found that the paƟ ent delay was relaƟ vely short (14 days), with accessibility 
of the healthcare provider being the main determinant of paƟ ent delay. The extended version 
of TPB did not associate with paƟ ent delay, but the role of psychosocial factors cannot be fully 
excluded. 
 
Chapter 4 describes the paƩ ern of care seeking behavior of individuals with TB symptoms in 
the community. We quanƟ fy the proporƟ on of TB suspects who did not seek care and explore 
the determinants of care seeking acƟ ons. We further assess the determinants of paƟ ent delay 
in the community. We did a populaƟ on based cross-secƟ onal survey. We interviewed adult 
individuals with cough longer than two weeks. Data on socio-demographics, TB status, onset of 
TB symptoms, TB knowledge, types of health faciliƟ es visited, and duraƟ on of each visit were 
collected. In total 746 individuals with TB symptoms in three urban, sub-urban and rural districts 
of Jogjakarta province were interviewed. We found that approximately 10% of TB suspects had 
not yet sought care. Of those who had sought care, less than half presented directly to medical 
health care providers. Female gender and mulƟ ple symptoms were associated with any care 
seeking acƟ on. Of those who sought care, 46% went directly to medical health providers. Being 
older and perceiving good quality of service were the determinants of directly visiƟ ng medical 
health providers, but recommendaƟ on from signifi cant others was associated with a direct visit 
to alternaƟ ve providers. The median duraƟ on of paƟ ent delay (17 days) was relaƟ vely short. 
Male gender and unemployment were associated with longer delay in presentaƟ on. 
 Chapters 5 and 6 explore the performance of the health system in providing TB services in 
Indonesia. Chapter 5 describes the interacƟ on between TB paƟ ents and health system during 
their diagnosƟ c process. Determinants of paƟ ents’ movement, diagnosƟ c delay, number of visits 
and TB diagnosis are explored. A cross-secƟ onal survey among newly diagnosed TB paƟ ents was 
conducted at 89 DOTS faciliƟ es in Jogjakarta province. We reconstructed the history of 253 TB 
paƟ ents care seeking processes through retrospecƟ ve interviews. We found that the total duraƟ on 
of diagnosƟ c delay was 5.4 weeks. The median number of visits was 4. Many of the paƟ ents’ 
socio-demographic determinants did not associate with the care seeking paƩ erns, and no socio-
demographic determinants were associated with longer diagnosƟ c delay. More than 60% of TB 
paƟ ents started their care seeking processes outside DOTS faciliƟ es, but the number of visits 
in DOTS faciliƟ es was higher during the overall care seeking process. Surprisingly, immediately 
visiƟ ng a DOTS facility did not correspond with shorter diagnosƟ c delay. The diagnosƟ c delay 
in Jogjakarta province was, therefore, mainly related with the exisƟ ng health system providing 
DOTS services. 
 Chapter 6 describes the TB diagnosƟ c performance at DOTS faciliƟ es. The study focuses on 
adherence to the exisƟ ng standardized naƟ onal TB diagnosƟ c guideline, determinants of lost 
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during diagnosƟ c work-up, TB diagnosis and quanƟ fi caƟ on of the duraƟ on of diagnosƟ c work-ups 
of TB suspects. We prospecƟ vely documented the diagnosƟ c work-up of new tuberculosis suspects 
unƟ l a diagnosis was reached. We used clinical audit forms to record each step chronologically. 
Data on paƟ ents’ gender, age, symptoms, types, dates and results of examinaƟ ons, and the fi nal 
diagnosis were collected. In all 43.5% of the tuberculosis suspects were lost during the diagnosƟ c 
work-up in health centers but none in lung clinics. None of the TB suspects in lung clinics and 
49% in health centers were diagnosed according to the naƟ onal TB diagnosƟ c algorithm. We 
also found a signifi cantly longer duraƟ on for diagnosƟ c work-up in health centers compared 
to lung clinics. All TB suspects who completed diagnosƟ c work-ups underwent sputum smear 
microscopic examinaƟ on at some point during their diagnosƟ c work-up, suggesƟ ng that these 
pracƟ ces are sƟ ll agree with the internaƟ onal standard for tuberculosis care (ISTC).
 Chapters 7 and 8 discuss the current and future challenges of the TB control program in 
Indonesia, parƟ cularly with the alarming increase of the number of HIV cases in Indonesia. In 
Chapter 7, we describe the burden and socio-demographic characterisƟ cs of HIV posiƟ ve cases 
among TB paƟ ents, and the up-take of voluntary HIV counseling and tesƟ ng (VCT) among TB 
paƟ ents. We introduced unlinked anonymous HIV tesƟ ng for newly diagnosed TB paƟ ents 
aƩ ending DOTS services and paƟ ents were addiƟ onally oī ered VCT services. As many as 987 TB 
paƟ ents, parƟ cipated in the survey. We found that the HIV prevalence was 1.9%. HIV infecƟ ons 
were less frequently diagnosed among TB paƟ ents who aƩ ended a public health center rather 
than a public hospital, and HIV was more common in TB paƟ ents with a university educaƟ on 
background and a history of HIV tesƟ ng. We found that only 13.4% paƟ ents who accepted 
unlinked anonymous tesƟ ng expressed interest in VCT. Of these only 39% (n=52) aƩ ended VCT. 
Interest was higher among students and those oī ered VCT by public health centers.
 Chapter 8 further discusses the challenges of introducing HIV tesƟ ng within the Indonesia 
TB control program. We explored the acceptance and perceived barriers of having HIV tesƟ ng 
among TB paƟ ents, health providers, and TB program managers. All TB paƟ ents who were tested 
for HIV infecƟ on in Chapter 7 were oī ered VCT services. To access the acceptance and perceived 
barriers of having HIV tesƟ ng, we conducted in-depth interviews with 33 TB paƟ ents, 3 specialist 
physicians and 3 disease control managers. We also conducted 4 focus Group Discussions with 
nurses. We found that paƟ ents’ and providers’ knowledge regarding HIV was poor. The main 
barriers perceived by paƟ ents were: burden for accessing VCT and fear of knowing the test 
results. SƟ gma caused concerns among providers, but did not play much role in paƟ ents’ aƫ  tude 
towards VCT. The main barriers perceived by providers were communicaƟ on, paƟ ents feeling 
oī ended, sƟ gmaƟ zaƟ on and addiƟ onal burden. 
 In Chapter 9, we provide and discuss answers to the research quesƟ ons. We also discuss 
the implicaƟ ons of study fi ndings to the TB control program in Indonesia, parƟ cularly the need 
to conƟ nuously strengthen the health system in providing DOTS services and the best way to 
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De doelstelling van dit proefschriŌ  is manieren te vinden om de opsporing van tuberculose gevallen 
in Indonesië te verbeteren. Daartoe richt dit proefschriŌ  zich op twee belangrijke kwesƟ es bij 
tbc-bestrijding: 1) de interacƟ e van tbc-paƟ ënten en mensen met verdenking op tbc met dat deel 
van de gezondheidszorg dat tbc-diensten levert en 2) de impact van de opkomende hiv-epidemie 
op het naƟ onale tbc-bestrijdingsprogramma. Dit proefschriŌ  heeŌ  negen hoofdstukken: zeven 
wetenschappelijke arƟ kelen (hoofdstukken 2-8), die vooraf worden gegaan door een algemene 
inleiding (hoofdstuk 1) en worden gevolgd door een afsluitende beschouwing (hoofdstuk 9).
 In hoofdstuk 1 geven we een algemene inleiding in de epidemiologie, het natuurlijke beloop, 
de diagnosƟ ek en de behandeling van tbc, en bespreken we de DOTS-strategie, die door de 
WHO wordt aanbevolen als mondiale strategie voor tbc-bestrijding. Tevens introduceren we 
de theorieën en concepten op het gebied van hulpzoekgedrag en het belang hiervan voor tbc-
beheersing. Ten sloƩ e worden ook het Indonesische gezondheidszorgstelsel en het naƟ onale 
tbc-beheersingsprogramma besproken, alsmede het gezondheidssysteem model 
dat we als theoreƟ sch kader gebruiken. De studies zijn uitgevoerd in de provincie Jogjakarta 
in centraal Java, Indonesië, waar 117 openbare gezondheidscentra, 24 ziekenhuizen en 5 
longklinieken de ruggengraat van het provinciale tbc-programma vormen. 
In dit proefschriŌ  hebben we de volgende onderzoeksvragen gesteld:
1. Welke patronen van hulpzoekgedrag worden in Indonesië aangetroī en bij mensen met 
verdenking op tbc?
2. Hoe eī ecƟ ef is het gezondheidszorgsysteem bij de verstrekking van DOTS-diensten?
3. Welke verbetering zou het grootste posiƟ eve eī ect op het tbc-programma hebben?
4. Hoe zal de hiv-epidemie van invloed zijn op het tbc-programma in Indonesië?
In hoofdstuk 2 introduceren we het theoreƟ sche kader voor het onderzoek naar de interacƟ e 
tussen tbc-paƟ ënten en het gezondheidszorgsysteem. Het kader is gebaseerd op een door 
Erasmus MC ontwikkeld wiskundig model voor tbc en gezondheidszorgsystemen. Het model is 
zodanig ingericht dat het een weergave is van het Indonesische gezondheidszorgsysteem, waarin 
de alternaƟ eve sector, parƟ culiere zorgaanbieders (non-DOTS) en openbare zorgaanbieders 
(DOTS) naast elkaar bestaan. Het model simuleert het traject dat paƟ ënten met long-tbc volgen 
door het gezondheidszorgsysteem, vanaf de eerste symptomen, gevolgd door hulpzoekgedrag. 
We hebben de inzichten van deskundigen gebruikt om de parameters van het model te 
kwanƟ fi ceren, waarna we een simulaƟ e hebben uitgevoerd om het funcƟ oneren van het huidige 
tbc-beheersingsprogramma in Indonesië te beschrijven. Vervolgens hebben we de eī ecten 
onderzocht van enkele mogelijke strategieën voor opsoring vantbc-gevallen. Het model toont de 
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mogelijke eī ecƟ viteit van acƟ eve opsporingsstrategieën in omgevingen met beperkte toegang 
tot DOTS-voorzieningen.
 Hoofdstukken 3 en 4 gaan over het hulpzoekgedrag van mensen met tbc-verdenking in zowel 
gezondheidszorgvoorzieningen als hun gemeenschappen. Er wordt gekeken naar vertraging 
in hulpzoekgedrag bij paƟ ënten en de determinanten hiervan. In hoofdstuk 3 worden de 
determinanten van het hulpzoekgedrag van mensen met verdenking op tbc verkend, waarbij de 
theorie van gepland gedrag (TPB) als theoreƟ sch kader wordt gebruikt. Er is een gestructureerde 
vragenlijst ontwikkeld, met vragen die betrekking hebben op socio-demografi sche 
omstandigheden, hulpzoekgedrag  en vertraging in hulpzoek gedrag bij de paƟ ënten een 
uitgebreide versie van TPB. In totaal zijn 194 paƟ ënten met verdenking op tbc in 5 longklinieken 
in de provincie Jogjakarta ondervraagd. We zagen daarbij dat de gemiddelde paƟ ëntvertraging 
relaƟ ef kort was (14 dagen), waarbij de toegankelijkheid van de gezondheidszorgaanbieder de 
belangrijkste determinant van paƟ ëntvertraging was. De uitgebreide TPB-versie vertoonde geen 
verband met paƟ ëntvertraging, maar de rol van psychosociale factoren kan niet geheel worden 
uitgesloten. 
 Hoofdstuk 4 gaat in op het patroon van hulpzoekgedrag van mensen met tbc-symptomen 
in hun gemeenschap. We kwanƟ fi ceren welk percentage van mensen met verdenking op tbc 
geen hulp zocht en verkennen de determinanten van hulpzoekgedrag. We gaan nader in op de 
determinanten van paƟ ëntvertraging in de gemeenschap. We hebben een populaƟ egebaseerd 
cross-secƟ oneel onderzoek uitgevoerd. We hebben daartoe volwassenen ondervraagd die langer 
dan twee weken hoestklachten hadden. Er zijn gegevens verzameld over socio-demografi sche 
omstandigheden, tbc-status, aanvang van tbc-symptomen, kennis over tbc, soorten bezochte 
gezondheidszorgvoorzieningen, en duur van de verschillende bezoeken. In totaal zijn interviews 
afgenomen bij 746 mensen met tbc-symptomen in drie stedelijke, voorstedelijke en rurale 
gebieden van de provincie Jogjakarta. We stelden vast dat circa 11% van de mensen met verdenking 
op tbc nog geen hulp had gezocht. Van hen die al wel hulp hadden gezocht, was 46% direct 
naar medische zorgaanbieders gegaan. De vrouwelijke sekse en meervoudige symptomen waren 
posiƟ ef geassocieerd met elke vorm van hulpzoekgedrag. Ouder zijn en het gevoel hebben dat 
de geleverde zorg van goede kwaliteit is, waren de determinanten voor het direct bezoeken van 
medische zorgaanbieders, maar aanbevelingen van belangrijke anderen in de directe omgeving 
was posiƟ ef geassocieerd met een direct bezoek aan alternaƟ eve aanbieders. De mediaan van 
de paƟ ëntvertraging was 17 dagen, waarmee deze relaƟ ef kort was. De mannelijke sekse en 
werkloosheid waren posiƟ ef geassocieerd met een grotere vertraging bij het zich aanmelden. 
 In de hoofdstukken 5 en 6 wordt onderzocht hoe de gezondheidszorg in Indonesië 
funcƟ oneert bij het verlenen van tbc-diensten. Hoofdstuk 5 beschrijŌ  de interacƟ e tussen 
tbc-paƟ ënten en de gezondheidszorgƟ jdens hun diagnosƟ sche proces. De determinanten 
van de bewegingen van paƟ ënten binnen de gezondheidszorg, diagnosƟ sche vertraging, het 
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aantal bezoeken en de tbc-diagnose worden onderzocht. Er is bij 89 DOTS-voorzieningen in de 
provincie Jogjakarta een cross-secƟ oneel onderzoek uitgevoerd onder paƟ ënten bij wie nog 
maar kort daarvoor tbc was vastgesteld. We hebben met behulp van retrospecƟ eve interviews 
de hulpzoekgeschiedenis van 253 tbc-paƟ ënten gereconstrueerd. De totale duur van de 
diagnosƟ sche vertraging bleek gemiddeld 5,4 weken te bedragen. De mediaan van het aantal 
bezoeken was 4. Veel van de socio-demografi sche determinanten van de paƟ ënten vertoonden 
geen verband met de hulpzoekpatronen, en geen ervan bleek geassocieerd met een langere 
diagnosƟ sche vertraging. Voor ruim 60% van de tbc-paƟ ënten begon het hulpzoekproces buiten 
DOTS-voorzieningen, maar het aantal bezoeken aan DOTS-voorzieningen was hoger Ɵ jdens 
het totale hulpzoekproces. Verrassenderwijs bleek het onmiddellijk bezoeken van een DOTS-
voorziening niet te corresponderen met een kortere diagnosƟ sche vertraging. De diagnosƟ sche 
vertraging in de provincie Jogjakarta hield derhalve vooral verband met de verlening van DOTS-
diensten binnen het gezondheidszorgsysteem. 
 Hoofdstuk 6 beschrijŌ  de prestaƟ es van DOTS-voorzieningen op het gebied van tbc-
diagnosƟ ek. Het onderzoek is gericht op naleving van de bestaande gestandaardiseerde naƟ onale 
richtlijn voor tbc-diagnosƟ ek, determinanten van verlies bij diagnosƟ sche work-up, tbc-diagnose 
en kwanƟ fi caƟ e van de duur van diagnosƟ sche workups van mensen met verdenking op tbc. 
We hebben de diagnosƟ sche workup van nieuwe tuberculose-verdenkingen bijgehouden en 
gedocumenteerd totdat er een diagnose was gesteld. We hebben klinische audiƞ ormulieren 
gebruikt om alle stappen chronologisch vast te leggen. Hiermee werden gegevens over de sekse, 
leeŌ ijd en symptomen van de paƟ ënt, alsmede de soorten, data en resultaten van onderzoeken, 
en de uiteindelijke diagnose verzameld. Alles bij elkaar werd in gezondheidscentra Ɵ jdens de 
diagnosƟ sche workups 43,5% van de mensen met verdenking op tuberculose verloren, maar 
niemand in longklinieken. Van de mensen met tbc-verdenking werd in de longklinieken niemand 
en in de gezondheidscentra 49% gediagnosƟ ceerd volgens het naƟ onale algoritme voor tbc-
diagnosƟ ek. We hebben ook vastgesteld dat de diagnosƟ sche workups in de gezondheidscentra 
signifi cant meer Ɵ jd in beslag namen dan in de longklinieken. Bij alle mensen met tbc-verdenking 
voor wie de volledige diagnosƟ sche workup werd uitgevoerd, is Ɵ jdens de workup op enig 
moment een microscopische speekseltest uitgevoerd, hetgeen erop duidt dat deze prakƟ jk nog 
in overeenstemming is met de ISTC (InternaƟ onal Standard for Tuberculosis Care).
 Hoofdstukken 7 en 8 gaan over de huidige en toekomsƟ ge uitdagingen voor het tbc-
bestrijdingsprogramma in Indonesië, met name tegen de achtergrond van de alarmerende 
toename van het aantal hiv-besmeƫ  ngen in het land. In hoofdstuk 7 beschrijven we het aandeel 
en de socio-demografi sche kenmerken van de hiv-posiƟ eve gevallen onder de tbc-paƟ ënten, en 
de mate waarin tbc-paƟ ënten vrijwillig kiezen voor hiv-counseling en -tests (VCT). We hebben 
anonieme hiv-tests voor pas gediagnosƟ ceerde tbc-paƟ ënten die gebruikmaken van DOTS-
diensten geïntroduceerd, en de paƟ ënten kregen ook nog VCT aangeboden. Aan dit onderzoek 
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werd door maar liefst 987 tbc-paƟ ënten deelgenomen. We hebben een hiv-prevalenƟ e van 1,9% 
vastgesteld. Er werden minder vaak hiv-infecƟ es aangetroī en bij tbc-paƟ ënten in een openbaar 
gezondheidscentrum dan in een openbaar ziekenhuis, en hiv kwam meer voor bij tbc-paƟ ënten 
met een academische opleiding en die zich al eerder op hiv hadden laten testen. We stelden vast 
dat slechts 13,4% van de paƟ ënten die instemden met een anonieme test belangstelling had voor 
VCT. Van hen heeŌ  slechts 39% (n=52) zich daadwerkelijk voor VCT gemeld. De belangstelling was 
groter onder studenten en hen die VCT kregen aangeboden door openbare gezondheidscentra.
 Hoofdstuk 8 behandelt verder de uitdagingen die gepaard gaan met de introducƟ e van hiv-
tests in het Indonesische tbc-bestrijdingsprogramma. We hebben gekeken naar de acceptaƟ e van 
en de ervaren obstakels voor het uitvoeren van hiv-tests onder tbc-paƟ ënten, zorgaanbieders, en 
tbc-programmamanagers. Alle tbc-paƟ ënten bij wie in hoofdstuk 7 werd getest op hiv-besmeƫ  ng 
kregen VCT aangeboden. Om de acceptaƟ e van en de ervaren obstakels voor het uitvoeren 
van hiv-tests te kunnen inschaƩ en, hebben we uitgebreide interviews afgenomen bij 33 tbc-
paƟ ënten, drie specialisten en drie ziektebeheersingsmanagers. Bovendien hebben we hier vier 
uit verpleegkundigen bestaande focusgroepen over laten praten. We hebben vastgesteld dat het 
kennisniveau over hiv bij zowel paƟ ënten als zorgaanbieders laag was. De belangrijkste obstakels 
zoals ervaren door de paƟ ënten waren: belemmering bij de toegang tot VCT en angst om de 
uitslag van de test te weten te komen. De mogelijkheid van sƟ gmaƟ sering speelde wel een rol 
voor de zorgaanbieders, maar niet zozeer voor de paƟ ënten bij hun houding ten opzichte van 
VCT. De belangrijkste obstakels zoals ervaren door de zorgaanbieders waren communicaƟ e, het 
risico dat paƟ ënten zich beledigd zouden voelen, sƟ gmaƟ sering en de extra last. 
 In hoofdstuk 9 geven we antwoorden op de onderzoeksvragen en bespreken we deze. We 
bespreken tevens de implicaƟ es van de onderzoeksresultaten voor het tbc-bestrijdingsprogramma 
in Indonesië, met name de noodzaak om het gezondheidszorgsysteem te blijven versterken op 
het gebied van DOTS-diensten en de beste manier om hiv-tests te integreren in het naƟ onale tbc-
bestrijdingsprogramma. Aan het eind van het hoofdstuk komen we uit op de volgende conclusies 
en aanbevelingen:
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CONCLUSIES
 – Het hulpzoekgedrag van mensen met verdenking op tbc in de Indonesische provincie 
Jogjakarta is relaƟ ef gunsƟ g.
 – Het gezondheidszorgsysteem dat DOTS-diensten in de provincie Jogjakarta levert ondervindt 
problemen bij het op eī ecƟ eve wijze diagnosƟ ceren van tbc-gevallen.
 – Het zal waarschijnlijk eī ecƟ ever zijn het zorgstelsel dat DOTS levert te versterken dan om te 
proberen het hulpzoekgedrag van mensen met verdenking op tbc te veranderen.
 – De hiv-epidemie in Indonesië heeŌ  vooralsnog een beperkte impact op het tbc-programma, 
maar de ontwikkeling van gelijkƟ jdige hiv- en tbc-besmeƫ  ngen moet zorgvuldig worden 
gevolgd zodat er Ɵ jdig met passende maatregelen kan worden gereageerd.
AANBEVELINGEN
 – Om in Indonesië tot een betere detecƟ e van tbc-gevallen te komen is het verstandig 
intervenƟ es te richten op versterking van het zorgstelsel dat DOTS-diensten aanbiedt.
 – De ontwikkeling van de hiv-epidemie onder tbc-paƟ ënten in Indonesië moet zorgvuldig 
worden gevolgd, zodat er Ɵ jdig met passende maatregelen kan worden gereageerd.
 – Pas de WHO-richtlijnen voor PPM-beoordelings- en implementaƟ eacƟ viteiten aan aan de 
situaƟ es in de betreī ende provincies en districten om zo de juiste PPM-strategieën voor de 
verschillende provincies en districten vast te kunnen stellen.  
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Ringkasan
Disertasi ini bertujuan untuk mengidenƟ fi kasi cara untuk meningkatkan penemuan kasus 
Tuberkulosis (TB) di Indonesia. Untuk mencapai tujuan tersebut, disertasi ini memfokuskan pada dua 
isu utama dalam pengendalian penyakit TB, yaitu: 1) interaksi antara pasien dan suspek TB dengan 
sistem kesehatan yang menyediakan layanan pengobatan TB, serta 2) dampak munculnya epidemi 
HIV terhadap program pengendalian program TB di Indonesia. Disertasi ini terdiri dari 9 bab, yang 
melipuƟ  pendahuluan (bab 1), tujuh publikasi peneliƟ an (bab 2-8) dan diskusi umum (bab 9).
 Bab 1 berisi gambaran umum tentang epidemiologi, riwayat alamiah penyakit, diagnosis 
dan pengobatan TB, serta strategi DOTS yang direkomendasi WHO sebagai strategi global 
pengendalian TB. Bab ini juga mengenalkan teori dan konsep perilaku mencari pengobatan dan 
kepenƟ ngannya dalam pengendalian TB. Gambaran sistem kesehatan dan program pengendalian 
penyakit TB di Indonesia beserta model sistem kesehatan yang digunakan sebagai kerangka 
teoriƟ s peneliƟ an juga dibahas. Seluruh peneliƟ an yang digunakan dalam disertasi ini dilakukan 
di propinsi Daerah IsƟ mewa Yogyakarta (DIY), Indonesia. Propinsi ini mempunyai fasilitas layanan 
kesehatan sejumlah 117 Puskesmas, 24 rumah sakit dan 5 BP4 sebagai ujung tombak dari 
program pengendalian TB di wilayah tersebut.
Pertanyaan peneliƟ an yang diajukan dalam disertasi ini adalah sebagai berikut:
1. Bagaimana pola perilaku pencarian pengobatan suspek TB di Indonesia?
2. Bagaimana efekƟ vitas kinerja sistem kesehatan di dalam memberikan layanan TB berbasis 
DOTS?
3. Intervensi-intervensi apakah yang memiliki daya ungkit terƟ nggi untuk memperbaiki kinerja 
program pengendalian TB?
4. Bagaimana pengaruh munculnya epidemi HIV terhadap program TB di Indonesia?
Kerangka teoriƟ s interaksi antara pasien TB dengan sistem kesehatan disajikan pada bab 2. 
Kerangka ini didasarkan atas model matemaƟ s sistem kesehatan dan pengendalian TB yang 
dikembangkan oleh Erasmus MC. Model tersebut disesuaikan dengan konteks sistem kesehatan 
di Indonesia, yang mempunyai Ɵ ga jenis penyelenggara layanan kesehatan, yaitu: fasilitas 
kesehatan pemerintah (DOTS), swasta (Non-DOTS) dan alternaƟ f. Model matemaƟ s tersebut 
mencerminkan perjalanan pasien TB sejak munculnya gejala TB hingga mencari pengobatan 
di dalam suatu sistem kesehatan. Opini ahli digunakan untuk mengidenƟ fi kasi parameter-
parameter perilaku mencari pengobatan, yang diƟ ndaklanjuƟ  dengan simulasi model untuk 
mendeskripsikan kinerja program pengendalian TB di Indonesia dan mengeksplorasi dampak 
berbagai strategi potensial dalam penemuan kasus. Simulasi model menunjukkan potensi 
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efekƟ vitas penemuan penderita TB secara akƟ f  pada situasi dimana penderita TB mempunyai 
keterbatasan akses terhadap fasilitas layanan kesehatan.
 Bab 3 dan 4 mendiskusikan perilaku suspek TB dalam mencari pengobatan, baik di fasilitas 
layanan kesehatan maupun di komunitas. Kedua bab ini mengekplorasi keterlambatan pasien dan 
faktor-faktor yang mempengaruhinya. Bab 3 bertujuan untuk mengekplorasi determinan perilaku 
suspek TB dalam mencari pengobatan dengan menggunakan kerangka teori perilaku terencana 
(the theory of planned behavior – TPB). Kami mewawancarai 194 suspek TB yang berkunjung 
ke lima BP4 di propinsi DIY dengan menggunakan kuesioner terstruktur. Kuesioner tersebut 
berisi pertanyaan-pertanyaan mengenai data sosiodemografi , keterlambatan pasien, perilaku 
pencarian layanan kesehatan dan modifi kasi teori perilaku terencana (TPB). Hasil peneliƟ an 
menunjukkan bahwa keterlambatan pasien relaƟ f singkat (14 hari), dengan determinan utama 
berupa kemudahan akses terhadap fasilitas layanan kesehatan. PeneliƟ an ini juga menunjukkan 
bahwa modifi kasi TPB Ɵ dak berhubungan dengan keterlambatan pasien, meskipun Ɵ dak dapat 
mengesampingkan peran faktor-faktor psikososial dalam menjelaskan keterlambatan pasien.
 Bab 4 menggambarkan pola perilaku suspek TB dalam pencarian pengobatan di komunitas. 
Survei potong lintang dilakukan untuk mengetahui proporsi suspek TB yang Ɵ dak mencari 
pengobatan dan mengeksplorasi determinan-determinan perilaku mencari pengobatan. Kami 
mewawancarai 746 suspek TB di komunitas di Ɵ ga kabupaten yang merepresentasikan wilayah 
urban, sub-urban dan pedesaan di propinsi DIY. Wawancara dilakukan untuk mengumpulkan 
data sosiodemografi , status TB, waktu mulainya gejala TB, pengetahuan tentang TB, jenis fasilitas 
kesehatan yang dikunjungi, dan durasi yang diperlukan untuk seƟ ap kunjungan. PeneliƟ an ini 
menemukan bahwa 11% suspek TB yang diwawancarai belum pernah mencari pengobatan. Dari 
suspek TB yang telah berobat, 46% diantaranya langsung mengunjungi layanan kesehatan modern 
(dokter, perawat, puskesmas dan rumah sakit) setelah gejala Ɵ mbul. Usia yang lebih tua dan 
persepsi tentang mutu layanan yang baik, merupakan determinan untuk langsung menggunakan 
layanan kesehatan medis, sedangkan saran dari orang terdekat berhubungan dengan 
penggunaan fasilitas kesehatan alternaƟ f setelah gejala Ɵ mbul. Median durasi keterlambatan 
pasien relaƟ f singkat (17 hari). Jenis kelamin laki-laki dan pengangguran merupakan determinan 
bagi peningkatan durasi keterlambatan pasien. 
 Bab 5 dan 6 mengeksplorasi kinerja sistem kesehatan dalam memberikan layanan TB di 
Indonesia. Bab 5 mendiskusikan interaksi antara pasien TB dan sistem kesehatan selama proses 
penegakan diagnosis, melipuƟ  eksplorasi determinan pergerakan pasien dalam sistem kesehatan, 
keterlambatan diagnosis, dan jumlah kunjungan pasien sebelum penegakan diagnosis TB. Untuk 
mencapai tujuan tersebut, dilakukan survei potong lintang pada pasien TB baru yang didiagnosis 
di 89 fasilitas DOTS di propinsi DIY. Kami merekonstuksi secara retrospekƟ f proses pencarian 
pengobatan pada 253 pasien TB hingga proses penegakan diagnosis. PeneliƟ an ini menemukan 
bahwa durasi keterlambatan diagnosis adalah 5,4 minggu, dengan median jumlah kunjungan ke 
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fasilitas kesehatan sebanyak empat kali. Determinan sosiodemografi  pasien banyak yang Ɵ dak 
berhubungan dengan durasi keterlambatan diagnosis. Lebih dari 60% pasien TB memulai proses 
pencarian pengobatan di luar fasilitas DOTS, akan tetapi jumlah kunjungan di berbagai fasilitas 
DOTS lebih Ɵ nggi dibandingkan fasilitas Non-DOTS selama proses pencarian pengobatan. Di luar 
dugaan, kunjungan langsung ke fasilitas DOTS setelah gejala Ɵ mbul ternyata Ɵ dak berhubungan 
dengan waktu diagnosis yang lebih pendek. Dengan demikian, disimpulkan bahwa keterlambatan 
diagnosis pasien TB di propinsi DIY terkait dengan sistem kesehatan yang Ɵ dak adekuat dalam 
memberikan layanan DOTS.
 Bab 6 mendeskripsikan kinerja fasilitas DOTS dalam mendiagnosis TB. PeneliƟ an ini 
memusatkan pada kepatuhan penyedia layanan kesehatan terhadap pedoman nasional untuk 
diagnosis TB, determinan Ɵ dak kembalinya suspek TB ke fasilitas kesehatan untuk menyelesaikan 
proses diagnosis, dan kuanƟ fi kasi durasi proses diagnosis pada suspek TB. Secara prospekƟ f, 
proses diagnosis TB didokumentasi sejak seorang pasien dinyatakan sebagai suspek TB hingga 
diagnosis ditegakkan. PeneliƟ an ini menggunakan formulir audit klinis untuk merekam jenis-jenis 
pemeriksaan yang dilakukan selama proses diagnosis TB secara berurutan. Kami mengumpulkan 
data tentang jenis kelamin penderita, umur, gejala-gejala TB, jenis, tanggal dan hasil seƟ ap 
pemeriksaan diagnosis, serta hasil akhir diagnosis. Hasil peneliƟ an menunjukkan bahwa 43,5% 
suspek TB di Puskesmas hilang selama proses diagnosis, sebaliknya Ɵ dak ada seorangpun 
suspek TB yang hilang di BP4. Seluruh suspek TB di BP4 dan 49% suspek TB di Puskesmas Ɵ dak 
didiagnosis sesuai dengan algoritma standard diagnosis TB yang diterbitkan oleh Sub-direktorat 
TB, Kementerian Kesehatan. Waktu yang diperlukan untuk proses diagnosis di Puskesmas secara 
staƟ sƟ k lebih lama dibandingkan dengan di BP4. Seluruh suspek TB yang menyelesaikan proses 
pemeriksaan diagnosis menjalani pemeriksaan mikroskopis dahak pada suatu waktu tertentu 
selama proses diagnosis dilakukan. Praktek ini sejalan dengan rekomendasi InternaƟ onal 
Standard for Tuberculosis Care (ISTC).
 Bab 7 dan 8 membahas tantangan program TB, terutama dengan semakin meningkatnya 
jumlah penderita HIV di Indonesia. Bab 7 menggambarkan beban dan karakterisƟ k sosio-
demografi  pasien TB-HIV, dan minat pasien TB untuk melakukan tes HIV dengan metode 
voluntary counseling and tesƟ ng (VCT). Kami melakukan serosurvei HIV pada pasien TB baru 
yang didiagnosis, dengan menggunakan metode unlinked anonymous. Pasien yang setuju untuk 
berparƟ sipasi dalam survei tersebut ditawari untuk melakukan VCT apabila ingin mengetahui 
status HIVnya. Sebanyak 987 pasien baru TB berparƟ sipasi dalam survei tersebut dan prevalensi 
HIV ditemukan sebesar 1,9%. Infeksi HIV lebih jarang ditemukan pada pasien TB yang berkunjung 
ke Puskesmas bila dibandingkan dengan yang mengunjungi rumah sakit pemerintah. Infeksi HIV 
juga lebih sering ditemukan pada pasien TB dengan latar belakang pendidikan seƟ ngkat perguruan 
Ɵ nggi dan riwayat tesƟ ng HIV sebelumnya. PeneliƟ an ini juga menunjukkan bahwa 13,4% dari 
pasien yang berparƟ sipasi dalam peneliƟ an tertarik untuk melakukan VCT. Diantara mereka yang 
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tertarik untuk VCT, hanya 39% (n=52) yang datang ke fasilitas VCT. Ketertarikan untuk melakukan 
VCT lebih banyak ditemukan pada kelompok pelajar dan pasien yang berkunjung ke Puskesmas.
 Bab 8 lebih lanjut mendiskusikan tentang tantangan untuk memperkenalkan layanan tes HIV 
di dalam program TB. Bab ini mengeksplorasi penerimaan dan persepsi tentang hambatan untuk 
memberikan layanan tes HIV bagi pasien TB. Pengumpulan data dilakukan melalui wawancara 
mendalam kepada 33 pasien TB, Ɵ ga dokter spesialis, dan Ɵ ga wasor TB. Selain itu, dilakukan 
pula empat diskusi kelompok terarah dengan perawat yang menjadi petugas TB di Puskesmas dan 
rumah sakit. Hasil peneliƟ an menunjukkan bahwa masih terdapat banyak miskonsepsi tentang 
HIV di kalangan petugas kesehatan dan pasien TB. Hambatan utama yang dirasakan oleh pasien 
TB antara lain: beban tambahan untuk mengunjungi layanan VCT dan kekhawaƟ ran tentang 
hasil tes. Meskipun sƟ gma menjadi perhaƟ an utama pada petugas kesehatan, akan tetapi hal 
ini Ɵ dak terlalu diperhaƟ kan dalam sikap pasien terhadap VCT. Hambatan utama yang dirasakan 
oleh petugas kesehatan adalah hambatan komunikasi, kekhawaƟ ran bila menyinggung perasaan 
pasien, sƟ gmaƟ sasi dan tambahan beban kerja.
 Bab terakhir (bab 9) mengulas keseluruhan hasil penelitan dan mendiskusikan jawaban 
atas pertanyaan-pertanyaan peneliƟ an. Bab ini lebih lanjut membahas mengenai implikasi hasil 
peneliƟ an terhadap program pengendalian TB di Indonesia, khususnya mengenai perlunya 
penguatan sistem kesehatan secara berkesinambungan dan cara terbaik untuk mengintegrasikan 
layanan tes HIV ke dalam program TB nasional. Bab ini ditutup dengan kesimpulan dan 
rekomendasi sebagai berikut:
KESIMPULAN
 – Perilaku mencari pengobatan diantara suspek TB di propinsi DIY Indonesia relaƟ f baik.
 – Sistem kesehatan yang menyediakan layanan DOTS di propinsi DIY Indonesia Ɵ dak mampu 
mempertahankan kinerja yang efekƟ f untuk mendiagnosis kasus-kasus TB.
 – Perbaikan sistem kesehatan yang memberikan layanan DOTS akan memberikan daya 
ungkit yang lebih efekƟ f terhadap kinerja program TB dibandingkan dengan intervensi yang 
dilakukan untuk mempengaruhi perilaku suspek TB dalam mencari layanan kesehatan.
 – Dampak epidemi HIV di Indonesia terhadap program TB masih terbatas, akan tetapi tren 
peningkatan kasus koinfeksi TB-HIV harus dimonitor secara haƟ -haƟ .
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REKOMENDASI
 – Untuk memperbaiki penemuan kasus TB di Indonesia, intervensi sebaiknya difokuskan pada 
penguatan sistem kesehatan yang memberikan layanan DOTS.
 – Tren peningkatan kasus TB-HIV harus dimonitor secara haƟ -haƟ  agar dapat melakukan respon 
yang memadai dan tepat waktu.
 – Melakukan adaptasi pedoman WHO mengenai penilaian kebutuhan dan implementasi 
strategi PPM agar sesuai dengan kebutuhan dan konteks sistem kesehatan di Ɵ ngkat propinsi 
dan kabupaten. 
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AbbreviaƟ ons
ACF : AcƟ ve Case Finding
AIDS : Acquired Immune Defi ciency Syndrome
BCG : Bacille CalmeƩ e-Guerin 
CDR : Case DetecƟ on Rate
CI : Confi dence Interval
CST : Care Support and Treatment
DALY : Disability Adjusted Life Years
DG : Directorate General
DOTS : Direct Observe Treatment Short-course
ECF : Enhanced Case Finding
FDC : Fixed Dose CombinaƟ on
FGD : Focus Group Discussion
FIND : FoundaƟ on for InnovaƟ ve New DiagnosƟ cs
FM GMU : Faculty of Medicine, Gadjah Mada University
HAART : Highly AcƟ ve AnƟ -retroviral Therapy
HBM : Health Belief Model
HDL : Hospital DOTS Linkage
HIV
HR
: Human Immunodefi ciency Virus
: Hazard RaƟ o
IDUs : InjecƟ ng Drug Users
IGRAs : Interferon Gamma Release Assays
IPT : Isoniazid PrevenƟ ve Therapy
IQR : Inter-quarƟ le Range
ISTC : InternaƟ onal Standard Tuberculosis Care
IUATLD : InternaƟ onal Union Against Lung Diseases
LED : Light Emiƫ  ng Diode
LJ media : Löwenstein-Jensen Media
MDGs : Millennium Development Goals
MDR-TB : MulƟ  Drug-resistant Tuberculosis
MHC : Microscopy Health Center
NAAT : Nucleic Acid Amplifi caƟ on Test
NTP : NaƟ onal TB Control Program
OR : Odds RaƟ o
OTC drugs : Over the Counter Drugs
PAL : PracƟ cal Approach To Lung Health
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PITC : Provider-iniƟ ated TesƟ ng and Counseling
PPD : Purifi ed Protein DerivaƟ ve
PPM : Public-Private Mix
SES : Socio-economic Status
SHC : Satellite Health Center
TB : Tuberculosis
TPB : Theory of Planned Behavior
TST : Tuberculin Skin Test
UNAIDS : The Joint United NaƟ ons Program on HIV/AIDS
VCT : Voluntary Counseling and TesƟ ng
WHO : World Health OrganizaƟ on
WHO/EPI : World Health OrganizaƟ on/Expanded Program on ImmunizaƟ on
XDR-TB : Extensive Drug-resistant Tuberculosis
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DQ\ERG\HYHQP\FORVHVWIDPLO\
 , OHDQPRVWRIP\JUDWLWXGHWRP\ ORYLQJZLIH<X\XO:XULDQLQJUXPDQGGDXJKWHU
.DQD\D$OLYLD<RXSXW\RXUOLIHORYHKRSHDQGHQHUJ\LQWUXVWLQJPHDQGLQUHWXUQ,OHW
\RXULGH LQWKLVUROOHUFRDVWHU%RWKRI\RXGHVHUYHVRPHWKLQJEHWWHU7KDQN\RXIRUDOO
MR\IXOWHDUVDQGWHDUIXOMR\VZHKDYHEHHQH[SHULHQFLQJDOOWKHVH\HDUV7KDQN\RXIRU
your unconditional support and love, even when I was away from home physically or when 
,ZDVDZD\HPRWLRQDOO\LQP\PLQGLQIURQWRIP\ODSWRS.DQD\D\RXUXQGHUVWDQGLQJ
WKDW´'DGG\KDVWRZULWHWKLVVWRU\DQGJLYHWR2RP6DNHEHIRUHKHOHWXVJRKRPHWR
,QGRQHVLDµKDGDOZD\VLPSUHVVHGPH<RXUSUHVHQFHLQGHHGJDYHSRLQWDQGSXUSRVHLQP\
OLIH
/DVWEXWQRWOHDVW,WKDQN\RX*RG«
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Curriculum Vitae
5LULV$QGRQR$KPDGZDVERUQ LQ%DQ\XPDV ,QGRQHVLDRQ0D\+HJUDGXDWHGDV
PHGLFDOGRFWRUIURP*DGMDK0DGD8QLYHUVLW\,QGRQHVLDLQ3ULRUWRKLVPHGLFDOGHJUHH
KHUHFHLYHGDPDVWHUWUDLQLQJLQ(SLGHPLRORJ\DQG3XEOLF+HDOWKIURP8PHD8QLYHUVLW\
6ZHGHQ LQ+H MRLQHG WKH'HSDUWPHQWRI3XEOLF+HDOWK*DGMDK0DGD8QLYHUVLW\
,QGRQHVLD LQ ,QKHZRUNHGZLWK:+2,QGRQHVLDDVDQDWLRQDOFRQVXOWDQWIRU
DQHPHUJHQF\DQGKXPDQLWDULDQSURMHFWLQ1RUWK0ROOXFDZKHUHKHFRRUGLQDWHGWKHSRVW
FRQÁLFW:+2SURMHFWRQKHDOWKV\VWHPVWUHQJWKHQLQJFRPPXQLFDEOHGLVHDVHFRQWURODQG
HPHUJHQF\ SUHSDUHGQHVV ,Q  KH ZRUNHG DV D SDUWWLPH FRQVXOWDQW IRU DQ 86$,'
IXQGHGSURMHFWRQDQLQWHJUDWHGPDODULDVXUYHLOODQFHV\VWHPLQ,QGRQHVLD)ROORZLQJWKH
FROODERUDWLRQEHWZHHQ*08(UDVPXV0&DQG,70$QWZHUSRQD7%+,9UHVHDUFKSURMHFW
IURPKHIRFXVHGKLVUHVHDUFK LQWHUHVWRQWXEHUFXORVLVDQG+,97KURXJKWKLV
SURMHFWKHZRUNHGFORVHO\ZLWKWKHQDWLRQDO7%SURJUDP173+HZDVDFWLYHO\LQYROYHG
LQVHYHUDOVWXGLHVRQ7%DQG7%+,9RSHUDWLRQDOUHVHDUFKLQ,QGRQHVLDIXQGHGE\WKH173
:+2DQG.1&9+HZDVDOVRLQYROYHGLQWKHGHYHORSPHQWRIWKH6WUDWHJLF3ODQ
IRU 7XEHUFXORVLV &RQWURO LQ ,QGRQHVLD DQG WKH ,QGRQHVLD *OREDO )XQG SURSRVDO LQ 
6WDUWLQJLQKHZDVLQYROYHGLQSURYLGLQJOHFWXUHVLQWKH7XEHUFXORVLV3XEOLF3ULYDWH
0L[&RXUVHDQGDFRXUVHFRRUGLQDWRUIRUWKH7%2SHUDWLRQDO5HVHDUFK&RXUVHDVSDUWRI
LQWHUQDWLRQDOFRXUVHVRIIHUHGE\WKH7%&7$5HJLRQDO7UDLQLQJ&HQWHU5HWUDF$VLD)DFXOW\
RI0HGLFLQH*DGMDK0DGD8QLYHUVLW\,QGRQHVLD
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Summary of PhD training and teaching
EĂŵĞWŚƐƚƵĚĞŶƚ͗ZŝƌŝƐŶĚŽŶŽŚŵĂĚ
ƌĂƐŵƵƐDĞƉĂƌƚŵĞŶƚ͗WƵďůŝĐ,ĞĂůƚŚ
ZĞƐĞĂƌĐŚ^ĐŚŽŽů͗E/,^
WŚƉĞƌŝŽĚ͗ϮϬϬϵͲϮϬϭϭ
WƌŽŵŽƚŽƌ;ƐͿ͗:ĂŶ,ĞŶĚƌŝŬZŝĐŚĂƌĚƵƐ
^ƵƉĞƌǀŝƐŽƌ͗^ĂŬĞ:ĂŶĚĞsůĂƐ
1. PhD training
Year Workload
(Hours/ECTS)
General courses 
 – ^ƵƌǀŝǀĂůŶĂůǇƐŝƐĨŽƌůŝŶŝĐŝĂŶƐ
 – ŽŶĐĞƉƚƵĂůĨŽƵŶĚĂƟŽŶŽĨĞƉŝĚĞŵŝŽůŽŐŝĐƐƚƵĚǇĚĞƐŝŐŶ
 – ĂƵƐĂůŝŶĨĞƌĞŶĐĞ
 – ,ŝƐƚŽƌǇŽĨĞƉŝĚĞŵŝŽůŽŐŝĐŝĚĞĂƐ
 – ĚǀĂŶĐĞƐŝŶĞƉŝĚĞŵŝŽůŽŐŝĐƐƚƵĚǇĚĞƐŝŐŶ
 – WƌŝŶĐŝƉůĞƐŽĨƉŝĚĞŵŝŽůŽŐŝĐĂƚĂͲĂŶĂůǇƐŝƐ
 – ŽƵƌƐĞƐĨŽƌƚŚĞƋƵĂŶƟƚĂƟǀĞƌĞƐĞĂƌĐŚĞƌ
 – ĂǇĞƐŝĂŶ^ƚĂƟƐƟĐƐ
 – ŝĂŐŶŽƐƟĐZĞƐĞĂƌĐŚ
 – WůĂŶŶŝŶŐĂŶĚǀĂůƵĂƟŽŶŽĨ^ĐƌĞĞŶŝŶŐ
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϭ
ϮϬϭϭ
ϮϬϭϭ
ϮϬϭϭ
ϮϬϭϭ
1.4
Ϭ͘ϳ
Ϭ͘ϳ
Ϭ͘ϳ
Ϭ͘ϰ
Ϭ͘ϳ
1.4
1.1
Ϭ͘ϳ
1.4
^ƉĞĐŝĮĐĐŽƵƌƐĞƐ;Ğ͘Ő͘ZĞƐĞĂƌĐŚƐĐŚŽŽů͕DĞĚŝĐĂůdƌĂŝŶŝŶŐͿ
 – /hd>/ŶƚĞƌŶĂƟŽŶĂůdƵďĞƌĐƵůŽƐŝƐŽƵƌƐĞ ϮϬϬϵ ϭϮϬŚŽƵƌƐ
^ĞŵŝŶĂƌƐĂŶĚǁŽƌŬƐŚŽƉƐ
 – ZĞŐŝŽŶĂůŵĞĞƟŶŐŽĨŶĂƟŽŶĂůdƉƌŽŐƌĂŵŵĞŵĂŶĂŐĞƌƐ͕
t,Kͬ^ZK͕EĞǁĞůŚŝ͕/ŶĚŝĂ͘
 – tŽƌŬƐŚŽƉŽŶĚĞǀĞůŽƉŵĞŶƚŽĨƐƚĂŶĚĂƌĚŝǌĞĚĐƵƌƌŝĐƵůƵŵ
ĨŽƌ/ŵƉůĞŵĞŶƚĂƟŽŶͬKƉĞƌĂƟŽŶĂůZĞƐĞĂƌĐŚ͕t,K͕'ĞŶĞǀĂ͕
^ǁŝƚǌĞƌůĂŶĚ͘
 – tŽƌŬƐŚŽƉŽŶĚĞǀĞůŽƉŵĞŶƚŽĨŐŽŽĚŚĞĂůƚŚƌĞƐĞĂƌĐŚƉƌĂĐƟĐĞ
ĐŽƵƌƐĞŵŽĚƵůĞ͕t,K͕'ĞŶĞǀĂ͕^ǁŝƚǌĞƌůĂŶĚ͘
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϬ
ϯϮŚŽƵƌƐ
ϯϮŚŽƵƌƐ
ϯϮŚŽƵƌƐ
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WƌĞƐĞŶƚĂƟŽŶƐ
 – KƌĂůƉƌĞƐĞŶƚĂƟŽŶĞŶƟƚůĞĚ͗/ŵƉƌŽǀŝŶŐƚŚĞŶĂƟŽŶĂůd
ĐŽŶƚƌŽůƉƌŽŐƌĂŵŝŶ/ŶĚŽŶĞƐŝĂ͗ĞǆƉůŽƌĂƟŽŶƐǁŝƚŚĂŚĞĂůƚŚ
ƐǇƐƚĞŵƐŵŽĚĞů͘WƌĞƐĞŶƚĞĚĂƚƚŚĞϱƚŚƵƌŽƉĞĂŶŽŶŐƌĞƐƐŽŶ
dƌŽƉŝĐĂůDĞĚŝĐŝŶĞĂŶĚ/ŶƚĞƌŶĂƟŽŶĂů,ĞĂůƚŚ͕ŵƐƚĞƌĚĂŵ͕dŚĞ
Netherlands
 – WŽƐƚĞƌƉƌĞƐĞŶƚĂƟŽŶĞŶƟƚůĞĚ͗ĐŽŶŽŵŝĐĞǀĂůƵĂƟŽŶŽĨWWDͲ
Kd^ŝŶ/ŶĚŽŶĞƐŝĂ͘WƌĞƐĞŶƚĞĚĂƚƚŚĞϯϵƚŚtŽƌůĚŽŶĨĞƌĞŶĐĞ
ĨŽƌ>ƵŶŐ,ĞĂůƚŚ͕ĂƉĞdŽǁŶ͕^ŽƵƚŚĨƌŝĐĂ͘
 – KƌĂůƉƌĞƐĞŶƚĂƟŽŶĞŶƟƚůĞĚ͗ŽŶĮƌŵĞĚdƉĂƟĞŶƚƐĐĂƌĞ
ƐĞĞŬŝŶŐďĞŚĂǀŝŽƌĂŶĚĚŝĂŐŶŽƐƟĐĚĞůĂǇŝŶ:ŽŐũĂŬĂƌƚĂWƌŽǀŝŶĐĞ͕
/ŶĚŽŶĞƐŝĂ͘WƌĞƐĞŶƚĞĚĂƚƚŚĞtŽƌůĚ&ĞĚĞƌĂƟŽŶWƵďůŝĐ,ĞĂůƚŚ
ƐƐŽĐŝĂƟŽŶŽŶŐƌĞƐƐ͕/ƐƚĂŶďƵů͕dƵƌŬĞǇ͘
 – KƌĂůƉƌĞƐĞŶƚĂƟŽŶĞŶƟƚůĞĚ͗/ŵƉůĞŵĞŶƚĂƟŽŶŽĨdĚŝĂŐŶŽƐƟĐ
ƉƌŽĐĞƐƐĂůŐŽƌŝƚŚŵŝŶWƵƐŬĞƐŵĂƐ͕ŝŶ:ŽŐũĂŬĂƌƚĂDƵŶŝĐŝƉĂůŝƚǇ͘
WƌĞƐĞŶƚĞĚĂƚEĂƟŽŶĂůdƵďĞƌĐƵůŽƐŝƐWĂƌĂĚĞĐŽŶĨĞƌĞŶĐĞ͕
ĂŶĚƵŶŐ͕/ŶĚŽŶĞƐŝĂ
 – WŽƐƚĞƌƉƌĞƐĞŶƚĂƟŽŶĞŶƟƚůĞĚ͗dŚĞĚŝĂŐŶŽƐƟĐƉƌŽĐĞƐƐŽĨd
ƐƵƐƉĞĐƚŝŶ:ŽŐũĂŬĂƌƚĂ͕/ŶĚŽŶĞƐŝĂ͗ĨƌŽŵĂůŐŽƌŝƚŚŵƚŽƌĞĂůŝƚǇ͘
WƌĞƐĞŶƚĞĚĂƚƚŚĞϯϵƚŚtŽƌůĚŽŶĨĞƌĞŶĐĞĨŽƌ>ƵŶŐ,ĞĂůƚŚ͕
EŽǀĞŵďĞƌϮϬϭϬ͕ĞƌůŝŶ͕'ĞƌŵĂŶǇ͘
 – KƌĂůƉƌĞƐĞŶƚĂƟŽŶĞŶƟƚůĞĚ͗dƌĞŐŝŽŶĂůƚƌĂŝŶŝŶŐĐĞŶƚĞƌ
;ZĞdƌĂͿ͕&D'Dh͘WƌĞƐĞŶƚĞĚĂƚƚŚĞϰϮŶĚtŽƌůĚŽŶĨĞƌĞŶĐĞ
ĨŽƌ>ƵŶŐ,ĞĂůƚŚ͕>ŝůůĞ͕&ƌĂŶĐĞ͘
ϮϬϬϳ
ϮϬϬϴ
ϮϬϬϵ
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϭ
15 hours
8 hours
15 hours
ϭϬŚŽƵƌƐ
ϮϬŚŽƵƌƐ
ϭϬŚŽƵƌƐ
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;/ŶƚĞƌͿŶĂƟŽŶĂůĐŽŶĨĞƌĞŶĐĞƐ
 – 39thtŽƌůĚŽŶĨĞƌĞŶĐĞĨŽƌ>ƵŶŐ,ĞĂůƚŚ͕ĂƉĞdŽǁŶ͕^ŽƵƚŚ
ĨƌŝĐĂ
 – tŽƌůĚ&ĞĚĞƌĂƟŽŶWƵďůŝĐ,ĞĂůƚŚƐƐŽĐŝĂƟŽŶŽŶŐƌĞƐƐ͕
/ƐƚĂŶďƵů͕dƵƌŬĞǇ
 – EĂƟŽŶĂůdƵďĞƌĐƵůŽƐŝƐWĂƌĂĚĞĐŽŶĨĞƌĞŶĐĞ͕ĂŶĚƵŶŐ͕
/ŶĚŽŶĞƐŝĂ
 – Eds'ƐǇŵƉŽƐŝƵŵ͕hƚƌĞĐŚƚ͕dŚĞEĞƚŚĞƌůĂŶĚƐ
 – ϰϭƐƚtŽƌůĚŽŶĨĞƌĞŶĐĞĨŽƌ>ƵŶŐ,ĞĂůƚŚ͕ĞƌůŝŶ͕'ĞƌŵĂŶǇ
 – ϰϮŶĚtŽƌůĚŽŶĨĞƌĞŶĐĞĨŽƌ>ƵŶŐ,ĞĂůƚŚ͕>ŝůůĞ͕&ƌĂŶĐĞ
ϮϬϬϴ 
ϮϬϬϵ 
ϮϬϭϬ 
ϮϬϭϬ
ϮϬϭϬ
ϮϬϭϭ
ϰϬŚŽƵƌƐ 
ϰϮŚŽƵƌƐ
ϭϮŚŽƵƌƐ 
8 hours
ϰϬŚŽƵƌƐ
ϰϬŚŽƵƌƐ
Other ϮϬϭϭ 8 hours
2. Teaching
Year Workload  
(Hours/ECTS)
Lecturing
 – >ĞĐƚƵƌĞŽĨƉŝĚĞŵŝŽůŽŐǇĐŽƵƌƐĞĨŽƌŵĞĚŝĐĂůƐƚƵĚĞŶƚƐ͕&ĂĐƵůƚǇ
ŽĨDĞĚŝĐŝŶĞ͕'ĂĚũĂŚDĂĚĂhŶŝǀĞƌƐŝƚǇ;&D'DhͿ͕/ŶĚŽŶĞƐŝĂ
 – >ĞĐƚƵƌĞŽĨƉŝĚĞŵŝŽůŽŐǇĐŽƵƌƐĞĨŽƌŵĂƐƚĞƌƐƚƵĚĞŶƚŝŶ
dƌŽƉŝĐĂů,ĞĂůƚŚƉƌŽŐƌĂŵ͕&D'Dh͕/ŶĚŽŶĞƐŝĂ
 – >ĞĐƚƵƌĞŽŶdƵďĞƌĐƵůŽƐŝƐWƵďůŝĐWƌŝǀĂƚĞDŝǆŽƵƌƐĞ͕dd
ZĞŐŝŽŶĂůdƌĂŝŶŝŶŐĞŶƚĞƌ;ZĞƚƌĂĐͿƐŝĂ͕&D'Dh͕/ŶĚŽŶĞƐŝĂ͘
 – >ĞĐƚƵƌĞŽŶŽƵƌƐĞŽĨdƵďĞƌĐƵůŽƐŝƐKƉĞƌĂƟŽŶĂůZĞƐĞĂƌĐŚ
ŽƵƌƐĞ͕ddZĞŐŝŽŶĂůdƌĂŝŶŝŶŐĞŶƚĞƌ;ZĞƚƌĂĐͿƐŝĂ͕&D
'Dh͕/ŶĚŽŶĞƐŝĂ͘
 – >ĞĐƚƵƌĞŽŶŝŶƚƌŽĚƵĐƟŽŶŽĨŵĂƚŚĞŵĂƟĐĂůŵŽĚĞůŝŶŐŝŶ
/ŶƚĞƌŶĂƟŽŶĂů,ĞĂůƚŚĐŽƵƌƐĞ͕ƌĂƐŵƵƐD
ϮϬϬϵ
ϮϬϬϵ
ϮϬϭϵ
ϮϬϭϬ
ϮϬϭϭ
4 hours
ϮϬŚŽƵƌƐ
ϭϮŚŽƵƌƐ
16 hours
8 hours
^ƵƉĞƌǀŝƐŝŶŐDĂƐƚĞƌ͛ƐƚŚĞƐĞƐ
 – ^ƵƉĞƌǀŝƐŝŶŐŵĂƐƚĞƌƚŚĞƐŝƐĂƚ'DhDĂƐƚĞƌŽĨWƵďůŝĐ,ĞĂůƚŚ
WƌŽŐƌĂŵ;ϮƐƚƵĚĞŶƚƐͿ
ϮϬϬϵ ϮϬŚŽƵƌƐ
Other
 – ŽƵƌƐĞĐŽŽƌĚŝŶĂƚŽƌŽĨƚŚĞƉŝĚĞŵŝŽůŽŐǇĐŽƵƌƐĞĨŽƌDĂƐƚĞƌ
ƉƌŽŐƌĂŵŝŶdƌŽƉŝĐĂů,ĞĂůƚŚ͕&D'Dh
 – ŽƵƌƐĞĐŽŽƌĚŝŶĂƚŽƌŽĨƚŚĞ/ŶƚĞƌŶĂƟŽŶĂůŽƵƌƐĞŽŶ
dƵďĞƌĐƵůŽƐŝƐKƉĞƌĂƟŽŶĂůZĞƐĞĂƌĐŚ͕ddZĞŐŝŽŶĂůdƌĂŝŶŝŶŐ
ĞŶƚĞƌ;ZĞƚƌĂĐͿƐŝĂ͕&ĂĐƵůƚǇŽĨDĞĚŝĐŝŶĞ͕'ĂĚũĂŚDĂĚĂ
hŶŝǀĞƌƐŝƚǇ͕ /ŶĚŽŶĞƐŝĂ͘
ϮϬϬϵ
ϮϬϭϬ
ϮϬŚŽƵƌƐ
ϰϬŚŽƵƌƐ
 

